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Abstract 
Extracorporeal membrane oxygenation is a life support system for infants and 
children with intractable cardiorespiratory failure. The risk for developing 
neurological injuries in this group of patients is considerable. The causes are 
multifactorial and are not yet fully understood. Induction of ECMO involves ligation 
of the major neck vessels – common carotid artery and internal jugular vein – which 
may cause lateralised cerebrovascular injury. Physiologic changes such as hypoxia, 
hypotension and hypercarbia associated with ECMO can disrupt cerebral 
autoregulation.  
Near infrared spectroscopy (NIRS) offers the advantage of continuous non 
invasive means of monitoring cerebral oxygenation at the bedside. To date, NIRS 
systems used clinically are single or dual channel systems and do not allow 
evaluation of the status of cerebral circulation in the extended cerebral regions. 
This work involves the development of a multichannel NIRS system for use in 
paediatric cardiothoracic intensive care with specific application on patients 
supported on extracorporeal circulation. A novel flexible neonatal cap was designed 
and constructed to accommodate an array of sources and detectors that provide 
measurements of multisite cerebral oxygenation from 12 channels.  Multimodal data 
collection (systemic and ECMO circuit parameters) simultaneous  with multichannel 
NIRS was established to allow monitoring of multisite cerebral oxygenation and 
haemodynamics.  
A novel method of analysis, wavelet cross-correlation, was generated to study the 
concordance between multisite oxyhaemoglobin concentration (HbO2) and mean 
arterial pressure (MAP) as a means to investigate regional variations in cerebral 
circulation and assess cerebral autoregualtion. Group data of 6 patients showed 
statistically significant differences in WCC between right and left hemispheres 
during sequential changes in ECMO circuit blood flow. WCC between HbO2 and 
MAP provides a useful method to investigate the dynamics of cerebral autoregulation 
during ECMO. Modest manipulations of ECMO flows are associated with regional 
changes in cerebral autoregulation which may potentially have an important bearing 
on clinical outcome. 
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Chapter 1  
 
INTRODUCTION 
 
 
 
 
 
 
1.1 Motivation and objectives 
The risk of neurological injury for infants and children with cardiac and/or acute 
respiratory defects undergoing surgical procedures which involve the use of 
extracorporeal circulation is considerable. Extracorporeal circulation may refer to 
either mechanical life support, such as extracorporeal membrane oxygenation 
(ECMO), or cardiopulmonary bypass (CPB) for the repair of congenital cardiac 
defects (CHD). The causes for neurological injuries in these patients are 
multifactorial and include preoperative brain malformations, perioperative 
hypoxemia and low cardiac output states, and brain injury occurring during patient‟s 
recovery. Extracorporeal life support in the form of extracorporeal membrane 
oxygenation (ECMO) importantly influences neurological outcome, the causes of 
which are not yet fully understood. Alterations in cerebral blood flow, reoxygenation 
injury, thromboembolism, and loss of pulsatility have been described as possible 
underlying pathomechanisms. With increasing overall survival, the understanding of 
the impact of long term neurologic sequelae on quality of life is crucial. Therefore, 
developing improved monitoring techniques for early detection of neurologic injury 
is highly significant and would both allow intervention on individual patients and 
drive refinements in strategies to reduce risk.  
26 
 
Near infrared spectroscopy (NIRS) offers the advantage of a continuous, non 
invasive means of monitoring cerebral oxygenation at the bedside. In the 1970s 
Jobsis demonstrated that transmittance measurements of near-infrared radiation 
could be used to monitor the degree of oxygenation of certain metabolites. 
Consequently, the diagnostic potential of optical methods was established, and since 
then there is an increasingly widespread use and development of clinical near 
infrared spectroscopy (NIRS). The use of NIRS in cardiopulmonary bypass (CPB) 
for infants suffering from CHD was introduced in the 1990s. To date, even though 
many centres have used this monitoring technique on patients with CHD, there is 
minimum literature on the use of this technique on ECMO patients. Furthermore, the 
primary focus in almost all the NIRS studies so far has been on absolute changes in 
tissue oxygen saturation – a number representing the percentage of oxygenated 
haemoglobin in the field of view. In addition, all the commercially available systems 
have only two channels, thus are not able to measure cerebral oxygenation in all 
regions of the brain. 
The main objective of my work was the development of a multichannel NIRS 
system and its use in an intensive care environment to monitor infants and children 
supported on ECMO. In conjunction with the system development, my work aims to 
develop analysis tools to assess regional variations in cerebral circulation and 
cerebral autoregulation during different ECMO phases. My work, which is described 
extensively in this thesis, forms the initial stages of a project whose long term aim is 
the real time assessment of regional dynamic cerebral autoregulation and 
establishment of a cerebral autoregulation index that will potentially aid clinical 
management. 
 
1.2 Thesis Overview 
Chapter 2 gives an overview of the basic human anatomy and physiology. It 
includes a description of blood circulation, from the function of the human heart to 
oxygen transport to tissue.  The chapter focuses on cerebral circulation with a brief 
description of brain anatomy and an extensive discussion on cerebral blood flow 
including cerebral autoregulation.  
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An introduction to the physics of optics of near infrared spectroscopy (NIRS) is 
given in chapter 3. The chapter also provides a description of the main NIRS 
instrumentation. It describes the dual channel NIRO-200 spectroscopy system 
(Hamamatsu Photonics KK) used for data collection as part of this work and lists 
other main commercially available dual channel systems.  The development and 
clinical application of a commercial multichannel system (ETG-100, Hitachi Medical 
Systems) forms the main part of this work and the hardware, operation and function 
of it are also presented in this chapter. An outline of the main multichannel NIRS 
systems available commercially and developed prototypes is also provided. 
Chapter 4 depicts the clinical background to the project providing a description 
of the physiology and pathophysiology of extracorporeal circulation, in the form of 
extracorporeal membrane oxygenation (ECMO), in infants and children with cardio-
respiratory failure. An overview of the physiology of cardiopulmonary bypass for 
congenital heart defects is also presented. Neurological morbidity on ECMO is 
discussed and non invasive methods of neurological monitoring are outlined. An 
extensive literature review on the use of NIRS technology on infants and children 
placed on ECMO and CPB for CHD is also provided. 
The work carried out with the dual channel NIRS system (NIRO-200) is 
thoroughly discussed in Chapter 5. This chapter describes and discusses the use of a 
dual channel NIRS system to study cerebral and peripheral oxygenation in infants 
and children supported on ECMO. The induction of the instrumentation in the 
intensive care unit, data collection, as well as the clinical protocol are presented. The 
spectral analysis in the Fourier domain in terms of power spectral density and 
coherence for peripheral and cerebral oxygenation are described, and the results are 
presented and discussed. 
Chapter 6 portrays the induction and use of the multichannel NIRS, optical 
topography system, ETG-100, in neonatal cardiac intensive care to study patients 
supported on ECMO. The development of the multichannel system for clinical use 
and application is described. An analytical illustration is given of the design and 
construction of a novel flexible neonatal cap incorporating an array of sources and 
detectors such that oxygenation measurements can be obtained from 12 channels. 
Results obtained with the multichannel system are shown along with systemic and 
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ECMO circuit parameters obtained simultaneously. Absolute changes in 
chromophore concentrations, systemic and ECMO variables are presented for each 
patient individually and discussed. 
Chapter 7 focuses on the results obtained from the multichannel NIRS, ETG-
100, system and presents in detail a novel method of spectral analysis based on 
wavelets. The analysis method uses wavelet-cross correlation (WCC) to investigate 
the relation between MAP and HbO2 as a means of assessing cerebral autoregulation 
in neonates supported on ECMO during alterations in the ECMO flows and during 
weaning off ECMO. The method was also used as a means of assessing regional 
variations during these procedures. The results are presented and discussed 
extensively. 
A summary of the thesis, conclusions and further work are outlined in chapter 8. 
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Chapter 2 
 
BASIC HUMAN ANATOMY AND PHYSIOLOGY  
 
 
 
 
 
 
2.1 Blood circulation in healthy humans 
The cardiovascular system consists of the pulmonary circuit and the systemic 
circuit. The pulmonary circuit consists of arteries and veins that transport blood from 
the right ventricle of the heart to the lungs and back to the right atrium of the heart. 
Oxygenated blood leaving the heart enters the major arteries of the body; it then 
travels through arterioles to capillaries transporting oxygen and nutrients to all 
organs and tissues. Deoxygenated blood then travels through the venules and veins 
before returning to the right atrium of the heart. 
 
2.1.1 Functional anatomy of the heart 
The heart contains four muscular chambers-the right and left atria and the right 
and left ventricles (figure 2.1). The right atrium receives blood from the superior 
vena cava and passes it to the right ventricle through the right atrioventricular 
(tricuspid) valve. From the right ventricle, blood flows through the pulmonary 
semilunar valve into the pulmonary trunk. The pulmonary trunk branches to form the 
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right and left pulmonary arteries, which conduct blood to the gas exchange tissues of 
the lung. From there, blood flows through pulmonary veins into the left atrium. The 
left atrium empties blood into the left ventricle through the left atrioventricular 
(mitral) valve. Then the blood passes to the aorta through the aortic semilunar valve 
which supplies blood to the systemic circuit. 
 
 
Figure 2.1: The cross section of a human heart. Deoxygenated blood from the vena 
cava enters the right atrium, passes to the right ventricle and the then to the lungs 
via the pulmonary arteries. Blood rich in oxygen enters the left atrium via the 
pulmonary veins and passes to the left ventricle and aorta which supply blood to the 
systemic circuit. (Martini 2006). 
 
A complete heartbeat consists of contraction (systole) and relaxation (diastole) of 
the heart chambers and is given the term cardiac cycle. The phases of the cardiac 
cycle – arterial systole, arterial diastole, ventricular systole, and ventricular diastole - 
are shown in figure 2.2. The amount of blood pumped out a single ventricle during a 
single beat is called the stroke volume (SV). 
Figure removed for copyright purposes 
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Figure 2.2: Description of the phases constituting a cardiac cycle. One heart beat or 
one full cardiac cycle lasts about 500 msec in infants and 800 msec in adults.   
(Martini 2006). 
   
 
2.1.2 Arterial blood pressure 
Blood flows because of a pressure gradient. The progressive fall in pressure as 
blood passes through the circulatory system is directly related to resistance. Although 
pumping of the heart causes fluctuations in aortic blood pressure the mean pressure 
remains almost constant. The greatest drop in pressure occurs across the arterioles 
where resistance to blood flow is greatest. Pressure waves at different sites in the 
arterial tree are shown in figure 2.3. Systolic, diastolic, and mean arterial pressures 
(MAP) are the three blood pressure (BP) values typically reported; to interpret a BP 
reading, all 3 must be evaluated. Systolic and diastolic BP are the pressures at the 
highest and lowest points of the arterial waveform, respectively. Mean arterial 
pressure is the average pressure during the entire cardiac cycle and integrates the area 
under the arterial pressure waveform. The value of MAP depends on the shape and 
size of the pressure-wave contour. If a MAP value is not available from a monitor, 
different formulas are available for estimating it. These formulas estimate MAP by 
Figure removed for copyright purposes 
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making assumptions about the shape of the arterial pressure waveform (for example, 
adding one third of the pulse pressure value to the diastolic value) (Stebor and Short 
2005). Systolic and diastolic pressure values in newborns are shown in figure 2.4. 
The principal determinant of the arterial blood pressure is the volume of blood in 
the arteries. Arterial blood volume is directly proportional to blood pressure. Cardiac 
output and peripheral resistance are directly proportional to blood volume and are 
therefore the two major factors influencing blood pressure. Cardiac output is the 
amount of blood that flows out of the heart per unit time (Cardiac output (CO) = 
stroke volume (SV) x heart rate (HR)) (Martini 2006). 
Mechanical, neural and chemical factors regulate the strength of the heartbeat and 
therefore of the stroke volume. The heart rate is influenced by the autonomic nervous 
system, circulating hormones and the venous return. Blood viscosity affects 
peripheral resistance. For a detail description of the factors affecting arterial blood 
pressure the reader is referred to (Martini 2006, Thibodeau and Patton 2007a). 
 
Figure 2.3: Pressure waves at different sites in the arterial tree. With transmission of 
the pressure wave into the distal aorta and large arteries, the systolic pressure 
increases and the diastolic pressure decreases. The quoted pressure values are for 
adults (Smith and Kampine 1990b). 
 
 
Figure removed for copyright purposes 
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Figure 2.4: Average values (dashed lines) and normal ranges (solid lines) for (a) 
systolic and (b) diastolic arterial blood pressure according o birth weight in 
newborn infants. (Versmold et al. 1981) 
 
2.1.3 Oxygen transport to tissue 
Exchange of gases in the lungs takes place between alveolar air and blood 
flowing through lung capillaries. Oxygen from the alveolar air enters the blood 
stream by diffusing down its pressure gradient and carbon dioxide molecules exit the 
blood out into the alveolar air. The amount of oxygen absorbed across the lung in the 
process of pulmonary gas exchange is exactly equal to the amount of oxygen 
consumed by peripheral tissues during metabolism regardless of the status of 
pulmonary function. 
Systemic oxygen delivery (DO2) is the amount of oxygen delivered to peripheral 
tissues each minute or the product of arterial oxygen content times cardiac output 
(CO). DO2 is controlled by cardiac output (CO), haemoglobin concentration, 
haemoglobin saturation, and dissolved oxygen in that order. The normal value for 
DO2 is 4-5 times oxygen consumption (VO2) regardless of the patient size (Levick 
2003). When VO2 changes, secondary to variations in metabolism, DO2 readjusts by 
increasing or decreasing CO to maintain the normal DO2/VO2 ratio. Since the oxygen 
content of normal arterial blood is the same for all ages and sizes of patients (20 cc 
O2/dl), variations in oxygen delivery for patients of different size and metabolic 
activity are caused by variations in CO (Levick 2003). The oxygen content is rarely 
measured directly for clinical applications, and it is standard practice to describe 
Figure removed for copyright purposes 
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blood oxygenation in terms of PaO2 (partial pressure of oxygen in arterial blood) or 
haemoglobin saturation. 
The chief constituent of the erythrocyte is haemoglobin (Hb). Haemoglobin is a 
quaternary protein containing four heme groups each of which contains an iron atom 
(Fe). An oxygen molecule can combine with the iron atom within each heme group 
to form oxyhaemoglobin (HbO2), the primary oxygen carrier. Each gram of 
haemoglobin can unite with 1.34 ml of oxygen so that the exact amount of oxygen in 
the blood depends mainly on the amount of haemoglobin present (Smith and 
Kampine 1990b). Normally the concentration of haemoglobin is 15 g/dl of whole 
blood (Levy and Pappano 2007). If blood is exposed to a sufficiently high oxygen 
pressure so that 100% of Hb is combined with oxygen to form HbO2, it is “fully 
saturated” with an “oxygen capacity” of 20.1 ml/dl of blood or 20.1 vol % 
(Thibodeau & Patton 2007a).  
 
Figure 2.5: Oxygen dissociation curve showing the relationship between partial 
pressure of oxygen (pO2) and the percentage of oxyhaemoglobin (HbO2) saturation 
of the blood. In adults, in the alveoli of the lungs (A) the pO2 is about 100 mm hg, 
which results in 97% HbO2 saturation. in the mixed venous blood returning from the 
tissues, the pO2 has fallen to about 40 mm Hg and the HbO2 saturation is 
approximately 75% (V). In neonates the curve is shifted to the left due to the greater 
oxygen affinity of the neonatal haemoglobin. (adapted from Smith & Kampine 
1990b) 
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Figure 2.6: The influence of pH, pCO2 and temperature on the oxygen dissociation 
curve. Small shifts of the curve to the right which occur in the tissues because of 
lower pH, higher pCO2, and higher temperature, tend to lessen the affinity of Hb for 
oxygen and assist ion release of oxygen to the tissues.(Smith & Kampine 1990b) 
 
The amount of oxygen with which each unit of Hb will actually combine is 
dependent primarily on the partial pressure of oxygen (pO2) to which the Hb is 
exposed. This relationship is defined by the oxygen dissociation curve (figure 2.5). In 
the alveoli of the lungs, where the pO2 is normally at a high level, the blood will be 
about 97% saturated, i.e., 97% of Hb is combined with O2 (A in figure 2.5). After the 
blood has given up some of its oxygen in the tissues and reached the large veins 
(mixed venous blood), its pO2 value would have decreased to about 40 mm Hg, V as 
indicated in figure 2.5, at this pO2 the blood will be only about 75% saturated with 
oxygen. Since mixed venous blood haemoglobin saturation reflects the DO2/VO2 
ratio, it is the most important indicator for managing critically ill patients. While 
oxygen content is determined primarily by the pO2, it is also influenced to a lesser 
Figure removed for copyright purposes 
36 
 
extent by other factors such as pH, pCO2, and blood temperature. A decrease in pH 
or an increase in any of the other three factors will produce a “shift to the right” in 
the oxyhaemoglobin dissociation curve (figure 2.6). The result is that at the same 
pO2, less O2 will be bound to the Hb and consequently more released to the tissues, 
which results in less affinity of Hb for O2. Conversely, an increase in pH or decrease 
in pCO2 and blood temperature will have the opposite effect (i.e. the dissociation 
curve will shift to the left so there is greater affinity of haemoglobin for oxygen). 
Furthermore, the upper “plateau” portion of the curve suggests that large changes in 
pO2 will have relatively little effect on HbO2 saturation than would ordinary be the 
case. On the other hand, in the capillaries, where the pO2 falls sharply, as represented 
by the steep portion of the curve, the tissues have the advantage of being able to pick 
up a large supply of oxygen with only a small decrease in pO2. 
 
2.1.4 Neonatal Circulation 
One of the most interesting aspects of circulatory development reflects the 
differences between the life of an embryo or fetus and that of an infant. Throughout 
embryonic and fetal life, the lungs are collapsed; yet after delivery, the newborn 
infant must be able to extract oxygen from inspired air rather than across the 
placenta.  
 
2.1.4.1 Fetal circulation 
Fetal circulation is shown in figure 2.7. Deoxygenated fetal blood is conducted to 
the placenta via a pair of umbilical arteries, which arise from the internal iliac 
arteries and enter the umbilical cord. Blood returns from the placenta in the single 
umbilical vein, bringing oxygen and nutrients to the developing fetus. The umbilical 
vein drains into the ductus venosus, a vascular connection to an intricate network of 
veins within the developing liver. The ductus venosus collects blood from the veins 
of the liver and from the umbilical vein and empties into the inferior vena cava 
(IVC). The IVC also drains blood returning from the lower trunk and extremities. On 
reaching the heart, blood is effectively divided into two streams by the edge of the 
interatrial septum: (1) one stream passes into right atrium where it is joined by blood 
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from the superior vena cava (SVC) which is blood returning from the myocardium 
and upper parts of body, and (2) a larger stream is shunted to the left atrium through 
the foramen ovale (lying between IVC and left atrium) (Murphy 2005). The foramen 
ovale, or interartrial opening, is associated with a long flap that acts as a valve. 
Although the interartial and interventricular septa develop early in the fetal life, the 
interartial partition remains functionally incomplete until birth. Blood can flow freely 
from the right atrium to the left atrium, but any backflow will close the valve and 
isolate the two chambers. Thus blood can enter the heart at the right atrium and 
bypass the pulmonary circuit. During diastole, blood enters the right atrium and flow 
into the right ventricle, but it also passes into the left atrium through the foramen 
ovale. About 25% of the blood arriving at the right atrium bypasses the pulmonary 
circuit in this way (Martini et al. 2006). Blood flowing through the foramen ovale 
and into left atrium passes into the left ventricle where it is ejected into the ascending 
aorta. This relatively oxygen rich blood passes predominantly to the head and upper 
extremities. A second short-circuit exists between the pulmonary and aortic trunks. 
This connection, the ductus arteriosus, consists of a short, muscular vessel. Because 
of the large pulmonary vascular resistance over 90% of the blood leaving the right 
ventricle passes through the ductus arteriosus and enters the systemic circuit rather 
than continuing to the lungs.  
 
2.2.4.2 Fetal Haemoglobin 
Fetal haemoglobin is the main oxygen transport protein in the fetus during the 
last seven months of development in the uterus and in the newborn until roughly 6 
months old (Murphy 2005). Functionally, fetal haemoglobin differs most from adult 
haemoglobin in that it is able to bind oxygen with greater affinity than the adult 
form, giving the developing fetus better access to oxygen from the 
mother's bloodstream. In newborns, fetal haemoglobin is nearly completely replaced 
by adult haemoglobin by approximately the twelfth week of postnatal life. Fetal 
haemoglobin‟s affinity for oxygen is substantially greater than that of adult 
haemoglobin (Murphy 2005). As a result, the oxygen saturation curve is left-shifted 
for fetal haemoglobin in comparison to the same curve in adult haemoglobin (figure 
2.5). 
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Figure 2.7: Fetal circulation (Murphy 2005) 
 
2.2.4.3 Circulatory changes at birth 
At birth, when the infant takes the first breath, the lungs expand, and so do the 
pulmonary vessels. There is therefore, a dramatic fall in the pulmonary vascular 
resistance and blood rushes into the pulmonary vessels. The increase in pulmonary 
blood flow leads to a large rise in pulmonary venous return to the left atrium. The left 
atrial pressure therefore exceeds the right atrial pressure. This reversal of pressure 
gradient across the atria allows the flap of the foramen ovale to push against the atrial 
septum and the atrial shunt is effectively closed. Although the initial closure of the 
foramen ovale occurs within minutes to hours of birth, anatomical closure by tissue 
proliferation takes several days. As a result, all blood from the right atrium now 
passes into the right ventricle. The ductus arteriosus constricts due to the high partial 
pressure of oxygen. The process is usually complete within 2 days after birth. Other 
changes over several weeks include a reduction in the thickness of the walls of right 
ventricle and the muscle layer of the pulmonary arterioles. 
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Under certain circumstances, the newborn may revert back to a fetal-type 
circulation, a pathophysiological state termed Persistent Fetal Circulation (PFC) 
(Thibodeau and Kevin 2007). In the presence of certain stimuli, such as hypoxia, 
hypercarbia and acidocis, the pulmonary arterioles will constrict and lead to an 
increase in Pulmonary Vascular Resistance (PVR). The increase in PVR favours a 
right to left shunt and the foramen ovale and ductus arteriosus subsequently remain 
patent. In the absence of a placenta for gas exchange, it is clear that this scenario can 
lead to a catastrophic outcome in the newborn. There are two categories of 
congenital heart disease (acyanotic and cyanotic) that result from structural, valvular 
and vascular abnormalities (see chapter 4). 
 
2.2 Cerebral Circulation 
The brain takes up 2% of total body weight but it receives 15% of cardiac output 
(Martini 2006). Oxygen and glucose utilisation are also high compared to other 
organs. Figure 2.8 depicts the arterial structure in the brain. The vascular anatomy is 
unusual in that multiple potential collateral channels exist to supply the high blood 
flow and metabolism. Since the brain is contained within the rigid skull, cerebral 
blood volume must be tightly controlled to prevent elevation of intracranial pressure 
(ICP).  
Blood in the brain is supplied by four major brain arteries, two carotid and two 
vertebral arteries. The carotid arteries contribute about 80% of the total perfusion and 
are therefore more important (Thibodeau & Patton 2007b). The common carotid 
arteries ascend deep in the tissue of the neck and they can usually be located by 
pressing gently along either side of the windpipe until a strong pulse can be felt. 
Each common carotid artery divides into an external and internal carotid artery 
(figure 2.8). The external carotid arteries supply blood to the neck, esophagus, 
pharynx, larynx, lower jaw and face. The internal carotid arteries enter the skull 
through the carotid canals of the temporal bones, delivering blood to the brain. The 
internal carotid arteries normally supply the arteries of the anterior half of the 
cerebellum. The vertebral arteries fuse to form the basilar artery which is 
interconnected with the carotid arteries to form a ring-shaped anastomosis, the circle 
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of Willis (figure 2.9). The circle of Willis helps to balance the blood pressure in the 
anterior and posterior regions and helps to protect the brain against further damage 
should one of these arteries become occluded. The venous return from the brain is 
accomplished through the superficial cerebral veins, deep cerebral veins and cerebral 
venous sinuses and they collectively drain to the internal jugular vein (figure 2.10). 
Figure 2.8: Arteries of the neck and head (Martini 2006) 
 
  
Figure 2.9: Origins of the blood vessels that form the arterial circle (Thibodeau and 
Patton 2007b)  
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Figure 2.10: Major veins of the head (Thibodeau & Patton 2007b) 
 
 
2.2.1 Basic anatomy of the human brain 
The brain, in conjunction with the spinal cord, forms part of the central nervous 
system (CNS). It consists of four main regions, the cerebral hemispheres, the 
diencephalons, the brain stem and the cerebellum (figure 2.11). The cerebral 
hemispheres are covered by an outer layer of grey matter, approximately 5mm thick 
(adults), known as the cerebral cortex. The surface of the cerebral hemispheres is 
highly convoluted consisting of ridges called sulci and deeper ridges called fissures, 
increasing the surface area of the cortex. The fissures separate the hemispheres into 
lobes (figure 2.12).   
The brain is protected by several layers: the scalp, skull, various membranes 
(meninges) and the cerebrospinal fluid (CSF). A cross section of the brain illustrating 
its protective layers is shown in figure 2.13. Pia matter covers the surface of the 
cortex tightly. The arachnoid mater, surrounds the pia matter loosely, without 
following the contour of the cortex. The space in between pia and arachnoid matter, 
namely subarachnoid space, is filled with the CSF and contains the blood vessels that 
serve the brain.  
Figure 2.14 shows the skull of a term neonate. The plates of the skull are not 
fused and fontanelles exist, composed of fibrous tissue rather than bone. The skull is 
soft and thinner than in an adult, and therefore likely to transmit near infrared (NIR) 
light more readily than the adult skull. The face-to-cranium ratio is 1 to 8 rather than 
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1 to 2 in the adult. Skull sizes and shapes vary between infants of the same 
gestational age, including the effects of illness and deformities. A plot of head 
circumference with age is shown in figure 2.15. 
 
 
Figure 2.11: Divisions of the brain (Thibodeau & Patton 2007b) 
 
 
Figure 2.12: Lobes of the brain (Martini 2006) 
 
 
 
Figure 2.13: Coverings of the brain (Thibodeau & Patton 2007b) 
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Figure 2.14: The skull of a term neonate (Hall-Craggs 1995). 
 
 
 
 
 
Figure 2.15: Head circumference charts for girls and boys from birth to 18 years 
(Nellhaus 1968). 
 
 
2.2.2 Cerebral Blood Flow (CBF) 
As in other vascular beds, the volume of inflow of blood to the brain depends 
upon the interplay of the various factors which on one hand determine the perfusion 
or effective head pressure and, on the other, the resistance to blood flow offered by 
the vessels. Cerebral blood flow can be expressed as being directly proportional to 
the cerebral perfusion pressure (CPP) and inversely proportional to the 
cerebrovascular resistance (CVR) (Steiner and Andrews 2006).  
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The simplest way of expressing CPP is to consider it as the net head of pressures 
forcing blood through the cerebral vessels and it is therefore the difference between 
the mean arterial (MAP) and jugular venous (JVP) pressures (Czosnyka and Pickard 
2004). In some tissues there is a third pressure to consider and this is the pressure 
external to the blood vessels because if high this pressure can restrict flow through 
the tissue. Such a situation exists in the brain where the external pressure is the 
intracranial pressure (ICP). Consequently, CPP = MAP − ICP (if ICP is higher than 
JVP) or CPP = MAP − JVP (if JVP is higher than ICP) (Walters 1998). Because JVP 
is very small, it is often disregarded and perfusion pressure is assumed to be 
equivalent to mean arterial pressure (MAP). 
 
2.2.2.1 Cerebral Autoregulation 
A characteristic feature of the cerebral circulation while the brain is in a resting 
state, is its ability to maintain total and regional blood flows relatively constant over 
a wide range of arterial blood pressures (Busija and Heistad 1984). The 
independence of cerebral blood flow from arterial blood pressure typically is called 
cerebral autoregulation (Busija 1993). The brain maintains its blood flow largely, but 
not completely, constant by vasodilation during decreases and vasoconstriction 
during increases in perfusion pressure. The resulting autoregulation curve, as 
depicted schematically in figure 2.16, thus represents a steady state relationship 
(Kuschinsky 1996). Autoregulation is the process which maintains CBF constant 
over a wide range of arterial blood pressure (60-140 mmHg in adults) (Edvinsson 
1993). However, there are certain limits beyond which the autoregulatory system 
fails; this results in cerebral oedema if the pressure exceeds approximately 
140mmHg (adults) and cerebral ischemia due to lack of flow if the pressure falls 
below about 60mmHg. In infants and children there is an incomplete understanding 
the limits of cerebral autoregulation (Brady et al. 2010b). The range of 
autoregulation and its upper limit is thought to be changing with gestational age and 
it can range from 45 mmHg to 100 mmHg at 33 and 47 weeks gestational age, 
respectively (Ramaekers et al. 1990). Blood flow in the brain is often better regulated 
than in most other organs. The arterial vessel wall allows its diameter to expand 
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about 4-fold, resulting in a 256-fold change in blood flow to suit the arterial pressure 
variation. Total absence of autoregulatory mechanisms would result in a flow-
pressure relationship that would be concave to the pressure axis because of the 
elasticity of the vasculature (Purves 1972). In such a situation, an increase in 
perfusion causes a passive distension of the cerebral vessels. 
 
 
 
Figure 2.16: The cerebral autoregulation curve. Cerebral blood flow is constant 
under a wide range of mean arterial pressures (Kuschinsky 1996). 
 
 
A number of mechanisms have been suggested to explain the nature of 
autoregulation: i) the myogenic mechanism in which the arterioles and small arteries 
constrict or dilate as an intrinsic response to an increase or decrease in the transmural 
pressure gradient, ii) the metabolic mechanism in which changes in the metabolic  
microenvironment are thought to be responsible for the vasomotor response, and iii) 
the neurogenic mechanism in which perivascular nerves have been proposed to play 
a role in the cerebral autoregulation. For more details on the mechanisms of 
autoregulation the reader is referred to (Edvinsson 1993) and (Kuschinsky 1996). 
The assessment of cerebral autoregulation is important for rational clinical 
management of specific conditions. In adults, these include severe head injury, acute 
ischemic stroke or subarachnoid haemorrhage, which are known to abolish 
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autoregulation. Preterm infants and infants and children supported on extracorporeal 
circulation, either in the form of mechanical support (i.e. ECMO) or CPB, are patient 
groups where impairment of cerebral autoregulation is also evident. The risk factors 
associated with loss of cerebral autoregulation in ECMO patients are discussed in 
chapter 4. A major aim of the work included in this thesis is the development of 
novel methods of analysis to assess cerebral autoregulation in infants supported on 
ECMO. Hence, the subject of cerebral autoregulation, including a detailed 
description of existing and novel methods of assessing cerebral autoregulartion is 
presented in chapter 7. 
 
2.2.2.2 Blood gases and cerebral blood flow  
The cerebral arteriolar response to CO2, pH and O2 can also alter the blood flow 
significantly. The response of these vessels to CO2 is the strongest and it is generally 
accepted that CBF is increased by a raised arterial pCO2 and a lowered arterial pO2. 
In contrast, CBF is decreased by a lowered arterial pCO2. Figure 2.17 shows the 
response of cerebral circulation to changes in pCO2 and pO2. 
 
 
Figure 2.17: Effect of pCO2 (left) and pO2 (right) on cerebral blood flow. The 
steepest pat of the pCO2 is near 40 mm Hg, indicating a high sensitivity of CBF to 
pCO2 at physiological levels. At normal pO2 levels of 80 to 120 mm Hg, the effect of 
CBF is practically nil. (Smith and Kampine 1990a) 
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Effects of CO2 
The changes of CBF with variations of the arterial pCO2 are basically mediated 
by concomitant changes in the pH of the brain tissue. The highly diffusible nature of 
CO2 evades the blood brain barrier causing changes in the pH of the perivascular 
fluid (CSF). When CO2 is dissolved into water it forms a weak acid, called carbonic 
acid (H2CO3), and the topical application of low-pH solutions induces vasodilation. 
Therefore, an increased arterial pCO2 (or hypercapnia) provokes an increase in the 
size of pial arteries. CO2 exerts its cerebrovascular effects by modulating 
extracellular pH in the immediate vicinity of the smooth muscle cells. 
Effects of O2 
In contrast to effects of altering pCO2, a decrease in arterial pO2 leads to an 
increase in CBF whereas an increase of arterial pO2 beyond the normal values has no 
effect. Hypoxia, or inhalation of low oxygen partial pressure, causes dilation of the 
pial arteries, whereas hyperoxia, or high oxygen partial pressure, causes a moderate 
vasoconstriction. 
 
2.2.3 Cerebral haemodynamic oscillations 
The presence of haemodynamic oscillations in the brain have been studied widely 
by different techniques, such as laser Doppler flowmetry (Hudetz et al. 1992), 
transcranial Doppler sonography (Zhang et al. 1998) and near infrared spectroscopy 
(NIRS) (Obrig et al. 2000). In general, these oscillations can be characterised as fast 
(originating from heart rate (HR) (1-2.7Hz) and respiratory rate (RR) (0.2-0.5Hz) 
(table 3.1)) and slow (<0.1Hz) spontaneous periodic oscillations. The use of NIRS in 
detecting oscillations in a wide range of frequencies (0.1-5Hz) was established by 
Chance et al. (1993). Elwell and coworkers (Elwell et al. 1999) demonstrated the 
presence of RR and HR in NIRS signals in human adults (figure 2.18). Similarly, 
oscillations related to RR and HR have also been observed in neonates (Roche-
Labarbe et al. 2007).  
 
 
48 
 
 
Figure 2.18: An example measurement showing the existence of systemic influence 
on the ΔHbO2 signal (Elwell et al. 1999).Respiratory and cardiac oscillation are 
shown by the nasal airflow and pulse waveforms, respectively. These oscillations are 
reflected in the HbO2 signal. 
 
 
Table 2.1: Respiration rate and heart rate in infants and children. 
Age Respiration rate Heart rate 
  
Breaths per minute 
High Low 
Beats per minute Beats per minute 
Birth-1 year 30-36 160 100 
1-3 years 24-40 150 90 
3-6 years 22-34 140 80 
6-12 years 18-30 130 70 
12-18 years 12-16 120 60 
 
 
The origin of the slow spontaneous periodic oscillations is unclear. They occur 
without any overt stimulus (spontaneity), they can be differentiated from other 
oscillatory phenomena (slowness) such as the HR and RR cycles, and they are 
altered by pharmacological and pathological conditions (modulability) (Obrig et al. 
2000). NIRS studies have revealed slow oscillations of the haemoglobin oxygenation 
state of infants (Livera et al. 1995). Taga et al. demonstrated, with the use of a NIRS 
multichannel optical topography system, that spatially synchronised slow oscillations 
of haemoglobin oxygenation state exist throughout the occipital cortex of neonates 
(Taga et al. 2000). The presence of slow spontaneous oscillations may be more 
significant in the oxyhaemoglobin signal measured by NIRS, rather than in the 
Figure removed for copyright purposes 
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deoxyhaemoglobin (or total haemoglobin) signal (Elwell et al. 1999, Obrig et al. 
2000). Also, hypercapnia may attenuate these oscillations (Obrig et al. 2000). 
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Chapter 3 
 
NEAR INFRARED SPECTROSCOPY: THEORY AND 
INSTRUMENTATION 
 
 
 
 
 
 
3.1 Light propagation in tissue 
In the 1970s Jobsis demonstrated that transmittance measurements of near-
infrared radiation could be used to monitor the degree of oxygenation of certain 
metabolites (Jobsis 1977). Consequently, the diagnostic potential of optical methods 
was established, and since then there is an increasingly widespread use and 
development of clinical near infrared spectroscopy (NIRS). 
Near infrared spectroscopy offers a safe, non-invasive means of monitoring 
cerebral and peripheral oxygenation. The technique has its basis on the fact that 
biological tissue is relatively transparent in the near infrared (NIR) region of the 
spectrum (600-1000nm). However, human tissue contains a variety of substances (or 
chromophores) with well defined absorption spectra at NIR wavelengths. 
Chromophores, whose concentration remains constant with time include, water, 
melanin, and bilirubin. Conversely, chromophores, such as oxygenated haemoglobin 
(HbO2), deoxyhaemoglobin (HHb), and oxidised cytochrome oxidase (CytOx), have 
concentrations in tissue which are strongly linked to tissue oxygenation and 
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metabolism. When chromophores in tissue are present in sufficient quantities, they 
can contribute significant attenuation to measurements of transmitted light. Light 
interaction with tissue involves scatter and absorption; the amount of each depending 
upon the type of tissue illuminated and the wavelength of incident light.  
 
3.1.1 Light Absorption 
The quantitative relationship between light 
absorption in a non-scattering, absorbing  
medium dissolved in a non-absorbing solution 
and the thickness of the medium was firstly 
determined by Bourger in 1729 and then by 
Lambert in 1760. They demonstrated that when 
light with intensity I is incident on a medium 
with successive layers of thickness δd the same 
fraction (dI) of the incident intensity I is absorbed 
(figure 3.1). The mathematical expression in known as Lambert-Bouguer: 
d
I
dI
a
     (3-1) 
where µa is a constant known as the absorption coefficient, usually expressed in cm
-1
. 
The absorption coefficient, μa, represents the probability of a photon being absorbed 
per unit length of travel. The reciprocal, 1/ μa, is called the absorption pathlength. 
Integration of the above expression gives: 
daeII 0      (3-2) 
Alternatively, the above expression can be expressed in base 10 logarithms: 
kdII 100      (3-3) 
µa 
d 
Figure 3.1: Light absorption 
in a non scattering medium. 
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where k is known as the extinction coefficient, expressed in cm
-1
. In 1852 Beer 
determined that the absorption coefficient of an absorbing compound is linearly 
dependent to its concentration c when dissolved in a non-absorbing solution: 
caa       (3-4) 
where a is the specific absorption coefficient measured in molar
-1
.cm
-1 
(Beer 1852). 
Substituting for μa in the Lambert-Bouguer law gives what is known as the Beer-
Lambert law: 
dcaeII 0 or  
dcII 100     (3-5) 
where ε is the specific extinction coefficient, usually expressed in units of molar-
1
.cm
-1
. 
The absorbance, A, of a medium (in optical density (OD)) is defined as the log10 
ratio of the incident and transmitted intensities: 
I
I
A 010log        (3-6) 
    dc        
In a solution containing a mixture of n absorbing compounds, the total absorbance is 
the sum of the individual extinction coefficients multiplied by the distance d 
dkkkA n )...( 21                       (3-7) 
dccc nn )...( 2211       
The Beer-Lambert law assumes a monochromatic and perfectly collimated beam, and 
that the sum of the transmitted and absorbed light equals the incident light. 
Therefore, it does not take into account losses due to reflection at the surface of the 
medium and most importantly scattering of light.  
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3.1.2 Absorbing compounds in tissue 
Biological tissue can be approximated as a homogeneous mixture of compounds, 
whose overall light absorption in tissue, at a given wavelength, depends on the type 
and concentration of the present chromophores. Each chromophore has its own 
distinctive absorption spectrum. The chromophores of interest for NIRS are those 
whose absorption characteristics vary with oxygenation status. However, 
chromophores whose concentration is likely to remain constant still contribute to the 
total loss of light in tissue. It is therefore important to look at the wavelength 
spectrum over which useful physiological information can be revealed from both 
types of tissue chromophores. 
 
Figure 3.2: Absorption spectrum of pure water over the range 200-2000nm and 650-
1000nm (Elwell 1995). 
 
Water 
The content of water in the in humans varies with tissue type, gender and age. In 
the neonatal brain water comprises 90% by mass, whereas in the adult skeletal 
muscle is around 74% (Woodard and White 1986). It is therefore considered to be 
the dominant tissue chromophore in spectroscopic measurements. The extinction 
spectrum of water is shown in figure 3.2. It can be seen that there is a relatively low 
absorption region between 600 and 900 nm. Beyond 900nm the absorption increases 
rather rapidly and peaks around 970nm followed by a minor trough and a more 
pronounced increase at longer wavelengths. The “window” transparency in the 
Figure removed for copyright purposes 
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region of low absorbance allows NIR spectroscopic measurements through several 
centimetres of tissue to be made. 
Lipids 
Lipids are present in subcutaneous tissue and constitute about 2.6% in newborns, 
6.1% in infants (18 months), and 11.6% in children (3-18 years) and adults (Cope 
1991). The extinction spectrum of lipids is similar to that of water (figure 3.3). 
However, the water content is much higher than lipids in the human brain and 
absorption in the later can be considered negligible. As with water, lipids are treated 
as a static absorption with a fixed concentration through the duration of 
measurements. 
 
Figure 3.3: Spectrum of pork fat in the NIR from 650 to 1000 nm. (van der Zee 1992) 
 
Haemoglobin 
Haemoglobin is carried in the red blood cells, or erythrocytes, and constitutes 40-
50% of the total blood volume, the balance being plasma (Marieb 1998). 
Haemoglobin consists of four haem groups each of which contains an iron atom in its 
ferrous (Fe
+2
) form. Iron atoms in haemoglobin physically bind to oxygen molecules 
to form oxy-haemoglobin (HbO2).  The de-oxygenated form, when the oxygen 
molecules separate from the iron atoms in the body tissue, is known as de-
oxyhaemoglobin (HHb). The sum of HbO2 and HHb give the total haemoglobin 
(HbT) in the body, which gives a good approximation of the blood volume. Arterial 
blood is about 98% oxygen saturated and has a bright red colour, whereas venous 
 
Figure removed for copyright purposes 
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blood is about 70% oxygenated and has a purple colour. Figure 3.4 shows the 
absorption spectra of HbO2 and HHb in the NIR region of the spectrum. The two 
absorption spectra differ significantly, hence the visible colour difference between 
venous and arterial blood. It can be seen that the two spectra cross at about 800nm, 
the isobestic point. Making simultaneous spectroscopic measurements at a minimum 
of two wavelengths around the isobestic point allows HbO2 and HHb to be monitored 
separately. 
 
 
Figure 3.4: Specific absorption spectra of HbO2 and HHb in the NIR. (Cope 1991) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: The difference absorption spectrum between the oxidased and reduced 
forms of cytochrome oxidase. (Cope 1991) 
 
 
 
Figure removed for copyright purposes 
Figure removed for copyright purposes 
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Cytochrome Oxidase 
Cytochrome oxidase (CytOx) is the terminal enzyme in the cellular respiratory 
chain, and is located in the mitochondrial membrane. The absorption spectrum of 
CytOx depends on its redox state which in turn depends on the availability of oxygen 
in the cells. The absorption spectrum of CytOx in its oxidised state shows a broad 
peak around 830nm. This peak is not present in its reduced state. This makes it 
possible to make inferences on the availability of oxygen in the cellular level by 
measuring the difference between the oxidised and reduced forms of CytOx (figure 
3.5). Although the magnitude of the absorption coefficient is similar to haemoglobin, 
the concentration of CytOx in tissue is low relative to that of haemoglobin, thus 
making it difficult to determine its absorption spectrum (Tachtsidis et al. 2007).  
 
3.1.3 Light Scattering  
 
Light scattering in tissue arises due to 
refractive index mismatch at a cellular 
(microscopic) scale. The highest contribution to 
scattering results from refractive index 
variations between the cell membranes and 
organelles within each cell. This can be 
attributed to the fact that they account for a 
large proportion of the solid content of tissue. 
Conversely, red blood cells account for approximately 2% of the solid content and 
their contribution to scattering is considered to be low (Cope 1991).  Scattering is the 
dominant mechanism in light propagation through tissue. Even for thin, sub-
millimetre, sections of tissue, injected photons are likely to be scattered several times 
before they reach the boundary. As a consequence a coherent, collimated input laser 
beam will be effectively incoherent and isotropic after traversing a few millimetres 
of tissue. Even though it has a dominant effect in light attenuation, scattering effects 
do not change over time and they are thus considered to be negligible when 
calculating the changes in chromophores concentrations. 
Figure 3.6: Attenuation of light 
through a scattering medium. 
d 
µa 
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Scattering deflects photons from their path, increasing their pathlength when 
traversing tissue and subsequently increasing their probability of being absorbed 
(figure 3.6). The scatter coefficient μs, for a medium containing a single type of 
scattering component, represents the probability of a photon being scattered per unit 
length of travel and can be defined as:  
)exp(0 dII s      (3-8) 
where I is the non-scattered light after traversing a non-absorbing sample of 
thickness d. The scattering pathlength, 1/μs is the average distance a photon travels 
between consecutive scattering events. In a simplistic model the path of single 
photon can be approximated to be the linear combination of scattering and 
absorption: 
ast      (3-9) 
The above expression is valid in the ideal case of a single scattering event within a 
medium. In reality, there are many systems, such biological tissue, for which the 
assumption that the particles are independent of one another is invalid and multiple 
scattering becomes important.  
 
Figure 3.7: Schematic illustrating the scattering phase function )ˆ,ˆ( ssf  
 
 
When a photon that is incident along a direction described by the unit vector 
sˆ experiences a scattering event, the angular probability of it being scattered into the 
direction sˆ  is given by the normalised phase function )ˆ,ˆ( ssf . This is illustrated in 
figure 3.7. For random, soft tissues it can be assumed that the probability distribution 
is a function of the angle between the incident and scattered photon only, and does 
not depend on the angle of incidence relative to the scatterer. Hence, the phase 
function can be conveniently expressed as a function of the cosine of the scattering 
)ˆ,ˆ( ssf  
sˆ  
sˆ
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angle cosˆˆ ss . When measuring light scattered many times by biological tissue, 
the precise form of the phase function is less relevant and can be represented by g, 
the mean cosine of the scattering angles or anisotropy factor:  
4
ˆcos sdsg      (3-10) 
For g = 1, all radiation travels along the forward incident direction, and for g = 0 
scattering is entirely isotropic. Scattering in human tissue is strongly forward 
directed with typically in the range 0.69 ≤g ≤0.99 (Cheong et al. 1990). Despite this 
forward scattering, typical values of the scattering coefficient ensure that photons 
travelling through a few millimetres of tissue quickly loose all of their directionality 
and thus become isotropically distributed. Therefore, it is often appropriate to assume 
isotropic scattering where the scattering coefficient has been reduced be a factor (1-
g): 
)1( gss     (3-11) 
where μs´ is the transport scattering coefficient or effective number of “isotropic” 
scatterers per unit length. Hence, the expression for the transport attenuation 
coefficient becomes: 
ast      (3-12) 
 
3.1.4 Models of light transport in tissue 
The time-dependent diffusion equation is an approximation of the radiative 
transfer equation (RTE) and is one of the most widely used analytical models of light 
transport through highly turbid media (Arridge et al. 1992). In the RTE wave 
phenomena such as polarisation and interference, and particle properties such as 
inelastic collisions are ignored. Consequently, the RTE is the expression of the 
balance of energy inside a volume element of the scattering medium. The equation 
describes the behavior of the energy radiance )ˆ,,( strI

, i.e., the energy, moving in the 
direction sˆ , per unit of solid angle, per unit of time, and per unit of area normal to the 
sˆ  direction: 
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)ˆ,,(1 2
4
strSsdstrIssfstrIstrIs
t
strI
c ssa


          
(3-13) 
where c is the speed of light inside the diffusing medium, μs and μa are the scattering 
and absorption coefficients, respectively. )ˆ,,( strS

is the source term, and )ˆ,ˆ( ssf  is 
the scattering phase function. The terms on the left of the RTE represent change of 
the energy radiance in time, change in energy flow, loss due to absorption and 
scattering, respectively and they balance with the terms on the right, gain due to 
scattering sources and gain due to radiation sources.  
The RTE is a complicated equation and it is almost impossible to obtain 
analytical solutions. The diffusion equation  
),(),(),(
),(1 2 trStrtrD
t
tr
c a


  (3-14) 
where c is the speed of light in the medium, Φ( r

,t) the photon fluence rate, 
4
ˆˆ,,, sdstrItr

     (3-15) 
D the diffusion coefficient,  
))1((3
1
sa g
D     (3-16) 
and S( r

,t) the photon source is an analytical approximation to the RTE used to 
describe photon migration through highly diffusing media. The approximation is 
valid when scatter dominates over absorption ( as ) when detected light is 
effectively diffuse (i.e. when the source detector separation sd /1 ). 
Analytical solutions to the diffusion equation exist in the form of Greens 
functions for various simple geometries including a slab (Contini et al. 1997, 
Patterson et al. 1989). For semi-infinite half-space geometry, the solution of the 
diffusion equation for an impulse (δ-function) is expressed as: 
Dvt
r
tctDctrR sa
s 4
exp)exp(
1
)4(),(
22
2/52/3  (3-17) 
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where R is the intensity of the reflected light at a distance r, t is the time from the 
impulse input, µa and µs
’
 are the absorption and transport scattering coefficients 
respectively.  
 
3.1.5 The modified Beer-Lambert Law 
The attenuation of NIR light in tissue is a result of both scattering and absorption. 
Scattering causes approximately 80% of the total attenuation and the remaining 20% 
is due to absorption. Attenuation is defined as the log (base 10) ratio of the incident 
to remitted (reflected or transmitted) intensities 
I
I
A 010log     (3-18) 
where I0 is the incident intensity and I reflected or transmitted intensity. Since 
attenuation is defined in the same way as absorbance, in the case of a non-scattering 
medium, it can be equated with the Beer-Lambert law (equation 3-6) (Delpy et al. 
1988). However, in the case of multiple scattering and absorption, the loss of light 
due to scattering and the increased optical pathlength as a result of scatter need to be 
incorporated to the existing attenuation equation. The attenuation in inhomogeneous 
layers of tissue can be approximated by a modified Beer-Lambert law (MBBL) to 
include an additional pathlength factor due to the effect of multiple scattering (Delpy 
et al. 1988): 
GBdc
I
I
A 010log    (3-19) 
where B  is the dimensionless differential pathlength factor (DPF) that accounts for 
photons extended pathlength and G is the geometry and scattering dependent term 
that accounts for scattering and other boundary losses. The product (d.B) is known as 
the “differential pathlength” or “effective optical pathlength”, and has the units of 
length (cm).  
The scattering component G is generally unknown and is highly dependent on the 
measurement geometry making it difficult to obtain absolute value of attenuation as a 
function of chromophore concentrations. However, under the assumption that G does 
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not change during the measurement period, it is possible to determine changes in 
attenuation. Therefore, the MBLL can be expressed as: 
BdCA     (3-20) 
Consequently, changes of light absorption at multiple wavelengths are mainly due to 
changes in chromophore concentration. In classical spectroscopy, HbO2 and HHb are 
the two common parameters of interest and changes in their concentrations can be 
obtained by solving equation 3-20 at a minimum of two wavelengths. If the number 
of wavelengths exceeds the numbers of chromophores under interest, the accuracy of 
the calculation can be improved by using a multi-linear regression to fit each 
chromophore spectrum (Cope 1991). Therefore, equation 3-20 can be expanded to 
account for the number of chromophores (j) measured and to form a set of 
simultaneous equations: 
dBCCA jijijijii ),(),(),(),()(   (3-21) 
where i corresponds to each of the wavelengths and j to each of the chromophores. 
When solving for HbO2 and HHb the above equation can be rewritten as 
dBHHbHbOA iHHbiHbOi )()(2)( 2   (3-22) 
or expressed as a matrix  
dB
A
A
HHb
HbO
HHb
HHb
HbO
HbO
)(
)(
1
)(
)(
)2(
)(2
2
1
2
1
2
12
  (3-23) 
The dimensions of a matrix depend on the number of chromophores of interest.  
The MBLL conversion matrix above requires the input of the optical pathlength 
which is the product of the optode spacing and the Differential pathlength factor 
(DPF). The DPF is an estimate of the additional distance the photons have to travel 
due to scattering. In highly scattered media, such as tissue, the DPF is not only 
strongly dependent upon the scattering coefficient µs but is also a weaker function of 
the absorption coefficient µa. The relationship between µa and DPF can be 
demonstrated using theoretical data generated using a diffusion equation model of 
attenuation as a function of µa in a scattering and non-scattering medium (Delpy and 
Cope 1997). The attenuation of light as a function of µa for a certain thickness and 
for four different scattering coefficients is shown in figure 3.8 .The differential 
pathlength can be determined by the gradient of the slope. The figure shows that the 
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differential pathlength increases with increasing scattering coefficient and decreases 
with absorption coefficient. The fact that attenuation is not zero at zero absorption 
can be accounted by light scattering at the boundary. Since µa and µs are wavelength 
dependent, the DPF is also dependent upon the wavelength used. The changes in 
attenuation caused by changes in chromophore concentrations are small compared to 
the large constant background and the DPF can therefore be assumed to be constant 
for a given tissue (Franceschini and Boas 2004).  It has been suggested that the 
absorption dependent variation in optical pathlength in physiological measurements 
in the NIR region is often lower than 15% with a typical value of approximately 5% 
(Elwell 1995).  
 
Figure 3.8: Predicted relationship of attenuation as a function of absorption 
coefficient for four different values of scattering coefficient (Delpy & Cope 1997) 
 
 
 
The optical pathlength of photons can be determined using Time domain systems 
(TDS) (Schmidt 1999) or Frequency domain systems (FDS) (Duncan et al. 1993). 
Duncan et al (1995) have reported an age dependence of DPF from a study of 283 
subjects and suggested the following relationship (Duncan et al. 1995): 
81.0
780 07.013.5 yADPF     (3-24) 
DPF780 is the calculated DPF at 780nm and Ay is the age of the subject in years.  
 
Figure removed for copyright purposes 
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3.2 Types of instrumentation 
Several review papers provide a description of the main recently developed NIRS 
instrumentation (Ferrari et al. 2004, Wolf et al. 2007). In general, near infrared 
spectroscopy and imaging systems can be categorised into three different 
measurement techniques: continuous wave (CW), frequency-domain (FD), and time-
domain (TD) systems. 
 
Figure 3.9: Types of measurements techniques used in near infrared spectroscopy 
systems. (a) Continuous wave measurement technique, (b) Time domain 
measurement technique, (c) Frequency domain measurement technique (Hebden et 
al. 1997). 
 
 
 
 
(a) 
(b) 
(c) 
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3.2.1 Continuous wave systems 
CW systems emit light continuously and provide a simple approach to measure 
intensity attenuation (figure 3.9a). A drawback of this type of system is the higher 
sensitivity to tissue immediately below the optodes, due to the so called photon 
measurement density function (PMDF) which typically has a banana-like shape 
(Arridge 1995). Measurements of intensity are not sufficient to separate the effects of 
absorption and scatter at a single wavelength. In general, these systems use the 
modified Beer-Lambert law to derive the relative changes in haemoglobin 
concentration and absolute concentration of the chromophores cannot be obtained. 
Consequently, CW instruments rely on the assumptions that changes in light 
intensity result from absorption changes in tissue and that scattering remains constant 
throughout the measurement. Furthermore, the actual photon pathlength cannot be 
measured using this method but it can be estimated from simulations and earlier 
studies (see section 3.1.5). However, CW systems are compact, relatively 
inexpensive and have fast acquisition rate when compared to TD and FD systems. 
Sections 3.2.4 and 3.2.5 give a detail description of the dual-channel CW NIRO-200 
and the multichannel CW ETG-100 systems which are used in the research carried 
out as part of this PhD.   
 
3.2.2 Time-domain systems 
TD systems use laser sources to emit pulses of light, in the order of picoseconds. 
The emerging intensity is detected as a function of time by fast photon counting 
detectors. In other words, TD systems measure the times of flight (TOF) of photons 
through tissue, providing a temporal distribution known as the Temporal Point 
Spread Function (TPSF) (figure 3.9b). The photon optical pathlength can then be 
calculated using the mean transit time of the scattered photons and the velocity of 
light in tissue (d=vt). Absolute absorption and scattering coefficients, and therefore 
absolute haemoglobin concentrations, can be calculated from the TPSF by using a 
model of the light transport in tissue (Arridge et al. 1992). As one of the early 
development of a TD system, MONSTIR-UCL is an optical tomography system that 
uses 32 time-resolved detectors to generate a sequence of 3D brain images from the 
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light transmitted across layers of tissue (Schmidt 1999). TD systems use expensive 
electronics and even though their photon counting detectors are highly sensitive 
detecting the whole TPSF can be slower compared to other techniques.  
 
3.2.3 Frequency Domain systems 
FD systems use radio-frequency (few hundreds of MHz) intensity modulated 
light sources. The detected signal is compared to a reference signal and the phase 
shift and modulated amplitude decay are recorded, in addition to the attenuated light 
intensity. FD systems record both the amplitude and phase which allows absorption 
and scatter to be separated. The phase shift can then be used to measure the optical 
pathlength, thereby allowing real-time computation of the absolute haemoglobin 
concentrations. Determination of the DPF in this way allows for an estimate of the 
depth resolution which is of great relevance in differentiating between extra- and 
intra-cerebral changes in the measured parameters. These systems are still relatively 
inexpensive and have fast image acquisition (but lower than CW) they are however 
limited by the finite number of modulated frequencies which can be used.  
 
3.2.4 Dual-Channel near infrared spectrometer NIRO 200 
NIRO 200 (Hamamatsu Photonics KK) is a dual channel, continuous wave near 
infrared spectrometer which measures changes in HbO2 and HHb concentrations by 
utilising the MBLL. Furthermore, the NIRO 200 consists of PIN silicon photodiode 
segmented into two and uses spatially resolved spectroscopy (SRS), described in 
section 4.2.1, to give an absolute value of tissue oxygen saturation as a percentage, 
namely Tissue Oxygenation Index (TOI) (Al Rawi et al. 2001, Suzuki et al. 1999). 
TOI is the ratio of oxygenated to total haemoglobin concentrations. 
This NIRS system uses laser diodes as light sources emitting at 3 wavelengths 
(778, 809 and 850nm). Light from the sources is sequentially pulsed and emitted 
through optical fibres which are built into the probe holder. It penetrates and 
propagates through tissue, where it gets absorbed and diffused. It is then detected as 
a function of distance by the segmented photodiode (figure 3.10). The distance 
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between the source and the midpoint of the detector is 4cm. Other commercially 
available single or dual- channel CW systems are listed in Table 1. 
 
  
Figure 3.10: NIRO 200 probe schematic (modified from (Suzuki et al.1999)). 
 
 
 
Table 3.1: List of main commercially available CW single or dual channel near 
infrared spectroscopy systems 
Name of instrument Company Webside 
FORE-SIGHT Casmed, USA www.casmed.com 
INVOS 5100 Somanetics, USA www.somanetics.com 
NIRO-300 Hamamatsu, Japan www.hamamatsu.com 
NIRO-200 Hamamatsu, Japan www.hamamatsu.com 
NIRO-100 Hamamatsu, Japan www.hamamatsu.com 
NIRO-100NX Hamamatsu, Japan www.hamamatsu.com 
OM-220 Shimadzu, Japan www.shimadzu.co.jp 
EQUANOX NONIN, USA www.nonin.com 
NIMO NIROX, Italy www.nirox.it 
ODISsey Vioptix, Inc., USA www.vioptix.com 
 
 
 
3.2.4.1 Spatially Resolved Spectroscopy 
Spatially resolved spectroscopy (SRS) is a NIRS technique used to derive an 
absolute value for mixed venous oxygen saturation. The technique is based in the 
solution of the diffusion approximation equation for semi-infinite half-space 
geometry (equation 3-17). For a continuous wave (cw) system, the light intensity, 
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I( r

), can be expressed as the integral of the reflected intensity, R( r

,t), over time. 
Hence, light attenuation is defined as the negative log of I( r

): 
0
10 ),(log)( dttrRrA

     (3-25) 
By differentiating )(rA

 with respect to r

and substituting for R( r

,t) in equation 3-17 
we obtain: 
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A
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10ln
1
   (3-26) 
By measuring ∂A/∂r at different wavelengths, we can obtain a value for the product 
sa using the above equation. If we assume that s is constant with respect to 
wavelength in the NIR region, then we can replace s with a constant k and obtain a 
value for the relative absorption coefficients k a . However, in reality s decreases 
slightly with respect to wavelength λ (Matcher et al. 1995) and an additional term can 
be added to express s : 
)1( hks     (3-27) 
where h is the normalized slope of s  with wavelength λ, which is fairly constant 
among tissue types and subjects (Matcher et al. 1996, Suzuki et al. 1999). Therefore, 
equation 3-26 can be rewritten as: 
2
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2)(
10ln
)1(3
1
rr
A
h
k a    (3-28) 
Substituting equation 3-4 in the above expression we get: 
)3(
)2(
)1(
1
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kHHb
kHbO
    (3-29) 
where λ1, λ2, λ3 are the 3 wavelengths of the system. If we assume k is constant then 
an index, namely tissue oxygenation index (TOI) representing the ration between 
oxygenated haemoglobin and total haemoglobin can be obtained: 
100
2
2
kHHbkHbO
kHbO
TOI     (3-30) 
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3.2.4.2 Tissue Oxygenation Index (TOI) 
As described in the section above TOI refers to the ratio between the 
concentration of oxy-heamoglobin and the concentration of total haemoglobin in the 
tissue illuminated by the source of the probe. However, the area under the field of 
view is a multi-compartmental system consisting of arteries, arterioles, capillaries, 
venules and veins with a typical arterial: venous volume ratio of 1:3 (25% arterial 
and 75% venous) (An and Lin 2002). Assuming that [HbO2]art and [HbO2]ven is the 
oxyhaemoglobin concentration (in mmolar) of the arterial and venous compartments, 
respectively, and Va and Vv the arterial and venous blood volume per unit mass of 
tissue (in L/g), respectively, then the total oxygenated haemoglobin per unit mass of 
tissue (in mmoles/g) can be represented by (Tachtsidis 2005): 
[HbO2 ] = Va [HbO2 ]art + Vv [HbO2 ]ven   (3-31) 
and the total haemoglobin per unit mass of tissue (in mmoles/g) by: 
)()10(][ 2 baHb VVMWHbHbT   (3-32) 
where Hb is the concentration of haemoglobin in blood (in g/dL), assumed constant 
in all compartments and MWHb is the molecular weight of haemoglobin (mmoles/g). 
Then, by substituting equations (3-31) and (3-32) in the TOI expression we get: 
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Therefore, TOI depends on both the arterial:venous volume ratio and their relative 
oxygenations. It is, however, more sensitive to venous oxygenation than arterial 
oxygenation. By considering the definitions of arterial oxygen saturation 
(SaO2=[HbO2]art/[HbT]art) and venous oxygen saturation 
(SvO2=[HbO2]ven/[HbT]ven), equation (3-33) can be rewritten as: 
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Considering the definition of the Fick equation (Purves 1972): 
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where CMRO2 is the oxygen consumption (in ml of Oxygen/min), k is the oxygen 
combining power of Hb (~1.306 ml of Oxygen/g of Hb) and CBF is cerebral blood 
flow (in ml/min) and Hb is the haemoglobin (in g of Hb/dL of blood), equation (3-
34) becomes (Tachtsidis et al. 2008): 
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The above equation shows that TOI depends directly on the arterial:venous volume 
ratio and CMRO2, and indirectly on CBF. Therefore an increase in TOI can be 
caused by: (i) venous constriction resulting from minor decrease in venous blood 
pressure (BP), (ii) arterial dilation caused by a minor decrease in arterial blood 
pressure (ABP) or a rise in arterial partial pressure of carbon dioxide (pCO2), (iii) a 
decrease in CMRO2 or (iv) an increase in CBF. Conversely, a decrease in TOI can be 
caused by: (i) venous dilation resulting from minor increase in venous BP, (ii) 
arterial vasoconstriction caused by minor increase in ABP or decrease in pCO2, (iii) 
an increase in CMRO2 or (iv) a decrease in CBF. 
 
3.2.5 Multichannel Optical topography ETG-100 
The Hitachi ETG-100 was the first commercial optical topography system. It was 
mainly designed for functional activation studies, and it has been used to study the 
activity of healthy brain and cerebral pathologies in adults, infants and newborns 
(Koizoumi et al 2005; Koizumi et al 2003). The Hitachi ETG-100 system has a 
maximum number of 18 optodes, 10 sources and 8 detectors. It uses laser diodes 
emitting at 2 wavelengths in the NIR region, 780 and 830 nm, and avalanche 
photodiodes as detectors (Kawaguchi et al. 2001, Yamashita et al. 1999). The power 
of each laser diode is fixed to about 1.5 mW
 
for each wavelength. A schematic 
diagram of the system configuration is shown in figure 3.11. Each laser diode is 
modulated at a different frequency between 1 to 8.7 kHz (chosen as to avoid any 
overlap in their harmonic frequencies). NIR light at the two different wavelengths 
reaches the skin of the scalp through a set of optical fibres. The reflected light is 
transmitted via optical fibres to the detecting photodiodes. Frequency lock-in 
amplifiers are used to distinguish signals from the different source-detector pairs. 
Each lock-in amplifier is fed with a reference signal locked to the modulation 
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frequency of the appropriate light source. This method, known as frequency 
multiplexing (FM), allows all of the sources to be illuminated simultaneously, so that 
an image can be obtained more quickly. An analogue-to-digital converter (ADC) is 
used to digitise the signal which can be shown in the monitor of the incorporated PC 
in real time. A disadvantage of this system is the relatively short monitoring period 
which depends on the system‟s capacity depending on the data acquisition rate. A 
sampling period of 0.1s allows for a monitoring period of 50min which might be 
sufficient for functional activation studies but can be insufficient for clinical 
applications. 
 
Figure 3.11: Schematic diagram of the lock in amplifier system used in the Hitachi 
ETG-100 system (Yamashita et al. 1999) 
 
 
The ETG-100 optical topography (OT) system uses the continuous wavelength 
(CW) approach to acquire multi-site HbO2, HHb and HbT concentrations 
simultaneously (Kawaguchi et al. 2001, Yamashita et al. 1999). The multichannel 
system does not give information on tissue oxygen saturation. Three standard 
measurement channel configurations are provided: A two-piece 3x3 configuration 
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usually used for bilateral monitoring, a 4x4 and a 3x5 configurations. Figure 3.12 
illustrates the 3x3 configuration. The illumination (in red) and detection (in blue) 
fibres are arranged alternately in a lattice configuration to maximise the channel 
density with a fixed separation distance of 30 mm. This configuration allows a 
maximum of 24 different measurement locations covering an estimated scalp area of 
6 by 6 cm on each hemisphere.  
 
 
Figure 3.12: ETG-100 OT 3x 3 configurations for bilateral monitoring. Sources are 
shown in red, detectors in blue and the channels are shown in squares.   
 
 
The more recent optical topography systems developed by Hitachi use a greater 
number of source-detector pairs and can obtain measurements from 48 and 120 
channels, ETG-4000 and ETG-7000, respectively. A more important advantage of 
these systems over the ETG-100 system is that the intensities of the lasers can be 
controlled automatically. 
 
3.2.5.1 Other multichannel optical systems 
Various multichannel optical systems for have been developed in various 
research laboratories. Table 2 lists main multichannel optical topography and 
tomography systems available commercially and developed prototypes. Optical 
topography enables two dimensional mapping of the brain activity from the light 
reflectance technique while optical tomography employs the light transmittance 
technique to interrogate deep brain tissue and to generate series of brain-slice images 
(i.e. tomographic map).  
A CW optical topography system was developed at University College London 
that employs 32 laser diodes (16 at 770nm and 16 at 850nm) and 16 avalanche 
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photodiodes. The system uses software incorporating fast Fourier transforms to 
demultiplex multiple source signals which are modulated at different frequencies in 
parallel. This allows for a more flexible, smaller, and less complex system than is 
achievable using traditional hardware demodulation techniques, such as lock-in 
amplifiers. A range of different optical fiber arrays can be used with only minor 
changes being needed to the software. Furthermore, the probe array of this system is 
comprised of multiple source-detector separations. By using multiple distances a 
range of depths can be covered resulting in improve depth resolution and spatial 
accuracy. In addition to the frequency multiplexed scheme, the system can also 
operate in a time multiplexed scheme, which involves illuminating individual laser 
sources in turn for a short period. Although this has the disadvantage of reducing the 
image acquisition rate, the overall signal to noise ratio of the data is increased as 
there is less background light contributing shot noise to the measurement. 
Similar to the UCL optical topography system, the CW4 and CW5 systems 
(developed at Photon Migration Lab, Massachusetts General Hospital and TechEn 
Inc.) are frequency multiplexed where the detected signals are demultiplexed using 
Fourier transformations.  
Among the currently commercially available multichannel optical systems are the 
Dynot (NIRx Medical technologies) and the Imagent (ISS, Inc.). The NIRx system 
uses a time multiplexed scheme, where the sources are illuminated sequentially, 
which decreases the frame rate but has the advantage of increasing the dynamic 
range. The ISS system is unique in quantifying the optical properties of biological 
tissues since it employs the FD technique. Another commercially available system is 
the optical multichannel monitoring (OMM) system, developed by Shimadzu 
Corporation. This is a TD system with up to 16 light sources and 16 detectors and an 
expanded detection dynamic range for measurements with various transmitter-
receiver distances. Simultaneous multi-distance measurements are useful to 
distinguish depth resolution. 
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Table 3.2: List of main multichannel optical systems 
  
Name of 
instrument Type parameters measured 
max. # of 
channels technical referene company/institution (website) 
T
o
p
o
g
ra
p
h
y
 
       
ETG 100 CW HbO2, HHb, HbT (changes) 24 (Yamashita et al. 1999) Hitachi, Japan (www.hitachi.med) 
ETG-4000 CW HbO2, HHb, HbT (changes) 52 Plichta et al 2006 Hitachi, Japan (www.hitachi.med) 
ETG-7000 CW HbO2, HHb, HbT (changes) 120 Koizumi et al 2003 Hitachi, Japan (www.hitachi.med) 
 CW HbO2, HHb, HbT (changes) 20 (Everdell et al. 2005) UCL, London (www. 
Imagent FDS 
HbO2, HHb, HbT (absolute 
value), SO2, µa, µs, DPF 128 Zhang et al 2005 ISS, USA (www.iss.com) 
OXYMON CW HbO2, HHb, HbT (changes) 96 van der Sluijs et al 1998 
Artinis, The Netherlands 
(www.artinis.com) 
              
T
o
m
o
g
ra
p
h
y
 
Dynot CW HbO2, HHb, HbT (changes) 32 Schmitz et al 2005 NIRx, USA (www.nirx.net) 
CW4, CW5 CW HbO2, HHb, HbT (changes) 4 or 58 (Franceschini et al. 2006) TechEn, Inc., USA (www.nirsoptix.com) 
MONSTIR TDS 
HbO2, HHb, HbT (absolute 
value), SO2, µa, µs, DPF 32 Schmitz et al 2000 UCL, London (www. 
OMM-2001 TDS 
HbO2, HHb, HbT (absolute 
value), SO2, µa, µs, DPF 42 (Oda et al. 2003) 
Shimadzu, Japan 
(www.med.shimadzu.co.jp) 
OMM-3000 TDS 
HbO2, HHb, HbT (absolute 
value), SO2, µa, µs, DPF 64   
Shimadzu, Japan 
(www.med.shimadzu.co.jp) 
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Chapter 4  
 
EXTRACORPOREAL CIRCULATION IN INFANTS 
AND CHILDREN 
 
 
 
 
 
 
4.1 Extracorporeal membrane oxygenation (ECMO)  
The history and evolution of paediatric cardiac mechanical support is interrelated 
to the history of cardiopulmonary bypass CPB. In CPB the heart/lung machine is 
used in the operating room (OR) to provide total support of the heart and lungs. 
However, when the heart/lung machine is used with extrathoracic cannulation for 
respiratory and/or cardiac support, the technique is called extracorporeal membrane 
oxygenation (ECMO). 
Reports of the first patients supported for several days by bedside extracorporeal 
devices begun to appear in the literature in the 1970s. Early trials of ECMO were 
marked by both success and failure. In 1976 Bartlett and coworkers (Barlett et al. 
1976) reported the first neonatal ECMO survivor, who was appropriately named 
“Esperanza” (“Hope”). This marked the new era of bedside CPB and presented the 
opportunity to treat intractable cardiorespiratory failure in a population with little 
hope of survival.  
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The indications for paediatric ECMO support can be divided into two groups, (a) 
patients with cardiac failure following open heart surgery and (b) patients with 
respiratory and/or cardiac failure due to a spectrum of diseases, including 
myocarditis, cardiomyopathy, arrhythmia, pulmonary hypertension, meconium 
aspiration syndrome, congenital diaphragmatic hernia (Karl et al. 2006). Therefore, 
there are two principal modes of ECMO support: veno-arterial (VA) ECMO 
bypasses both the heart and lungs and is thus the appropriate type of ECMO for 
patients with circulatory failure, and veno-venous (VV) ECMO provides only 
respiratory support (Karimova and Goldman 2006). Survival to discharge rates of 
patients treated with ECMO for short-term cardiac support are in the range 40-80%, 
depending on the patient‟s diagnosis and underlying pathophysiology 
(Zwischenberger and Barlett 2005). 
 
4.1.1 The ECMO circuit 
Figure 4.1 shows a typical ECMO circuit. The circuit comprises of venous (1) 
and arterial (2) cannulae, pump (3), membrane oxygenator (4), heat exchanger (5), 
bridge (6), venous saturation probe (7), and flow and arterial saturation probe (8). In 
VA ECMO surgeons insert cannulae in the right common carotid artery (RCCA) and 
right internal jugular vein (RIJV). Venous blood drains from the patient by gravity 
and is then pumped through a membrane oxygenator for O2 and CO2 exchange. The 
oxygenated blood then passes through a countercurrent heat exchanger, where it is 
warmed to the desired temperature before emptying from the arterial cannula into the 
aorta. The ECMO bridge allows circulation when the patient is clamed off ECMO 
(i.e. arterial and venous cannulae are clamped off). Venous and arterial saturation as 
well as flow and hematocrit are continuously monitored by the probes on the venous 
and arterial cannulae. VV ECMO bypasses only the lungs and in this case the patient 
has only one double lumen cannula inserted into the RIJV. ECMO circuits may 
incorporate either a roller head pump or a centrifugal pump. A two headed roller 
pump compresses the cannula, thereby pushing the blood through the circuit, and a 
centrifugal pump uses a high speed rotating device that pulls the blood into the pump 
and then accelerates it radially outwards. 
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Figure 4.1: Illustration of the ECMO circuit. Deoxygenated blood leaves the patient 
through the venous cannula inserted in the jugular vein (1), passes through the 
membrane oxygenator (4) where it gets oxygenated and flows back to the patient 
through the arterial cannula which is inserted in the right common carotid artery 
(2). 
  
 
4.1.2 Physiology of ECMO 
 
4.1.2.1 Cannulation 
In contrast to conventional CPB, ECMO cannulation takes place in the intensive 
care unit (ICU). In VA ECMO the cannulation procedure begins by the surgeon 
dissecting the right side of the neck to expose RCCA and RIJV. After exposing the 
RCCA the surgeon pulls the artery out and places clamps distal and proximal to the 
right atrium. It then ligates the artery and inserts the arterial cannula securing it with 
stitches. The same thing is then carried out with the RIJV. The clamps are then 
removed first from the RCCA and then from RIJV and the patient is on ECMO. 
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4.1.2.2 Oxygen delivery in ECMO 
During extracorporeal life support (ECLS), oxygen delivery is controlled by the 
combination of blood oxygenation in the membrane lung, flow through the 
extracorporeal circuit, oxygen uptake through the native lung and CO through the 
native heart.  
The size of the ECMO circuit and extracorporeal flow rate are set so that there 
will be no gas exchange across the native lung. Under this assumption, in VV bypass, 
PaO2 and oxygen saturation will be identical to the values in the mixed venous blood. 
Because of the nature of VV bypass, this saturation will never be higher than 95% 
and typically will be closer to 80%. Improvement in native lung function results in 
increasing arterial oxygenation and the amount of native lung function during VV 
bypass can be identified as the difference between venous and arterial saturation. 
In VA bypass, the perfusate blood is typically 100% saturated. When the lung is 
not functioning the left ventricular ejected blood is identical to the right atrial blood, 
typically with saturation of 75%. The systemic oxygen content is determined by the 
following formula: Systemic O2 content = Perfusate O2 content x (ECC flow/Total 
flow) + LV blood O2 content x (lung flow/total flow), where ECC is the 
extracorporeal circuit flow and LV is left ventricle (Bartlett et al 2005). Thus, during 
VA bypass, an increase in systemic PaO2 may be indicative of improving lung 
function at constant flows, decreasing native CO at constant extracorporeal flow, or 
increasing extracorporeal flow at constant native CO.  
 
4.1.2.3 Blood flow and oxygenation 
The total systemic arterial blood flow is the sum of ECMO pump output and left 
heart output. ECMO pump output is increased to maintain adequate mean arterial 
pressure (>40 mm Hg for the infant) and mixed venous saturation (SvO2>60%) 
(Barlett 2006). Similarly, the arterial oxygen saturation is the weighted average of 
ECMO blood and left heart blood saturations. In the beginning of the ECMO 
treatment, when the patient‟s lungs and/or heart are at their most critical state, 
ECMO pump flow is the principal, or the only, component contributing to systemic 
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arterial flow and oxygen saturation. Later in the course, the patient‟s lungs and/or 
heart start recovering, taking over the ECMO pump, thus the left heart blood is 
assumed to contribute to a greater proportion in the arterial blood flow. This is 
reflected in an improving arterial wave contour on the monitor. 
 
Figure 4.2: Haemodynamics and gas exchange changes during VA ECMO (Barlett 
2006). 
 
 
Figure 4.2 shows the physiology in haemodynamics and gas exchange during a 
VA bypass. This example depicts trends in oxygen consumption (VO2), arterial 
saturation (SaO2) and venous saturation (SvO2) when several changes occur in the 
ECMO circuit (ECC flow), such as flow reduction, blood transfusion, oxygenator 
failure, weaning (Barlett 2006). It also shows what happens to these trends when the 
patient undergoes clinical conditions, such as seizures and bleeding. Initiation of 
ECMO is associated with an increase in SaO2 and SvO2. ECMO flow can then be 
adjusted accordingly so as to maintain SaO2 over 95% and SvO2 around 75%. In this 
case, a decrease in flow is associated with a decrease in SvO2. Seizures are 
associated with an increase in VO2 which causes a decrease in SvO2, due to an 
increase in oxygen extraction. Bleeding is linked with a decrease in venous return 
and therefore a decrease in systemic blood flow, projected as a decrease in SvO2. 
Transfusion allows return of flow to normal. However, if excess transfusion volume 
is given at a constant ECMO flow, the extra blood volume results in an increase in 
patient lung flow, causing systemic hypoxemia (decrease in SaO2) when the lungs 
are not functioning properly, followed by venous hypoxemia. An increase in ECMO 
flow would compensate for this. In the case of oxygenator failure, a drop in arterial 
Figure removed for copyright purposes 
80 
 
and then venous saturation is expected. Weaning from ECMO involves the 
progressive decrease in ECMO flow while maintaining normal arterial and venous 
saturation during constant VO2. 
 
Figure 4.3: Haemodynamics and gas exchange changes during VV ECMO (Barlett 
2006). 
 
Similarly, figure 4.3 shows heamodynamic and gas exchange changes for VV 
ECMO cannulation during the same events as VA bypass above. Unlike VA bypass, 
SaO2 and SvO2 are nearly the same during VV bypass. Changes related to increased 
in VO2, bleeding and transfusion reflect SaO2 and SvO2 in the same fashion. 
Weaning from VV ECMO follows the same pattern as VA ECMO. 
 
4.1.2.4 Pulsatility in blood flow 
The effect of VA on systemic perfusion is reflected in the pulse contour and 
pulse pressure. The extracorporeal pump creates a flow that is essentially non-
pulsalite. Consequently, as more blood is routed through the extracorporeal circuit, 
the systemic arterial pulse contour becomes flatter, then intermittent, and then stops 
all together when total bypass is reached. Typically, VA ECLS is run at about 80% 
of normal resting CO, which allows 20% or more of the blood to pass through the 
lungs and left heart, resulting in a diminished but discernible pulse contour. The 
discussion concerning pulsatile and non-pulsatile flow has been the subject of much 
research. As long as total blood flow and is adequate and mean arterial pressure 
remains within the cerebral autoregulatory range (see chapter 2), fluctuations in the 
Figure removed for copyright purposes 
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pump flow are not physiologically important and do not result in significant changes 
in cerebral blood flow. 
 
4.1.2.5 Weaning from ECMO 
One of the greatest challenges of cardiac ECMO is determining the point of 
which there has been adequate ventricular recovery to allow for a trial of weaning 
from mechanical support. 
During weaning the ECMO flow is gradually reduced over a period of 1-2 hours 
until the lowest safe flow is achieved. If flow reduction does not cause inadequate 
mean arterial pressure and/or oxygen saturation, the arterial and venous cannulae are 
clamped off and the pump is left to re-circulate via the bridge. The patient is 
considered to be off ECMO support and is usually tried off ECMO for a period of 1-
3 hours before a decision about decannulation is made. During this time the cannulae 
are flushed regularly, by removing the clamps and allowing blood to be flushed in 
the patient. This is done in order to avoid clotting in the cannulae. If the patient is 
deemed to have failed the trial off ECMO, as indicated by unstable haemodynamics 
and/or signs of inadequate tissue oxygen delivery, then full ECMO support is 
recommenced. 
 
4.2 Cardiopulmonary bypass for repair of congenital 
heart defects  
Cardiopulmonary bypass (CPB) is a form of extracorporeal circulation consisting 
primarily of a pump, a venous reservoir and an oxygenator. During CPB, 
deoxygenated venous blood returning from the body to the heart is drained out of the 
circulation via venous cannulae into the artificial extracorporeal circuit. Typically, 
the blood collects in a reservoir, from which it is pumped through an oxygenator and 
heat exchanger before being returned to the patient, usually via an arterial cannula 
placed in the ascending aorta, thereby eliminating the need for blood to go through 
the heart or lungs (Jones and Elliott 2004). The overall principle and objective is to 
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provide a bloodless operative field enabling good surgical exposure with prevention 
of end organ function. The safe conduct of CPB in the neonate and infant requires a 
comprehensive understanding of the physiologic alterations associated with CPB. 
These variables include circuit design, hemodilution, altered perfusion, degree of 
hypothermia, acid-base management. 
 
4.2.1 Congenital cardiovascular Defects 
Congenital heart defects result from abnormal cardiac development or 
inappropriate connections between the heart and major arteries and veins. Heart 
defects are among the most common birth defects and are the leading cause of birth 
defect-related deaths. They can be put into four major categories: 
i) Septal defects: defects in the interatrial septum (Arterial septal defects 
(ASD)) or the interventricular septum (ventricular septal defects (VSD)), 
allowing blood to flow from the left side of the heart to the right, reducing 
the heart's efficiency. 
ii) Obstruction defects: Obstruction defects occur when heart valves, 
arteries, or veins are abnormally narrow or blocked. Common obstruction 
defects include pulmonary valve stenosis, aortic valve stenosis, and 
coarctation of the aorta. 
iii) Cyanosis: called such because they result in cyanosis, a bluish-grey 
discoloration of the skin due to a lack of oxygen in the body. Such defects 
include persistent truncus arteriosus, total anomalous pulmonary venous 
connection, tetralogy of Fallot, transposition of the great vessels, and 
tricuspid atresia. 
iv) Hypoplasia: failure of the right ventricle or the left ventricle to develop 
adequately, leaving only one side of the heart capable of pumping blood 
to the body and lungs. Hypoplasia of the heart is rare but is the most 
serious form of CHD; it is called hypoplastic left heart syndrome when it 
affects the left side of the heart and hypoplastic right heart syndrome 
when it affects the right side of the heart. 
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For a more detail description of CHD the reader is referred to (Lissauer and Clayden 
2001). Congenital heart diseases can be surgically corrected by placing the patient on 
cardiopulmonary bypass (CPB). Recovery from cardiac surgery may include placing 
the patient on extracorporeal membrane oxygenation (ECMO). The most serious 
congenital heart defects associated with neurodevelopmental dysfunction are 
transposition of the great arteries (TGA) and hypoplastic left heart syndrome 
(HLHS). Treatments of these two congenital conditions involve complicate surgical 
techniques which include hypothermia and circulatory arrest and can potentially lead 
to neurological complications. 
 
4.2.1.2 Hypothermia 
The principle clinical effect of hypothermia is the reduction in metabolic rate and 
molecular movement (Jaggers and Ungerleider 2006). Figure 2.9 shows the 
relationship between whole body oxygen consumption and body temperature. As 
body temperature decreases both basal and functional cellular metabolism are 
reduced. Therefore, hypothermia allows a reduction in flow rates and facilitates 
surgical exposure by reducing the amount of blood returning to the heart through 
collateral vessels.   
Three methods of CPB are used: (1) mild hypothermia (30 to 34 °C), (2) 
moderate hypothermia (25 to 30°C), and (3) deep hypothermia (15 to 22°C), 
depending on the needs of low flow and the duration of aortic cross-clamp (Jones & 
Elliott 2004). Recommendations for optimal pump flow rates for children are based 
on the body surface area and maintaining efficient organ perfusion as determined by 
arterial blood gases, acid-base balance, and whole body oxygen consumption during 
CPB. Normothermic flow rates for children are based on body weight (table 2.1).  
Also, the use of hypothermia is mandatory for brain protection when prolonged 
periods of circulatory arrest are utilized. In the brain the most important determinant 
of cerebral blood flow (CBF) is cerebral metabolic activity (CMRO2) with regional 
and total CBF increasing or decreasing to match fluctuations in the metabolic 
demands of a region. Cerebral metabolism is reduced 5-7% for each degree Celsius 
reduction in temperature with a smaller but corresponding reduction in CBF (Stump 
et al. 1999).  
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Figure 4.4: Whole body oxygen Consumption as a function of temperature (Jaggers 
& Ungerleider 2006) 
 
While in moderate hypothermia cerebral autoregulation is preserved, during deep 
hypothermic conditions autoregulation of cerebral blood flow is lost and cerebral 
blood flow seems to be more directly correlated with mean arterial blood pressure. 
At deep hypothermia, cellular metabolism is so low and membrane fluidity is 
reduced to such a large extent that cellular basal metabolic needs and cellular 
membrane integrity can be maintained for a relatively long period of time and this is 
probably why the clinical outcomes following periods of deep hypothermia 
circulatory arrest (DHCA) seem to be unaffected by arrest durations below 45 min at 
18 °C (Wypij et al. 2003). The maximum duration of DHCA is unknown. It is logical 
that the period should be as short as possible but long enough to accomplish 
satisfactory surgical repair. Increased periods of DHCA are associated with increased 
brain injury (Jones & Elliott 2004).  
 
Neurologic injury in Cardiopulmonary bypass for congenital heart defects 
The neonate or infant with congenital heart disease constitutes a patient at risk for 
neurologic impairment. This risk seems to have three elements: (1) pre-existing risk 
associated with various congenital heart lesions, (2) injury induced by CPB and the 
various CPB strategies that can be employed by the surgical team, and (3) injury 
sustained during the “vulnerable” period after exposure to CPB. 
Figure removed for copyright purposes 
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In children, the most prominent acute complications are focal and generalized 
seizures, intracranial haemorrhage, and spinal cord infarction. The chronic or late 
sequelae of cardiac surgery include learning disorders, cerebral palsy, gait disorders, 
seizures, and learning disorders (Tasker 2006). Global cerebral hypoperfusion may 
result from a variety of problems, such as incorrect cannulae placement, prolonged 
cardiopulmonary bypass, or inadequate perfusion pressure in the perioperative 
period. 
The most effective means of protecting the brain from cardiopulmonary bypass 
induced injury is hypothermia.
 
The periods or events of particular concern, when the 
brain is at increased risk of neurologic insult, are the active cooling period; the period 
of low-flow cardiopulmonary bypass or total circulatory arrest; and the period during 
weaning and separation from cardiopulmonary bypass. Deep hypothermic circulatory 
arrest can have significant effects on intracranial haemodynamics via effects on 
cerebral blood flow and intracranial pressure. These changes may occur both during 
the surgical procedure and for a significant period after surgery, with the 
consequence of changes or disruption in normal cerebral oxygenation and 
metabolism, and ensuing ischemia (Greeley et al. 1989, Taylor et al. 1992). In 
comparison with deep hypothermic circulatory arrest, low-flow cardiopulmonary 
bypass may, theoretically, maintain some cerebral blood flow (Bellinger et al. 2003). 
However, at the extreme of the low-flow state, the effects of the two techniques on 
cerebral blood flow are indistinguishable (Tasker 2006).  
 
4.3 Neurological morbidity on ECMO 
Since the first use in neonates in 1974, extracorporeal membrane oxygenation 
(ECMO) has been a life-saving technology for newborns. Most patients are placed on 
ECMO due to severe hypoxemia from respiratory failure or decreased oxygen 
delivery from cardiac failure. ECMO has been used to treat a variety of cardio-
respiratory problems, including meconium aspiration syndrome (MAS), persistent 
pulmonary hypertension of the neonate (PPHN), congenital diaphragmatic hernia 
(CDH), sepsis, and cardiac anomalies. Severe respiratory failure has been a major 
cause for return hospitalization and late deaths, but mortality has remained specific to 
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the primary diagnosis prior to ECMO. For example, ECMO patients with the 
diagnosis of CDH or total anomalous pulmonary venous return (TAPVR) have about 
50% mortality while the diagnosis of MAS has a mortality of about 5% (Van Meurs 
et al. 2005b). For all diagnoses, the mortality for newborns placed on ECMO is about 
20% according to the ELSO registry (Van Meurs et al. 2005a). Even though ECMO 
therapy has significantly improved outcome in the newborn, morbidity and mortality 
associated with brain injury is considerable for this population.  
Multiple factors increase the risk of intracranial injury in infants undergoing 
ECMO. The reported frequency of abnormal neuroimaging has ranged from 28% to 
52%, depending on the neuroimaging techniques and methods of classification 
(Bulas and Glass 2005). Patients placed on ECMO as a group have experienced 
significant pre ECMO haemodynamic instability and have been potentially exposed 
to hypoxia, hypotension, alkalosis, hypercarbia, and profound acidosis (Graziani et 
al. 1997a, Von Allmen and Ryckman 1991). Several physiologic changes, including 
asphyxia, hypoxia and hypercarbia, can all disrupt cerebral autoregulation leaving 
the cerebral microcirculations vulnerable to alterations in systemic blood pressure. 
Loss of autoregulation in an already injured brain in the presence of systemic 
heparinisation, such as occurs with ECMO, can result in cerebral haemorrhage (Short 
et al. 1994a). Hypotension before or during ECMO may result in cerebral ischemia. 
Liem and coworkers demonstrated changes on ECMO including increased cerebral 
blood volume, loss of autoregulation, reactive hypoperfusion and hemodilution 
(Liem et al. 1995a). 
In addition, a risk for cerebral injury is introduced by the various aspects of the 
ECMO procedure itself. The ECMO run exposes the patient to carotid artery and 
jugular vein ligation, heparinisation, coagulopathy and hypertension, all of which can 
predispose to neurologic complications (Weber et al. 1996). In addition, alteration of 
blood flow dynamics can similarly affect cerebral blood flow. There has been 
concern that ligation of the carotid artery may cause lateralised cerebrovascular 
injury. Hunter et al in their study of cerebral blood flow using laser Doppler 
flowmetry in newborn lambs, showed that carotid ligation caused a transient (60 
seconds) decrease of CBF in the right cerebral cortex (Hunter et al. 2004). Several 
early studies noted an increase in injuries to the right hemisphere in infants who 
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underwent ligation of the right carotid artery (Hahn et al. 1992, Hofkosh et al. 1991, 
Mendoza et al. 1991). Graziani et al used magnetic resonance angiography and 
demonstrated asymmetric cerebrovascular response to carotid ligation of the right 
versus left middle cerebral artery but they report no selective or greater injury to the 
right hemisphere as compared with the left (Graziani et al. 1997b). Whether or not 
the neuroimaging data sufficiently support increased structural vulnerability to the 
right hemisphere in ECMO treated neonates, some evidence of increased right 
hemisphere vulnerability is present at a functional level. The preliminary question, 
however, is whether there is sufficient neurospecificity in the neonate in regard to 
neuropsychological or motor functions. Selective deficits in receptive and expressive 
language, visual/motor integration, and behaviour problems have been identified in 
early childhood following unilateral brain injury during the perinatal period (Bulas & 
Glass 2005).  
Given the relatively high rate of neuroimaging abnormality among ECMO-
treated neonates, neurodevelopmental outcome studies have been important in 
defining the functional impact. There is growing concern that infants with congenital 
diaphragmatic hernia (CDH) treated with ECMO have a worse neurological outcome 
when compared to infants that were not treated with ECMO and other non-CDH 
ECMO-treated patients (Khan and Lally 2005). Stolar et al. found that 89% for 
infants treated with ECMO for indications other than CDH were cognitively normal. 
In contrast, only 60% of infants with CDH treated with ECMO had a normal 
cognitive outcome (Stolar 1996). McGahrn et al. showed a survival rate of 75% 
among infants with CDH that were treated with ECMO, of which 67% exhibited 
signs of neurological compromise (McGahren et al. 1997). Based on these finding it 
has been suggested that the poor neurological outcome maybe a function of the 
severity of the illness, although independent ECMO factors could not be excluded. 
Numerous investigators have reported on the neurodevelopmental outcome of the 
ECMO patient and consistently report Bayley scores in the normal range in the first 2 
years of life. Fewer studies of ECMO survivors at older ages have been performed. 
Glass et al. reported that by 5 years of age, mean IQ scores remain in the normal 
range, but are lower than controls. Approximately 15% of ECMO survivors at age of 
5 had a major handicap, most commonly mental retardation, while <5% had severe 
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or profound impairment. Nevertheless, 50% of ECMO survivors have an increased 
risk of learning and behavioural problems when compared to normal controls (Bulas 
& Glass 2005). As a result of these deficits, ECMO survivors are vulnerable to 
academic and psychosocial difficulties.  
Neuroprotective strategies are adopted on ECMO which include mild 
hypothermia (Horan et al. 2004). Mild hypothermia has been studied in the context 
of perinatal asphyxia and cardiac arrest and long term neurological outcome is as yet 
not studied in children. Hypercarbia increases cerebral blood flow and can increase 
cerebral oxygenation but can cause cerebral hyperaemia. In addition, it is a systemic 
vasodilator and can improve cardiac output and systemic oxygenation. 
 
4.4 Neurological monitoring on extracorporeal 
circulation 
The most serious complications of the ECMO patient have been neurological 
complications (e.g. learning disorders, motor dysfunction, and cerebral palsy). 
During the ECMO course, frequent neurological examinations should be performed 
and real-time neurologic monitoring should be an integral part of neuroprotective 
strategies for paediatric patients on extracorporeal circulation. Ideally, monitoring 
should allow easy, reliable, and reproducible detection of adverse neurologic events. 
Several monitoring modatilites such as electroencephalograph, transcranial Doppler 
and near infrared spectroscopy are available. 
 
4.4.1 Electroecephalographic monitoring  
Electroencephalography (EEG) examines the electrical activity of the brain. The 
standard EEG records up to 16 channels and was used repeatedly to investigate 
cortical function during and after ECMO. Post-ECMO EEG was used as a predictor 
of neurodevelopmental outcome in ECMO survivors but it was shown that EEG 
abnormalities had no correlation with neurodevelopmental outcome (Kumar et al. 
1999). EEG studies during ECMO, if highly correlated with later definitive 
neuroimaging, might be used to affect the acute clinical care (Gannon et al. 2001). 
However, described pathological findings lack clinical relevance or are found to be 
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poorly predictive for permanent neurological impairment (Goodman et al. 2001, 
Graziani et al. 1994, Trittenwein et al. 2006).  
EEG has also been used in cardiac surgery during CPB and deep hypothermia 
and it has been shown that it can predict the risk of clinical seizures (Lozano and 
Mossad 2004). However, seizure activity on CPB has little predictive value for later 
neurologic outcome in neonates (Hoffman 2006). EEG has also been used as a rough 
guide to anesthetic depth and can be used to determine electrocerebral silence before 
using DHCA .  
EEG is non invasive, continuous and portable but there are several considerations 
limiting its use during extracorporeal circulation. EEG slowing is not specific for 
ischemia or hypoxia and does not differentiate among the effects of anesthetics, 
hypothermia, hypoglecemia, hemodilution, PCO2 changes or extreme hypotension. 
 
4.4.2 Transcranial Doppler 
Trascranial Doppler ultrasound (TCD) is another non invasive technique that can 
be used for neuromonitoring. TCD measures velocities in the proximal segment of 
the middle cerebral artery (MCA), which provides 70% of blood flow to the 
ipsilateral cerebral hemisphere. As such, TCD may facilitate detection of cerebral 
ischemia.  
TCD has rarely been used on ECMO patients but has been used in several studies 
during congenital heart surgery. Weber et al (1994) have used TCD to investigate the 
effects of venous occlusion on cerebral blood flow during ECMO and concluded that 
cephalic venous drainage may help prevent the neurological complication of ECMO 
by maintaining normal cerebral blood flow. TCD also showed slight but significant 
differences in BFV between right and left MCA (Graziani et al. 1994). TCD has been 
used extensively in paediatric cardiac surgery to examine cerebral physiology in 
response to CPB, hypothermia, low-flow bypass, RLFP to the brain and DHCA 
(Andropoulos et al. 2003a, Hillier et al. 1991). A unique contribution of TCD stems 
from the detection of high-intensity transient signals, which signify embolic 
phenomena (O'Brien et al. 1997).  
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TCD allows noninvasive, continuous monitoring of acute changes in blood flow 
velocity caused by perfusion changes and therefore cannula malposition can be 
quickly identified (Rodriguez et al. 2000). However, the validity of blood flow 
velocity measurements as a surrogate of cerebral blood flow relies on the assumption 
that the diameter of the MCA remains constant. CBFV is dependent on the diameter 
of the blood vessel, whereas cerebral blood flow depends on the cerebral vascular 
resistance, which changes in response to changes in CO2, temperature, cerebral 
perfusion pressure, and bypass flow. Reproducibility varies with transducer position. 
TCD velocities reveal trends on changes in CBF and not absolute values. Prospective 
studies addressing the association between cerebral blood flow velocity 
abnormalities measured by TCD and neurologic outcome are necessary.  
 
4.4.3 Near infrared spectroscopy 
Near infrared spectroscopy (NIRS) is a noninvasive optical technique that can 
measure oxyhaemoglobin and deoxyhaemoglobin concentrations and can determine 
cerebral oxygen saturation. For a detailed description of NIRS systems and their 
operation the reader is refer to chapter 3 of this thesis.  
To date there are three commercially available NIRS systems; (1) NIRO 
(Hamamatsu Photonics, Japan), (2) INVOS, (Somanetics Corp., Troy MI) and (3) 
FORE-SIGHT (CAS medical systems, Bradford CT). All three systems use source 
and segmented photodetector pairs to perform spatially resolved spectroscopy and 
obtain an absolute value for tissue oxygen saturation as a percentage. The major 
difference between the NIRO system and the rest is that it provides additional 
information related to the concentrations of oxy- and deoxy-haemoglobin. The NIRO 
system uses differential spectroscopy to obtain relative changes in the concentrations 
of the two chromophores making it possible to identify whether changes in oxygen 
saturation result from changes in blood volume or changes in oxygen consumption. 
An increase/decrease in blood volume causes an increase/decrease in total 
haemoglobin concentration which in return causes a change in oxygen saturation. 
Changes in oxygen consumption are reflected by changes in oxy- and deoxy-
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haemoglobin concentrations in opposite directions so that the total haemoglobin 
concentration stays the same.  
This section reviews the application of NIRS systems in neonatal and paediatric 
patients supported on ECMO and in neonatal patients undergoing cardiopulmonary 
bypass procedures for the correction of congenital cardiac defects. Tissue oxygen 
saturation measured by the various NIRS systems is referred to by different 
acronyms in the literature depending on the system used. For the purpose of this 
chapter a general term is given to tissue oxygen saturation namely tissue oxygen 
saturation (TOS).  
 
4.4.3.1 Near Infrared Spectroscopy on ECMO patients 
The first study on ECMO patients using NIRS was reported in 1995 by Liem et 
al. They investigated cerebral oxygenation in relation to changes in some physiologic 
variables during induction of ECMO in 24 newborn infants. The patients were 
monitored from cannulation until 60 minutes after starting ECMO and 
haemodynamic parameters such as heart rate (HR), mean arterial blood pressure 
(MAP), oxygen and carbon dioxide partial pressures (pO2 and pCO2), and arterial 
saturation (SaO2) were also measured simultaneously. They found that carotid 
ligation causes a decrease in oxyhaemoglobin concentration (HbO2) and increase in 
deoxyhaemoglobin concentration (HHb), while jugular ligation showed no changes. 
Also, HbO2, SaO2, pO2 and MAP showed significant increase 60 minutes after 
starting ECMO compared to precannulation values. These were related to an increase 
in mean blood flow velocity (MBFV) and cerebral blood volume (CBV) which may 
result from loss of autoregulation, reactive hypoperfusion and haemodilution. They 
also report a positive correlation of total haemoglobin concentration (HbT) with 
MAP and negative correlation with pO2 (Liem et al. 1995a). 
The effects of right carotid artery ligation and variations in ECMO flow on 
regional cerebral oxygenation index were investigated by Ejike et al. They used a 
duel channel NIRS system placing the probes on the right and left frontal 
hemispheres. Their study demonstrated no relationship between ECMO flow and 
TOS changes. A brief period of cerebral oxygen desaturation of the right frontal 
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region at the time of right carotid ligation was seen in patients examined during 
cannulation. Right sided TOS remained depressed for 17-45 mins. Following this 
depression in TOS on the right, there was a transient increase in TOS above baseline 
observed in both hemispheres. Periods of “trialling off” ECMO were not related to 
any change in  TOS in either hemisphere (Ejike et al. 2006). 
Van Heijst et al use NIRS to study oxygenation and haemodynamics in left and 
right cerebral hemispheres during induction of VA ECMO in 10 newborn infants. 
They demonstrated that RCCA ligation causes a decrease in oxyhaemoglobin 
concentration and an increase in deoxyhaemoglobin concentration which were 
reversed 60 minutes after initiation of ECMO. Right internal jugular vein (RIJV) 
ligation caused no changes. Although the results suggest a potential ischemic period 
after right common carotid artery (RCCA) ligation, there was no difference in NIRS 
parameters between the right and left cerebral hemispheres (Van Heijst et al. 2004). 
Another study, neonates were monitored with NIRS before, during, and after 
cannulation for ECMO to determine the direct effects of ligation of the main vessels 
in the neck in cerebral oxygenation (Fenik and Rais-Bahrami 2009). They observed a 
decrease in TOS for most subjects during ECMO surgery (ligation of RCCA and 
RIJV), and gradual increase in TOS for the first hours of ECMO.  
NIRS was also used in an animal study to investigate the cause of the 
haemodynamic changes occurring during opening of the bridge in VA ECMO 
infants, demonstrating significant decrease in mean arterial blood pressure with 
associated decreases in cerebral oxygenation and peripheral arterial saturation. The 
cerebral haemodynamic changes were found to be related to an arteriovenous shunt 
over the bridge that may contribute to the occurrence of cerebral ischemia and/or 
intracranial haemorrhages (Van Heijst et al. 2001).  
Rais-Bahrami et al compared cerebral TOS obtained using NIRS with venous 
saturation in 17 VV ECMO neonates and showed a high level of agreement between 
the two (Rais-Bahrami et al. 2006).   
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4.4.3.2 NIRS in neonates with congenital heart diseases 
The use of NIRS technology for the monitoring of the cerebral oxygenation and 
haemodynamics during congenital heart surgery was first reported in 1991 by 
Greeley et al (Greeley et al. 1991). Since then, the application of NIRS has gained 
increasing interest. Several review articles capture the widespread acceptance of 
NIRS in the field of neonatal and paediatric cardiac surgery (Andropoulos et al. 
2004a, Chakravarti et al. 2008, Hirsch et al. 2009, Hoffman 2006, Lozano and 
Mossad 2004, Williams and Ramamoorthy 2007). A comprehensive publication list 
of the application of NIRS in neonates with CHD preoperatively, intraoperatively 
and postoperatively is shown in table 4.1. 
NIRS has been used preoperatively to study the indication of hypoxia-ischemia in 
patients with CHD prior to cardiac surgery (Ramamoorthy et al. 2002). A 
comparison of cerebral TOS between healthy patients and patients with CHD has 
shown that cerebral TOS varies with anatomy and arterial saturation (Kurth et al. 
2001). It has been shown that cerebral TOS in patients with acyanotic lesions is 
similar to healthy subjects, in contrast with cyanotic patients where cerebral TOS 
was decreased. In addition, Toet el al. have shown that lower TOS obtained prior to 
arterial switch operation are related with lower DQ (developmental quotient) (Toet et 
al. 2005). 
NIRS has also been used intraoperatively to evaluate the effects of various 
operative techniques on cerebral oxygenation and metabolism. In an attempt to 
identify vulnerable periods for the development of neurologic injury, Daubeney et al 
(1998) used NIRS on patients undergoing CPB with or without deep hypothermia 
circulatory arrest (DHCA). They showed that the onset of bypass caused an increase 
in TOS. Furthermore, during circulatory arrest TOS decreased with rate of decay 
influenced by temperature at onset of arrest. Repurfusion caused an immediate 
increase in TOS followed by a decrease during rewarming. Discontinuation of 
bypass caused a precipitous decrease in TOS (Daubeney et al. 1998). Hoffman et al 
used NIRS during the Norwood procedure with DHCA and showed that TOS was 
maintained during regional cerebral perfusion at prebypass levels with DH. 
However, after rewarming and separation from CPB, TOS was lower compared with 
prebypass (Hoffman et al. 2004). Tobias et al report the use of NIRS during DHCA 
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and showed that TOS increases after cooling on CPB, while after the onset of DHCA 
an incremental decrease in TOS with an average rate of 0.9% per min is obtained 
(Tobias et al. 2009).  
NIRS technique has also been used to examine brain oxygenation during regional 
low-flow cerebral perfusion (RLFP), a technique whereby the brain is perfused via 
the right innominate artery to provide unilateral cerebral perfusion during CHD 
surgeries involving aortic arch reconstruction. Bilateral NIRS has been used to 
examine correlation between right and left hemispheres (Andropoulos et al. 2004a, 
Hofer et al. 2005). Also NIRS has been used to study the impact of acid-base 
management (pH-stat vs. α-stat) during CPB on cerebral oxygenation (Sakamato et 
al. 2004).  
The use of NIRS postoperatively has been employed by several groups. Phelps et 
al used NIRS to study cerebral oxygenation in patients with hypoplastic left heart 
syndrome (HLHS) after the Norwood procedure to relate cerebral oxygenation with 
the risk of adverse outcome (Phelps et al. 2009). Li et al sought to quantitatively 
define the effects of stepwise increase in arterial carbon dioxide tension on systemic 
oxygen transport and cerebral and splanchnic circulation after the Norwood 
procedure (Li et al. 2008). In addition, NIRS was used in postoperative CHD patients 
to study the relationship between TOS and central venous oxygenation and it was 
found that even though they correlate, interchangability is precluded due to wide 
limits of agreement (McQuillen et al. 2007b, Nagdyman et al. 2004). 
 
4.4.3.3 Concluding Remarks 
NIRS due to its unique qualities, including non invasive, continuous and real 
time measurement of cerebral oxygenation, has gained increasing use as a 
monitoring technique in neonatal and paediatric cardiothoracic care. The continued 
desire to mitigate the neurologic complications associated with this group of patients 
and its surgical intervention is laudable.  
The significant variability in NIRS measurements, temporally and between 
individual patients, precludes the establishment of absolute threshold values. 
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Furthermore, the wide heterogeneity in anatomy and physiology in CHD and ECMO 
patients results in varying baseline levels of oxygenation. Caution must be exercised 
in extrapolating regional measurements to global findings. Therefore, it is important 
to look at trends in NIRS signals rather than relying on a single marker such as tissue 
oxygen saturation.  
Alterations in regional oxygen saturation may reflect local changes and not 
necessarily indicate global hypoperfusion. The clinically commercially available 
NIRS systems monitor TOS in only a small tissue volume of the frontal cerebral 
cortex; other areas of the cortex and deeper structures in the brain are not assessed by 
these systems.  The development of a multichannel NIRS system that will allow 
global monitoring of cerebral oxygenation to be used clinically in neonatal and 
paediatric cardiac patients should be highly beneficial. 
Although clinical evidence suggests a correlation between low cerebral oxygen 
saturations and adverse neurologic outcome, additional prospective outcome data in 
infants and children using this modality are necessary. As additional studies are 
performed and as technologic advancements are made, NIRS will continue to 
provide important insights into the haemodynamics and pathophysiology of neonates 
and children, and will likely find its way into routine clinical practice.  
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Author Device Patient Population Total 
Number 
Objectives Results 
Anesthesia      
(LeBlanc et al. 
2000) 
NIRO Elective ASD or 
VSD with (n=11) or 
without (n=13) 
propofol 
 
24 Effect of propofol on the redox status 
of Cytaa3 and neurologic 
complications 
Prpofol has similar effects on Cytaa3 
as hypothermia; no gross neurologic 
complications 
(Nagdyman et al. 
2008) 
NIRO/INVOS children with 
congenital heart 
defects 
31 Compared two different near-infrared 
spectrophotometers: TOS measured 
using NIRO 200 and INVOS 5100 
with venous oxygen saturation in the 
jugular bulb (SjO2) and central 
venous oxygen (SvO2) from the 
superior caval vein (SVC) during 
elective cardiac catheterization in 
children. 
Cerebral TOS measured with NIRO 
and SjO2 were significantly correlated 
(r = 0.56, P < 0.0001), as well as 
NIRO TOS and SvO2 with r = 0.74 (P 
< 0.0001). Cerebral TOS measured 
with INVOS and SjO2 showed a 
significant correlation (r = 0.83, P < 
0.0001) and INVOS TOS and SvO2 
showed excellent correlation with r = 
0.93 (P < 0.0001). 
 
Coarcatation repair     
(Berens et al. 2006) INVOS Aortic coarctation 
repair via left 
thoracotomy 
26 Describe the changes in regional 
cerebral and somatic TOS with aortic 
coarctation repair 
The decrease in somatic TOS with 
coarctation repair is less in children 
than neonates and infants (P<.01), 
significant increase in cerebral TOS 
during coarctation repair in children > 
1 year 
 
(Azakie et al. 2005) NIRO Aortic coarctation 
repair via left 
thoracotomy 
 
18 Determine whether aortic occlusion 
impairs left hemispheric cerebral 
oxygen balance 
Significant decrease in HbO2-HHb 
between the right and left (P=0.03), 
significant decrease in HbO2-HHb 
with nitroprusside (P<0.001) 
 
 
 
Table 4.1: NIRS monitoring in Patients with congenital heart diseases (modified from (Hirsch et al. 2009)) 
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Deep hypothermia with and without circulatory arrest (CA)  
(Kussman et al. 
2005) 
INVOS Infant biventricular 
repair (no arch 
reconstruction) 
62 Evaluate the differences in 
bihemispheric measurement of TOS 
during hypothermic CPB. 
Relationship between cerebral HbO2 
and Cytaa3 
No difference between right and left 
TOS measurements irrespective of 
CA. Median time to nadir of HbO2 
during CA was 25 minutes, increased 
HbT and HbO2 above baseline with 
rewarming (P<.001) with delayed 
Cytaa3 recovery, dissociation 
between intravascular and 
mitochondrial oxygenation in patients 
> 2 weeks 
 
 
(Greeley et al. 1991) NIRO Deep hypothermia 
with or without CA in 
neonates and 
children 
15 The effect of CA on CMRO2 and 
oxygenation 
HbO2 and Cyaa3 decreased during 
CA, CMRO2 and Cyaa3 remained 
lower that baseline after CPB with CA 
but returned to normal in non-CA 
patients (P < .01) 
(Kurth et al. 1992) NIMS Neonates 
undergoing surgery 
with CA 
17 Kinetics of HbO2 in neonates during 
DHCA 
HbO2 increases during cooling (P < 
.05), decrease during CA in a 
curvilinear distribution until a plateau 
at 40 minutes (P < .001), and returns 
to baseline with rewarming 
 
(Kurth et al. 1995) NIMS Repair of palliation 
using CA 
26 Variation in changes of intraop TOS 
between neonates, infants, children 
and are these changes associated 
with postop neurologic dysfunction 
The half life of TOS during CA is 
longer for neonates > infants > 
children (P < .001), patients with 
neurologic complications had less of 
an increase in TOS on CBP and a 
significant shorter cooling time pre-CA 
(P < .05), no significant difference in 
TOS between groups 
Table 4.1 (continued) 
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(Tobias et al. 2009) INVOS Patients with CHD 
undergoing surgery 
with DHCA 
8 To present data regarding use of a 
commercially available near infrared 
spectroscopy monitor during deep 
hypothermic circulatory arrest in 
paediatric patients undergoing 
surgery for congenital heart disease. 
The baseline cerebral oxygenation 
was 63 ± 11% and increased to 88 ± 
7% after 15 min of cooling to a 
nasopharyngeal temperature of 17-
18°C on cardiopulmonary bypass. In 
5 of 8 patients, the cerebral 
oxygenation value had achieved its 
peak value (either ≥90% or no change 
during the last 2-3 min of cooling on 
cardiopulmonary bypass). After the 
onset of deep hypothermic circulatory 
arrest, there was an incremental 
decrease in cerebral oxygenation to a 
low value of 53 ± 11%. The greatest 
decrease occurred during the initial 5 
min of deep hypothermic circulatory 
arrest (9 ± 3%). Over the entire period 
of deep hypothermic circulatory 
arrest, there was an average 
decrease in the cerebral oxygenation 
value of 0.9% per min (range of 0.5 to 
1.6% decline per minute). 
(du Plessis et al. 
1995) 
NIRO Infant biventricular 
repair with low flow 
or CA 
63 Relationship between cerebral HbO2 
and Cytaa3 
Median time to nadir of HbO2 during 
CA was 25 minutes, increased total 
HbT and HbO2 above baseline with 
rewarming (P<.001) with delayed 
Cytaa3 recovery, dissociation 
between intravascular and 
mitochondrial oxygenation more 
pronounced in patients > 2 weeks. 
 
 
 
 
    
Table 4.1 (continued) 
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Regional low flow perfusion (RLFP) 
(Hofer et al. 2005) 
 
INVOS RLFP for Norwood 
procedure 
10 Correlation of bilateral NIRS 
monitoring during RLFP with variable 
flow rates 
There was a significant decrease in 
bilateral TOS and SvO2 with 
decreasing RLFP rates (P < .001). 
Wide interindividual variation in TOS 
(Andropoulos et al. 
2004a) 
INVOS RLFP for Norwood 
procedure or aortic 
arch reconstruction 
19 Correlation of bilateral NIRS 
monitoring during RLFP adjusted for 
CBFV with TCD 
During RLFP, correlation between 
hemispheres was poor and only 
partially returned to baseline after 
RLFP with the left side always being 
the lower value 
 
(Hoffman et al. 
2004) 
 
INVOS RLFP for Norwood 
procedure 
9 Relative changes in cerebral and 
somatic oxygenation during RLFP 
adjusted for TOS and CBFV 
TOS was maintained during RLFP but 
decreased below baseline after CPB. 
There was no correlation between 
cerebral and somatic oxygenation at 
any time point. 
(Andropoulos et al. 
2003a) 
 
INVOS RLFP for Norwood 
procedure or aortic 
arch reconstruction 
34 Describe the addition of CBFV 
monitoring by TCD to TOS as a 
guide to bypass flow during RLFP 
Poor correlation between MAP and 
required CPB flow. 14/34 had TOS 
greater than 95% during RLFP 
increasing the risk of hyperperfusion. 
No outcomes correlation for the 
addition of CBFV to TOS to guide 
CPB flow. 
 
(Kilpack et al. 2004) INVOS RLFP for Norwood 
or aortic arch 
reconstruction 
34 Demonstrate maintenance of 
adequate TOS with RLFP when CPB 
flow adjusted for TOS and CBFV 
No difference in TOS on full flow 
CPB, RLFP, and resumption of full 
flow CPB. However, CPB flow was 
adjusted to maintain value within 10% 
of baseline 
 
(Andropoulos et al. 
2003b) 
INVOS RLFP for Norwood 
procedure or aortic 
arch reconstruction 
20 Demonstrate the correlation between 
CBVI based on NIRS and CBFV by 
TCD 
Poor correlation   between CBVI and 
CBFV. Right sided CBFV did not 
correlate with RLFP flow rate 
Table 4.1 (continued) 
Table 5.1 (continued) 
Table 4.1 (continued) 
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(Pigula et al. 2001) INVOS RLFP for Norwood 
procedure or aortic 
arch reconstruction 
15 Ability of RLFP to provide 
subdiaphragmatic somatic circulatory 
support as measured be somatic 
NIRS 
Abdominal aortic blood pressure, 
quadriceps blood volume, and 
quadriceps TOS were significantly 
greater during RLFP than DHCA (P < 
0.05) 
(Pigula et al. 2000) INVOS/NIRO Neonatal aortic arch 
reconstruction with 
RLFP (n=6) and 
neonatal cardiac 
repair with DHCA 
(n=6) 
12 Experiential report of using NIRS 
guided RLFP versus DHCA 
RLFP flow rate of 20 mL/kg/min 
maintained baseline values. TOS and 
CBVI decrease significantly during 
DHCA but are maintained during 
RLFP. 
 
Perfusion techniques 
    
(Han et al. 2004) INVOS Repair of ASD or 
VSD with bloodless 
(n=18) or blood 
(n=18) prime 
36 Compare the effect of blood versus 
bloodless CPB prime on TOS 
TOS decreases below baseline in 
both groups at the start of CPB and 
during rewarming (P<.001) with a 
greater reduction in the bloodless 
prime group (P<.01). 
(Sakamato et al. 
2004) 
NIRO CPB in cyanotic 
patients using 
alpha-stat (n=19) 
versus pH-stat 
(n=21) strategy 
 
40 Evaluate the effect of pH strategies 
on TOS and SPCC 
TOS was significantly lower (P=0.008) 
and the HHb was significantly higher 
(p<0.0001) with alpha-stat. SPCC 
was significantly lower with pH-stat 
(P<0.0001). 
(Shaaban et al. 
2004) 
NIRO Cold (25°C) (n=9) 
versus warm (35°C) 
(n=9) CPB for 
biventricular repair 
18 Compare the effect of cold versus 
warm CPB in terms of extent of 
cerebral damage (measured by 
S100b) and HbO2 
S100b increased significantly in both 
groups. No correlation between 
S100b and NIRS measurements 
except lowest post-CPB Cytaa3 level 
(P=0.016). TOS was significantly 
impaired during rewarming 
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(Wardle et al. 1998) NIRO Deep hypothermia 
(15°C) (n=15) 
versus mild–
moderate 
hypothermia (22 –28 
°C) (n=15) CPB 
30 Investigate the effect of hypothermia 
and CA on cerebral FOE. 
FOE increases with the institution of 
CPB in cyanotic patients FOE 
decreases during cooling and only 
increases during rewarming in the 
continuous flow group. No significant 
difference between groups at any 
time in Cytaa3 
(Chow et al. 1997a) NIRO CPB using pulsatile 
and nonpulsatile 
flow 
40 Examine the relationship between 
pump flow rate and cerebral 
haemodynamics during pulsatile and 
nonpulsatile CPB 
CBF decreased by 36% per Lm
2
/min 
decrease in pump flow rate 
regardless of pulsatility 
(Kurth et al. 1997) NIMS CPB: warm (n=10), 
hypothermic (25°C) 
(n=10), 
hypothermic/low 
flow (n=9), and 
hypothermic /low 
Hct (n=9) 
38 Evaluate the effect of purfusate 
temperature, pump flow rate and Hct 
on cerebral O2 extraction 
TOS increases during cooling 
(P<0.001), TOS increased after CPB 
was discontinued in the low flow and 
low Hct group 
 
Intraoperative monitoring 
    
(Fenton et al. 2007) INVOS Single ventricle 
stage palliation 
(n=34) and ductus 
dependent complete 
repair (n=12) 
46 Determine whether TOS is related to 
the stage of single ventricle palliation 
TOS at the end of the operation was 
significantly lower in patients who 
died (P=0.01), TOS decreases 
significantly after stage 1 palliation 
(P=0.001) and increases after stage 2 
palliation (P=.04). No correlation with 
neurologic complications 
(Murayama et al. 
2006) 
NIRO Repair of cyanotic 
(n=10) and 
noncyanotic (n=10) 
heart defects 
20 Differences in TOS at the initiation of 
CPB for cyanotic and noncyanotic 
heart defects. 
 Cerebral HbO2, HHb, and HbT 
decrease and then plateau on CPB. 
HHb and HbT decreased more 
markedly in the cyanotic patients 
(P<0.01). 
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(Hayashida et al. 
2004) 
PSA-3N Noncyanotic CHD 
repaired with CPB 
65 Measure the incidence of cerebral 
ischemia using bispectral index and 
NIRS in children having cardiac 
surgery. 
Cerebral ischemia (defined as abrupt 
decrease in both TOS and bispectral 
index with acute hypotension) was 
more common and frequent in 
children<4 years. TOS was more 
dependent on arterial pressure in 
children<4 years. Cerebral ischemia 
frequency correlated negatively with 
Hct (P<0.0001). 
(Morimoto et al. 
2003) 
NIRO Repair of VSD 16 Examine changes in cerebral 
oxygenation using NIRS during VSD 
repair 
HbO2 decrease on CPB with no 
change in HHb. 
(Daubeney et al. 
1998) 
INVOS Biventricular repair 18 Identify periods of cerebral oxygen 
supply and demand mismatch using 
NIRS 
TOS decreased by >15% in 10/18 
patients with cardiac manipulation. 
TOS increases with the institution of 
CPB and decays at 0.25%/min at 
<20°C and 2%/min at>20°C. TOS 
varied inversely with the rate of 
cooling (P=0.04) 
 
(Austin et al. 1997) INVOS CHD repair with 
CPB 
250 Examine the potential benefit of 
interventions based on intraop 
neurophysiologic monitoring (TCD, 
EEG, NIRS) in decreasing postop 
neurologic complications and length 
of hospital stay 
Of patients with neurologic changes, 
significantly more had noteworthy 
intraop changes that were not 
intervened on (P=0.003) with 
significantly fewer of these patients 
discharged from the hospital within 1 
week (P<0.05) 
(Chow et al. 1997b) NIRO Noncyanotic CHD 
repaired with CPB 
14 Explore the relation between arterial 
oxygen tension and CBF during CPB 
No relation between arterial oxygen 
tension and CBF. DBF is associated 
with CPB flow rate (decreases 4.2 
fold per l/m
2
/min) 
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(Van Bel et al. 1996) Radiometer Neonatal and infant 
CDH repair with 
CPB 
12 Investigate the changes in cerebral 
haemodynamics and oxygenation 
during DHCA 
CBV decreased significantly with 
cooling and increased significantly 
with rewarming (P<.001). CBV did not 
change with pumo flow rate of MAP 
 
(Skov and Greisen 
1994) 
Radiometer Biventricular 
cyanotic (n=5) and 
noncyanotic (n=9) 
CHD repair with 
CPB 
14 Examine the changes in cerebral 
Cyaa3 during induction of CPB 
In cyanotic patients, the HbT 
decreased rapidly and then reached a 
plateau, Cyaa3 decreased and HbO2 
index increased. There were no 
significant changes in the noncyanotic 
patients. The magnitude of the 
change in Cyaa3 was associated with 
the magnitude of change on HbT 
(P<0.0001). Signal noise analysis 
raised concern about the validity of 
the results. 
 
 
(Fallon et al. 1993) NIRO Repair of CHD with 
CPB 
13 Use of NIRS to monitor CBF, CBV, 
and CBVR 
CBVF significantly decreased during 
hypothermic (25°C) bypass 
 
(Redlin et al. 2008) NIRO Repair of CHD with 
CPB 
20 Assess the extent to which mixed 
venous oxygen saturation as a 
measure for adequacy of perfusion, 
reflects the oxygenation status of 
upper and lower body compartments. 
Venous oxygen saturation was lower 
and lactate concentration higher in 
blood from superior relative to inferior 
venous line. Mixed venous oxygen 
saturation correlated with venous 
oxygen saturation from inferior 
venous line and tissue oxygenation 
index of lower limb. No correlation 
was found between mixed venous 
oxygen saturation and venous oxygen 
saturation from superior venous line 
or cerebral tissue oxygenation index. 
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(Fallon et al. 1994) NIRO Elective CHD repair 
with CPB 
19 Measure the change in CBV 
associated with changing PaCO2 
(CBVR) under anaesthesia and 
during hypothermic CPB 
CBVR is preserved under 
anaesthesia and hypothermic CPB. 
The relationship between CBV and 
PaCO2 is linear 
 
Intraoperative combined with preoperative/postoperative monitoring 
  
(McQuillen et al. 
2007a) 
NIRO Patients with CHD, 
preop/postop MRI 
and intraop NIRS 
16 Define the risk factors for preop and 
postop brain injuries and association 
with functional cardiac anatomic 
groups (intraop NIRS was a 
secondary analysis) 
TOI significantly decreased during 
aortic XC in patients with positive 
postop MRIs (P=.008) 
(Dent et al. 2006) INVOS Norwood procedure 
with RLFP, 
preop/postop MRI, 
preop/introp/postop 
NIRS 
22 Preop and postop MRI findings in 
neonates undergoing a Norwood 
procedure with RLFP 
Prolonged low postop TOS (<45% for 
>180 minutes) was associated with 
new or worsening lesions (P=.029) 
with a positive predictive value of 90% 
for positive MRI findings 
(Toet et al. 2005) INVOS Transposition of the 
great arteries repair 
with DHCA, 
preop/intraop/postop 
NIRS 
20 Monitoring NIRS before, during, and 
after arterial switch operation to 
evaluate its relation to 
neurodevelopmental outcomes 
Recovery time for the EEG did not 
correlate with normalisation of the 
TOS. Complete recovery of the TOS 
takes 6-72 hours postop. Preop 
decrease in TOS tended to correlate 
with decreased Bayley score but was 
not significant 
 
 
 
Monitoring technigue 
    
(Roberts et al. 1998) NIRO Repair of CHD with 
CPB 
19 Describe a novel method to measure 
CBF using indocyanine green tracer 
with NIRS 
11% variation between 
measurements within individual 
patients, 73% of the variability was 
accounted for by pump flow and 
temperature 
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Preoperative ICU monitoring 
(Takami et al. 2005) NIRO CHD patients with 
increased 
pulmonary blood 
flow 
8 Evaluate serial changes in 
oxygenation state in the head and 
body in patients with increased 
pulmonary blood 
With decreased TOS after the 
initiation of hypoxia, cerebral and 
brachial HbO2 decreased with an 
increase in HHb 
(Ramamoorthy et al. 
2002) 
NIM-
prototype 
Single ventricle 
neonates 
15 Evaluate changes in TOS with 
inspired 17% FiO2 or 3% CO2 
Significant increase in TOS and MAP 
with 3% CO2, no change in TOS or 
MAP with 17% FiO2 
(Kurth et al. 2001) NIM-
prototype 
CHD and normal 110: 91 with 
CHD,19 
normal 
Correlation of TOS and CEo2 
between CHD patients and normal 
TOS was significantly decreased in 
patients with PDA, TOF, HLHS, PA, 
SV with shunt and BDG but was the 
same for VSD, CoA, and Fontan. 
CEo2 was significantly increased for 
PDS and HLHS. SaO2 was correlated 
with TOS but was not a good 
substitute (R
2
=0.4) 
Postoperative ICU monitoring     
(McQuillen et al. 
2007b) 
INVOS Postop CHD 
patients 
70 Relationship between changes in 
TOS with changes in regional flank 
SO2 and central SvO2 Monitored for 
24 hours 
Central SvO2 was correlated with TOS 
and flank TOS with wide limits of 
agreement precluding 
interchangeability. Changes in PaCO2 
and MAP were associated with 
changes in TOS but not flank TOS or 
SvO2. Changes in SaO2 were 
associated with SvO2 but not TOS. 
(Mott et al. 2006) INVOS Bidirectional Glenn 
(BDG) 
10 Response of TOS to (1) 
hyperventilation with increased TV, 
(2) hyperventilation with increased 
RR, (3) hypoventilation with 
decreased RR. Monitoring for 4 
hours 
(1) Increased pH, decreased PCO2, 
PCO2, as 1; (3) no change in pH, 
increased PCO2, and increased TOS. 
Hyperventilation should be avoided in 
patients with BDG due to potential 
decrease in TOS. 
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(Nagdyman et al. 
2006) 
NIRO Elevated pulmonary 
vascular resistance 
after CPB 
13 Examine alterations in cerebral 
oxygenation in children treated with 
increasing doses of sildenafil for 
elevated vascular resistance. 
Monitored for 1 hour 
TOS increased significantly after the 
first two doses but quickly returned to 
baseline (P=.01), no change with the 
third dose. There was no correlation 
between cardiac index and TOS 
(Li et al. 2006) INVOS Postop Norwood 
patients 
11 Determine if NIRS cerebral and 
splanchnic monitoring accurately 
reflects systemic oxygen delivery 
when compared with direct 
measurements. Monitored for 72 
hours. 
TOS correlates with SaO2 and PaO2 
(P<0.0001) with large interindividual 
variation, TOS correlates with SvO2 
(P<0 .0001) with no interindividual 
variation. Overall, large interindividual 
variability and intraindividual temporal 
variability. 
(Bassan et al. 2005) NIRO Postop CHD 
patients 
43 Correlation of NIRS parameters 
(HbD = HHb–HbO2) with CBFV by 
TCD; identify pressure-passive 
cerebral perfusion by simultaneous 
measurements of HbD and MAP; 
and associate higher CO2 levels with 
pressure passive Measurements at 6 
and 20 hours postop. 
Significant relationship between 
change in CBFV and change in HbD 
(P<0.0001), also with change in HbO2 
(P<0.001). 13% of patients had 
disturbed cerebral pressure 
autoregulation at 6 hours that 
persisted at 18 hours, high end tidal 
CO2 was correlated with pressure 
passive rather than autoregulated 
cerebral perfusion (P<0.001) 
(Tortoriello et al. 
2005) 
INVOS Elective postop 
CHD patients 
20 Compare TOS with SvO2 (oximetry) 
after paediatric cardiac surgery. 
Single measurement 6 hours postop 
TOS correlated with SvO2 (P<0 .001). 
There was low intrasubject variation 
with significant intersubject variation; 
therefore cannot predict absolute 
values but can follow trends. 
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(Srinivasan et al. 
2009) 
INVOS Postop Norwood 
patients 
80: 40 with 
standardise 
management, 
40 without 
standardise 
management 
Study the impact of a standardised 
management protocol for neonates 
undergoing NP 
Hospital survival (95% vs. 70%, P= 
0.003) and survival to S2P (85% vs. 
58%, P= 0.006) was better in the 
group receiving standardise 
management. By univariate analysis, 
regional low flow perfusion, 
gastrostomy usage, and near infrared 
spectroscopy were associated with 
improved hospital and survival to 
S2P. 
 
(Phelps et al. 2009) INVOS Postop Norwood 
patients 
50 Determine whether regional cerebral 
TOS by NIRS technology could 
predict risk of adverse outcome after 
the Norwood procedure. 
There were 18 adverse events among 
the 50 subjects. The mean cerebral 
TOS for the entire cohort at 1 hour, 4 
hours, and 48 hours after surgery was 
51% +/- 7.5%, 50% +/- 9.4%, and 
59% +/- 8.1%, respectively. Mean 
cerebral TOS for the first 48 
postoperative hours of less than 56% 
was a risk factor for subsequent 
adverse outcome (odds ratio 11.9, 
95% confidence interval: 2.5 to 55.8). 
Mean cerebral NIRs of less than 56% 
over the first 48 hours after surgery 
yielded a sensitivity of 75.0% and a 
specificity of 79.4% to predict those at 
risk for subsequent adverse events. 
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(Chakravarti et al. 
2009) 
INVOS Postop CHD 
patients 
23 To determine if a relationship exists 
between TOS measured at various 
body locations by NIRS and blood 
lactate level in children after cardiac 
surgery. 
Cerebral TOS had the strongest 
inverse correlation with lactate level 
followed by splanchnic, renal, and 
muscle TOS (r = -0.74, p < 0.0001, r = 
-0.61, p < 0.0001, r = -0.57, p < 
0.0001, and r = -0.48, p < 0.0001, 
respectively). The correlation 
improved by averaging the cerebral 
and renal TOS values (r = -0.82, p < 
0.0001). 
 
(Nagdyman et al. 
2004) 
 
 
NIRO Postop CHD 
patients 
43 Correlation between TOS as a value 
for regional TOS and global SvO2 
(right atrial saturation via central 
line). Single measurement 2 to 3 
hours postop. 
TOS correlated with SvO2 (P< 0.001). 
PaO2 (P=0 .031), SaO2 (P=0.027), 
SBP (P=0.035), and MAP (P=0.042). 
There was no correlation with PaCO2, 
heart rate, and haemoglobin 
(Kaufman et al. 
2008) 
INVOS Postop CHD 
patients 
20 Splanchnic oximetry, as measured 
by near-infrared spectroscopy 
(NIRS), correlates with gastric 
tonometry as a means of assessing 
regional (splanchnic) oxygenation 
and perfusion. 
There was strong correlation between 
the abdominal TOS and pHi (r = 0.79; 
p < 0.0001) as well as between 
abdominal TOS and SvO2 (r = 0.89; p 
< 0.0001). There was also significant 
negative correlation between the 
abdominal TOS and serum lactate (r 
= 0.77; p < 0.0001). Correlations 
between the dorsal lateral (renal) 
TOS measurements and serum 
lactate and SvO2 were also significant 
but not as strong. 
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Post operative circulatory assist device monitoring 
(Giacomuzzi et al. 
2005) 
INVOS HLHS with postop 
circulatory support 
5  rScO2 on circulatory support after 
SV repair 
TOS levels dropped significantly after 
separation from CPB and remained 
20% below baseline for 24 hours and 
did not normalize until 48 hours 
despite stable SvO2, MAP, and 
decreasing lactates. 
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Author Device Total Number Oblectives Results 
Animal Studies    
(Van Heijst et al. 
2001) 
 
Radiometer 8 Investigate the haemodynamic 
changes occurring during opening of 
the bridge in VA ECMO 
Bridge opening resulted in change of flow direction 
between venous cannula and bridge and arterial cannula. A 
bi phasic response with initial decrease and secondary 
increase occurred in mean arterial blood pressure and 
mean left carotid artery blood flow. CVP, HHb and CBV 
increased, whereas HbO2 decreased. These effects 
occurred in each combination of ECMO flow rate and 
opening time. 
(Liem et al. 
1996) 
Radiometer 12: 6 
hypoxemic, 6 
normoxemic 
To compare the effect of ECMO on 
cerebral oxygenation and 
haemodynamics in normoxemic and 
hypoxemic piglets. 
Cannulation procedure resulted in increased CBV, HHb, 
and left common carotid artery blood flow (LCaBF) in both 
groups. At 60 and 120 min after starting ECMO, the values 
of HbO2, CBV, and LCaBF in both groups were significantly 
higher than precannulation values. In the hypoxemic 
groups HHb decreased and SaO2 increased. Between 
hypoxemic and normoxemic groups no significant 
differences in the response of CBV and LCaBF at 60 and 
120 min were found. In piglets cannulation for ECMO 
resulted in cerebral venous congestion and compensated 
increase in LCaBF. After starting ECMO, the cerebral O2 
supply increased due to increased arterial O2 content. It 
was accompanied by similar increase of CBV in both 
groups, probably as a result of hyperperfusion, which 
seems to be related to the ECMO procedure itself. 
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(Liem et al. 
1995a) 
Radiometer 4 groups of 6 
piglets: 
1.normoxaemi
a without 
ECMO, 
2.ECMO after 
normoxaemia,  
3.hypoxaemia 
without ECMO,  
4.ECMO after 
hypoxaemia 
To investigate the cerebrovascular 
response to changes in arterial CO2 
tension. 
Hypercapnia resulted in increased CBV, HbO2 and ICP in 
all groups, while HHb was decreased. Hypocapnia resulted 
in decreased cerebral HbO2 and increased cerebral HHb 
except in group 3. LCaBF decreased in all groups except 
group 2. CBV decreased only in groups 2 and 4. No effect 
on ICP was observed in any of the groups. The other 
variables showed no important changes either during 
hypercapnia or hypocapnia. ECMO after hypoxaemia 
resulted in a greater response of cerebral HbO2 and 
cerebral HHb during hypocapnia. The effect of hypercapnia 
on CBV while on ECMO was greater than without ECMO. 
 
(Liem et al. 
1995b) 
Radiometer 12 piglets and 
10 newborn 
infants 
investigate changes of cerebral 
oxygenation and haemodynamics 
related to opening of the bypass 
bridge during veno-arterial 
extracorporeal membrane oxygenation 
(ECMO) 
Opening of the bridge for 10 s in the infants resulted in a 
significant decrease in MABP, SaO2, and cerebral HbO2, 
whereas cerebral HHb increased. CBV did not change 
significantly. In piglets biphasic changes were observed for 
MABP, CaBF, cerebral HbO2, and CBV, showing an initial 
decrease followed by a smaller increase. Cerebral HHb and 
CVP showed reverse biphasic changes. ICP increased but 
SaO2 was unchanged. In all cases heart rate and cCyt.aa3 
did not change significantly. Opening of the bridge for 1 s 
resulted in minor changes in only a few variables. In 
conclusion, opening of the bridge resulted in a decrease of 
CBV and cerebral O2 supply due to a decrease of cerebral 
blood flow, followed by a compensatory increase of 
cerebral O2 extraction and vasodilatation. 
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(Tyree et al. 
2009) 
INVOS 12 Compare brain tissue oxygen tension 
(PbtO2) with cerebral near infrared 
spectroscopy (NIRS) and mixed 
venous oxygen saturation (SvO2) 
during venoarterial extracorporeal 
membrane oxygenation (VA ECMO) in 
a porcine model. 
TOS and SvO2 correlated only marginally with PbtO2 
(R
2
=0.32 and R
2
=0.26, respectively) while the correlation 
between TOS and SvO2 was significantly stronger 
(R
2
=0.59). Cerebral metabolites and TOS were significantly 
altered during attenuation of PbtO2, p<0.05). A subset of 
animals, following exposure to hypoxia, experienced 
markedly delayed recovery of both TOS and PbtO2 despite 
rapid normalization of SvO2. Upon further analysis, these 
animals had significantly lower blood pressure (p=0.001), 
lower serum pH (p=0.01), and higher serum lactate 
(p=0.02). Additionally, in this subgroup, TOS correlated 
better with PbtO2 (R
2
=0.76). These findings suggest that, in 
our ECMO model, TOS and SvO2 correlate reasonably well 
with each other, but not necessarily with brain PbtO2 and 
that NIRS-derived TOS may more accurately reflect 
cerebral tissue hypoxia in sicker animals. 
Human Studies    
(Van Heijst et al. 
2004) 
Radiometer 10 Oxygenation and haemodynamics in 
the left and right cerebral hemispheres 
were measured during induction of 
veno-arterial extracorporeal membrane 
oxygenation (VA-ECMO). 
RCCA ligation caused a decrease in HbO2 concentration 
and an increase in HHb concentration. RIJV ligation caused 
no changes. 60min after the start of VA-ECMO, HbO2 
concentration and CBV had increased, and HHb 
concentration had decreased. There were no differences 
between the hemispheres. Mean CBFV had increased in 
the left internal carotid artery, and it increased equally in 
both middle cerebral arteries. Flow direction was reversed 
in the right internal carotid artery. Three patients had 
asymmetric cerebral lesions, not related to differences in 
the measurements between the cerebral hemispheres. 
 
(Rais-Bahrami et 
al.2006) 
FORE-
SIGHT 
17 veno-
venous ECMO 
with cephalad 
catheter 
Validation of the NIRS system with the 
cerebral oxygen saturation measured 
from blood drawn in neonates.  
Compared to the reference values, the bias±precision for 
cerebral TOS was 0.4±5.1% and derived SvO2 was 
0.6±7.3% 
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(Liem et al. 
1995a) 
Radiometer 24 To investigate cerebral oxygenation 
and haemodynamics in relation to 
changes in some relevant physiologic 
variables during induction of ECMO 
After carotid ligation, HbO2 decreased whereas HHb 
increased. After jugular ligation, no changes in cerebral 
oxygenation were found. At 60 minutes after starting 
ECMO, the values of HbO2, SaO2, tcPO2, and MABP were 
significantly higher than the precannulation values, 
whereas the value of HHb was lower. The MBFV was 
significantly increased in the major cerebral arteries except 
the right middle cerebral artery, whereas PI was decreased 
in all measured arteries. Cerebral blood volume, calculated 
from changes in HbT and HHb, was increased in 20 of 24 
infants after starting ECMO. A positive correlation of HbT 
with MABP and a negative correlation with tcPO2 were 
found. 
 
(Fenik & Rais-
Bahrami 2009) 
FORE-
SIGHT 
17 Neonates were monitored with a 
cerebral oximeter before, during, and 
after cannulation for ECMO to 
determine the direct effects of 
ligation of the right internal jugular vein 
and right carotid artery on cerebral 
oxygenation. 
12 experienced low cerebral TOS <60% during pre-ECMO 
surgery, with most exhibiting the lowest TOS values 
between cannulation to the onset of ECMO. Two subjects 
received cardiopulmonary resuscitation (CPR) during 
surgery and experienced very low TOS (5 and 36%). Pulse 
oximetry was found to be unreliable during CPR because of 
diminished pulsatile flow. TOS increased above 60% after 
the onset of ECMO for all subjects and remained stable. 
 
(Ejike et al. 
2006) 
INVOS 11 Observe the effects of right carotid 
artery ligation and variations in 
extracorporeal life support (ECLS) flow 
on TOS measured using near infrared 
spectroscopy. 
Ligation of the right carotid artery resulted in a 12–25% 
decrease in TOS from baseline in the right frontal region for 
a duration ranging from 17 to 45 mins before returning 
toward baseline. No substantial change in the left frontal 
region TOS was detected during cannulation. Following this 
depression in TOS on the right, there was a transient 
increase above baseline in TOS observed in both 
hemispheres on initiating ECLS. No correlation between 
ECLS flow and TOS was found over the 72-hr period. 
Periods of “trialing off” ECLS were not related to any 
change in TOS in either hemisphere. 
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(Papademetriou 
et al. 2010) 
NIRO 200 4 Investigate differences between 
oscillations in cerebral and peripheral 
tissue oxygenation during changes in 
ECMO flow 
Spectral analysis in the form of Fourier transforms were 
used and to identify the presence of oscillations in different 
frequency bands. Oscillations related to heart rate and 
respiration rate appeared in both the brain (cerebral) and 
the leg (peripheral) data. The presence of mechanical 
oscillations related to the ECMO pump was also identified 
in both the brain and the leg in patients where a roller pump 
was used in the ECMO circuit. Slow frequency oscillations 
related to Mayer-waves were found in the brain and very 
slow oscillations related to the endothelia were observed in 
the leg data.  
 
(Papademetriou 
et al. 2011) 
ETG-100 1 To develop a novel multichannel NIRS 
protocol for providing regional 
measurements of cerebral oxygenation 
and haemodynamics  
The preliminary results on single VA-ECMO infant identified 
differences in regional cerebral oxygenation with changes 
in ECMO flows 
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Chapter 5 
 
CEREBRAL AND PERIPHERAL OXYGENATION IN 
CHILDREN SUPPORTED ON ECMO FOR CARDIO-
RESPIRATORY FAILURE 
 
 
 
 
 
 
5.1 Introduction 
Extracorporeal membrane oxygenation (ECMO) is a life support system for 
neonates, infants and children with intractable cardio-respiratory failure. It is aimed 
at supporting the heart and/or lungs temporarily whilst giving them a chance to 
recover. There are 2 forms of ECMO support–venoarterial (VA) ECMO and 
venovenous (VV) ECMO. Establishing VA ECMO involves cannulation of major 
vessels in the neck–right common carotid artery (RCCA) and internal jugular vein–
and supports both heart and lungs. VV ECMO involves supporting only the lungs 
and does not involve cannulation of the RCCA. The ECMO system can operate using 
two types of blood pumps: 1) A centrifugal pump which uses a high speed rotating 
device that pulls the blood into the pump and then accelerates it radially outwards 
and 2) a roller pump which compresses the cannula, thereby pushing the blood 
through the circuit. 
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As ECMO is used in patients who are otherwise likely to die, the results focus on 
survival. However, the reported frequency of abnormal neuroimaging in these 
patients ranges from 28% to 52%, depending on neuroimaging techniques, and is 
related both to pre-ECMO events and to the ECMO procedure itself (Bulas and Glass 
2005). Patients placed on ECMO as a group have experienced a critical period of 
haemodynamic instability and have been potentially exposed to dangerously low 
levels of oxygen in blood, low blood pressure and cell dysfunction. Physiologic 
changes, such as hypoxia, hypotension, and hypercapnia, associated with ECMO can 
disrupt cerebral autoregulation. In addition, induction of this life support system 
exposes the patients to manipulations of the major vessels in the neck. Also, the 
blood needs to be anticoagulated to maintain flow within the circuit adding risk of 
bleeding in various organs including the brain. Furthermore, procedures on ECMO 
affect flow in the circuit and these can similarly affect blood flow to the brain, 
causing alterations in cerebral perfusion and oxygen delivery to the brain. Previous 
studies in newborn lambs have shown that VA ECMO alters the ability of the 
cerebral vasculature to respond, resulting in an impairment of cerebral autoregulation 
(Short et al. 1993). These alterations were minimal in venovenous ECMO animals 
(Walker et al. 1996). All the above can have adverse effect on the brain function 
which can cause neurological disability in the long term. 
The development and application of monitors to enhance detection and direct 
treatment of conditions associated with brain injury is considerable. Near infrared 
spectroscopy (NIRS) offers the advantage of a continuous, non invasive means of 
monitoring cerebral oxygenation at the bedside. Ejike et al. report the use of NIRS on 
ECMO patients during ligation of the RCCA and during variations in the ECMO 
circuit flows (Ejike et al. 2006). They concluded that regional cerebral oxygenation 
is not primarily affected by alterations in flows but did demonstrate a significant 
decrease in right sided cerebral oxygenation during ligation.  Previous studies using 
NIRS to evaluate the effects of vessel ligation showed a decrease in oxy-(HbO2) and 
increase in deoxy -(HHb) haemoglobin in the right hemisphere (Liem et al. 1995a) 
and in both hemispheres (Van Heijst et al. 2004).  
To date, NIRS studies on ECMO patients have been concentrated on relative and 
absolute changes in the amplitudes of HbO2, HHb and TOI signals, related to vessel 
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ligation and alterations in the ECMO flows. However, spectral analysis on the NIRS 
signals may allow us to explore the occurrence of cerebral and peripheral oscillations 
and potentially relate them to ECMO variables.  Furthermore, it has been previously 
shown that spectral analysis of NIRS signals can be used to assess cerebral 
autoregulation (De Smet et al. 2009, Tsuji et al. 2000, Wong et al. 2008). Cerebral 
intravascular oxygenation (HbD), measured by NIRS as the difference between 
HbO2 and HHb, can be used as CBF surrogate (Tsuji and du Plessis 1998).  Hence, 
cerebral autoregulation can be evaluated by studying the concordance between HbD 
and mean arterial blood pressure (MAP), assuming no changes in oxygen 
consumption, in oxygen saturation and in blood volume. 
The long-term aim of this study is to use a multichannel NIRS system, optical 
topography (OT), to investigate global cerebral oxygenation changes in ECMO 
patients. However initially regional cerebral and peripheral tissue oxygenation were 
monitored using a dual channel system, with the aim of investigating the relationship 
between brain and peripheral tissue oxygenation and how these relate to 
haemodynamic parameters such as MAP. 
 
5.2 Protocol  
All VA and VV ECMO candidates admitted in the intensive care unit (CICU) at 
Great Ormond Street Hospital (GOSH) were eligible to take part in the study. 
The study protocol was designed by the clinical team of the cardiac intensive care 
unit in GOSH. The ECMO patients as a group go through routine procedures that can 
cause alterations in cerebral blood flow. These include cannulation, weaning the 
patient off ECMO prior to decannulation and decannulation. The plan was to assess 
the effects of these routine procedures on cerebral oxygenation. Therefore, the study 
period included data collection prior to start of cannulation until 10 minutes post 
establishment of full ECMO flows and prior to start of weaning for decannulation 
until 10 minutes post removal of cannulae. In addition we wanted to assess the effect 
of altering ECMO circuit flows on cerebral oxygenation. This intervention was 
performed on day 1 or 2 of ECMO support when the patient was on stable ECMO 
flows with minimal native cardiac output. Manipulations of ECMO circuit flows 
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were carried out by reducing the circuit flows in consecutive steps of 10% of the 
initial flow every 10-15 minutes and then stepping the flow back to its initial value.  
Mild hypothermia is adopted on ECMO as a neuroprotective strategy. The 
protocol included an assessment of the effect on cerebral oxygenation of a reduction 
in temperature to 34°C. Temperature changes were performed on day 1 or 2 of 
ECMO support when the patient was on stable ECMO flows. The temperature was 
decreased consecutively by 1°C, from normal body temperature to 34°C, every 10-15 
minutes and subsequently gradually increased back to normal body temperature.  
Increasing CO2 levels in the blood results in increased cerebral blood flow and 
can increase cerebral oxygenation. A CO2 challenge is therefore a useful test of 
cerebral response. This response has not yet been studied in patients on ECMO.  The 
protocol included periods of mild hypercapnia induced by changing the flow of the 
sweep gases through the membrane oxygenator to achieve pCO2 of 4.5kPa, 6 and 
7kPa consecutively.  
Ethical approval was obtained from Great Ormond Street Hospital committee on 
the Ethics of Human Research. Written, informed parental consent was obtained 
before each study.  
 
5.3 Instrumentation 
Acquiring data in an intensive care environment and especially on this critically 
ill group of patients was particularly challenging. Setting up the instrumentation was 
a particularly complex task because the space around the bedside is limited but most 
importantly because bedside management of this type of patients requires intensive 
nursing, frequent examinations and routine tests. 
A dual channel near infrared system (NIRO 200, Hamamatsu Photonics KK) was 
used to measure changes in HbO2 and HHb haemoglobin concentrations using the 
modified Beer-Lambert Law, and tissue oxygenation index (TOI) using spatially 
resolved spectroscopy (see chapter 3). NIRS data were collected at frequency of 2Hz 
or 6Hz and were exported in PC with the use of software designed in Matlab. 
Channel 1 was placed on the forehead (cerebral) and channel 2 on the calf 
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(peripheral) of the patients. The optodes were held in place using a double sided tape 
and elastic bandage to eliminate possible drifts in the signal arising from gradual loss 
of contact between the optode and the skin. For the conversion of the optical 
attenuation changes to chromophore concentration changes a differential pathlength 
factor (DPF) of 4.99 was applied when the patient was younger than 1 year old 
(Duncan et al. 1995). Otherwise, the age dependence equation of DPF was used (see 
section 4.1.5). 
 
 
Figure 5.1: Schematic diagram of the instrumentation used. A PC is connected to the 
Philips monitor via SRS-323 port. Systemic data were collected and exported to the 
PC via Trendface software. An SD card was used to export the ECMO data for off 
line analysis. The NIRO-200 was connected to the PC via a SRS-323 port and data 
were collected via software designed in Matlab.. 
 
Figure 5.1 shows a diagram of the instrumentation used. Simultaneous collection 
of systemic and ECMO circuit parameters was a complicated task. Data exported for 
off line analysis of these parameters was not being implemented on the intensive care 
unit. Various methods for exporting the data were investigated; the most 
straightforward involved using customised software (Trendface, Ixellence GmbH, 
Germany). The software was installed on a PC and systemic data from the Philips 
monitors (Intellvue MP70, Philips Medical) were collected through a SRS 323 port. 
Systemic data; arterial blood pressure (ABP), central venous pressure (CVP), end-
tidal CO2, heart rate (HR), respiration rate (RR), pulse, temperature and arterial 
oxygen saturation (SaO2), were continually measured, recorded and displayed in real 
time at the bedside (Intellvue MP70, Philips Medical). ABP and CVP were obtained 
invasively, usually from radial artery and femoral vein respectively. SaO2 was 
obtained from a pulse oximeter placed on the toe of the patients. ABP, CVP, RR and 
NIRO 200 
HbO2, HHb, HbT, 
TOI 
PC 
ECMO circuit 
monitor 
SaO2, SvO2, 
Haematocrit, Flow 
Philips monitor 
HR, ABP, CVP, RR, 
Temperature, SpO2, 
end-tidal CO2 
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end-tidal CO2 were recorded as continuous waveforms at a frequency of 125Hz 
(ABP and CVP) and 62.5Hz (RR and end-tidal CO2). These four parameters were 
also collected as averaged values at 1Hz.  HR, SpO2, temperature and pulse were also 
collected at 1Hz.  
Parameters related with the ECMO circuit were also collected continually at the 
bedside (M3 monitoring system, Spectrum Medical Ltd.). These included arterial 
oxygen saturation measured at the arterial cannula side (SaO2) and blood flow in the 
ECMO circuit measured using probes placed at the arterial cannula, venous oxygen 
saturation (SvO2) measured using a probe placed on the venous cannula, and 
haemotocrit. An S.D. memory card was used to collect the ECMO circuit parameters 
by inserting it in the slot of the Spectrum Medical monitor. 
  
 
Figure 5.2: Illustrating the sequence followed for obtaining simultaneous collection 
of systemic, ECMO parameters and with optical parameters from the dual-channel 
NIRS system NIRO-200. 
 
 
In order to proceed with data analysis, synchronisation of the time base axes 
between the three monitors was addressed. Synchronisation between the NIRO data 
and systemic parameters was achieved by placing an event marker on the NIRO 
system at the time when the Trendface software started the collection of the systemic 
data. To synchronise the ECMO circuit parameters with the systemic parameters the 
clock stamps on the ECMO monitor and Trendface software were used. Figure 5.2 
demonstrates the sequence followed for synchronising the data from the three 
monitors. 
   NIRO-200 
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5.4 Subjects 
A total of 8 ECMO patients, aged between 1 day and 5 years, were monitored 
during the different ECMO phases as described in the protocol. The patients are 
listed in table 5.1. This is a rather inhomogeneous group consisting of 7 VA ECMO 
cases, 3 of which operated on centrifugal pumps and the other 4 on roller pumps, and 
1 VV ECMO on roller pump. Even though the aim was to follow the complete 
protocol with every patient this was not achievable in practice.  It was difficult to be 
present in the intensive care unit at all hours and hence made it particularly difficult 
to monitor procedures such as cannulation, weaning and decannulation, especially 
when they these were scheduled at inconvenient hours. However, all 8 patients were 
monitored during alterations in the ECMO flows. Alterations in the ECMO flows 
refer to sequential reduction or increase in the ECMO circuit flows from baseline. 
Flows were reduced/increased in increments of 10% approximately every 10-15. 
Two patients were monitored during cannulation, 1 patient during weaning “trial off” 
period, 1 during pCO2 changes and 1 during temperature changes. The temperature 
and CO2 challenges were attempted only once, on different patients. Due to the 
complex physiology of the ECMO circuit it was particularly difficult to induce 
changes in both these parameters and these two interventions were later excluded 
from the protocol. 
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Table 5.1: List of ECMO patients monitored using the dual channel NIRO-200 system.  
Patient 
ID 
Indication for 
ECMO 
Clinical 
condition 
Age ECMO 
Type 
Cannulation sides Type of 
pump 
Sampling 
rate (Hz) 
Cannulation Flow 
changes 
Weaning 
“trial off” 
CO2 
changes 
Temperature 
changes 
Systemic & ECMO 
circuit parameters 
D1 Cardiac - post 
cardiac surgery 
Post TAPVC 
repair 
9 days VA RCCA & IJV Roller 2 - Yes Yes - - - 
D2 Cardiac - 
cardiomyopathy 
Dilated 
cardio-
myopathy, 
ventricular 
tachycardia 
5 years VA RCCA & IJV & FV Centrifugal 6 - Yes - - - - 
D3 Neonatal 
Respiratory 
failure 
Neonatal 
hypoxaemic 
respiratory 
failure with 
PPHN 
3 days VV IJV Roller 6 - Yes - - - - 
D4 Cardiac - 
myocarditis 
Parvovirus 
Myocarditis 
1 year VA RCCA & IJV Centrifugal 6 Yes Yes - - - - 
D5 Cardiac - post 
cardiac surgery 
Post 
Interrupted 
Arch/VSD 
and later 
Norwood I 
surgery 
5 days VA RCCA & IJV Roller 6 - Yes - - - - 
D6 Neonatal 
Respiratory 
failure 
 
Neonatal 
hypoxaemic 
respiratory 
failure with 
PPHN 
3 days VA RCCA & IJV Roller 6 - Yes - - - - 
D7 Paediatric 
Respiratory 
Failure 
RSV 
broncholitis 
3 months VA RCCA & IJV Roller 6 - Yes - - - - 
D8 Cardiac Kawasaki 
disease 
6 months VA RCCA & IJV Centrifugal 6 - Yes - Yes Yes Yes 
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5.5 Cerebral and Peripheral tissue oxygenation 
during various ECMO phases 
Varying baseline levels of tissue oxygenation index (TOI) where observed 
between individual patients. The range of TOI value in both the brain and leg of the 
patients varied between 55-80% with significant intersubject variability. In addition, 
variability in the trends of other NIRS parameters (HbO2, HHb and HbT) were also 
observed. The small sample size in combination with the diverse population studied 
made it impractical to formulate group observations by investigating trends or 
absolute changes in NIRS parameters. 
In this section HbO2, HHb and TOI data obtained during each of the different 
ECMO phases, cannulation, weaning off ECMO, pCO2 and temperature challenges, 
are presented (figures 5.3-5.7). 
 
5.5.1 Cannulation  
Monitoring commenced when surgeons begun dissecting the neck and finished 
when full ECMO was established. Figure 5.3 shows how HbO2 (red), HHb (blue), 
HbT (black) and TOI (green) vary in the brain and leg of the patient D1 during the 
procedure. The dotted lines mark the time when the right common carotid artery 
(RCCA) was clamped and ligated, right internal jugular vein (RIJV) was clamped 
and ligated and when all clamps were off and the patient was on ECMO. Clamping 
the RCCA causes a drop in HbO2 and an increase in HHb while HbT stays the same, 
resulting in a drop in TOI. This was observed in both brain and leg. Clamping the 
RIJV caused an increase in HHb in both brain and leg. When all clamps were off and 
the patient went on ECMO there was an immediate decrease in HbO2, HHb and HbT, 
followed by a decrease in TOI. Then, HbO2, HbT and TOI in the leg increased and 
returned to their original values while the same parameters showed an increase in the 
brain but were still below their original values. 
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5.5.2 Weaning 
The weaning procedure starts by reducing the ECMO circuit flows by 10% 
approximately every 15 minutes. This is similar to the alteration in the ECMO flows 
included and described in the protocol above. Figure 5.4 shows NIRS data (HbO2 
(red), HHb (blue), HbT (black) and TOI (green)) in the brain and leg of patient 
during flow reduction from baseline (100%) flow down to 70% of the baseline flow. 
The raw data in the brain and leg differ significantly. The leg data showed a gradual 
decrease followed by a gradual increase in HbO2 (and HbT) and a gradual increase 
followed by a gradual decrease in HHb when the flows were reduced from 100% to 
90% of baseline flows. A similar pattern was shown when the flows were decreased 
further to 80%. The increase in HbO2 when the flows were decreased further to 70% 
might be an indication that the heart of the patient started to take over. In addition the 
leg data showed strong very slow oscillations clearly visible when the flow was at 
80% of baseline flow. The brain data did not reveal such large changes. However, an 
increase in HbO2 was seen when the flows were decreased to 70% of baseline flow. 
The weaning procedure, involves reduction of the ECMO circuit flows to 
minimum, followed by clamping of the arterial and venous cannulae such that blood 
form the ECMO circuit stops flowing in and out of the patient. The patient is then off 
ECMO but the ECMO circuit is still connected to the patient with blood circulating 
through the ECMO circuit bridge. The patient stays connected but off ECMO for 
several hours in order to verify whether the patient‟s heart and/or lungs have 
recovered. This usually called the “trial off” period prior to decannulation. During 
this period, the arterial and venous cannulae are unclamped and clamped every 15 
minutes, “flushing” blood in the patient. This is done in order to prevent blood 
clotting in the cannulae.  
Figure 5.5 shows data collected during ECMO “trial off” period. The dotted lines 
in the plots represent “flushing” of the cannulae. Flushing the cannulae caused a 
sharp increase in HbO2 and decrease in HHb, in both the brain and leg, while HbT 
increased indicating a rush of blood from the ECMO circuit flowing in the patient. 
This was reflected as a sharp increase in TOI. 
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5.5.3 CO2 challenge 
Figure 5.6a shows NIRS data obtained during changes in pCO2 (HbO2 (red), HHb 
(blue), HbT (black) and TOI (green)) in the brain and leg of a patient D8. A change 
in pCO2 was achieved by changing the amount of O2 gas sweep though the 
membrane oxygenation in the ECMO circuit. In this case, O2 sweep gas was reduced 
to 50% of its original value (from 2 lpm to 1 lpm) shown by the first dotted line in 
the graphs and maintained for about 10 minutes before it was reduced by further 50% 
(to 0.5 lpm). After 10 minutes the sweep gas was brought back to its original value. 
During the first reduction pCO2 was increased from 4.94 kPa to 5.46 kPa, it was then 
increased further to 7.12 kPa and then brought back to 5.61 kPa (figure 5.6b). An 
increase in pCO2 caused a gradual increase in cerebral HbO2 and HHb, and resulted 
in a gradual increase in TOI. Furthermore, a decrease in pCO2 caused a decrease in 
cerebral HbO2, HHb and TOI. These changes were not observed in the peripheral 
oxygenation data. 
 
5.5.4 Temperature challenge 
Figure 5.7 shows data collected during the temperature challenge. The dotted 
lines in the graphs represent a reduction/increase in temperature. Temperature was 
reduced by 1°C consecutively every 10 minutes and then increased back to original 
value. A decrease in temperature was associated by a decrease in HbO2 and TOI and 
an increase in HHb. Conversely, an increase in temperature caused an increase in 
HbO2 and TOI and a decrease in HHb. 
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Figure 5.3: HbO2 (red), HHb (blue), HbT (black) and TOI (green) data for the brain 
and leg of patient D4 monitored during cannulation. The dotted lines mark events 
during the cannulation procedure: clamping of the right common carotid artery 
(RCCA) (1), ligating RCCA (2), clamping of the right internal jugular vein (RIJV) 
(3), ligating RIJV (4), all clamps removed and patient goes on ECMO support (5). 
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Figure 5.4: HbO2 (red), HHb (blue), HbT (black) and TOI (green) data for the brain 
and leg of patient D1 monitored during reduction in ECMO circuit flows. Each 
reduction in flow is shown by the dotted lines. 
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Figure 5.5: HbO2 (red), HHb (blue), HbT (black) and TOI (green) in the brain and 
leg of patient D1 monitored during ECMO “trial off” period. Each dotted line 
represents “flushing” blood in the cannulae. 
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Figure 5.6: (a) HbO2 (red), HHb (blue), HbT (black) and TOI (green) data for the 
brain and leg of patient D8 during changes in pCO2 (b). Each change is shown by 
the black dotted lines. 
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Figure 5.7: HbO2 (red), HHb (blue), HbT (black) and TOI (green) data for the brain 
and leg of VA ECMO patient D8 during changes in temperature. Each change is 
shown by the black dotted lines. 
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5.6 Spectral Analysis 
 
5.6.1 Power spectral density 
  
5.6.1.1 Methods 
Power spectral density analysis was performed on 7 patients monitored during 
alterations in the ECMO flows (patients D1-D7 on table 5.1). The data were divided 
into sections each representing each flow period. Power spectral densities (PSD) 
were obtained for the HbO2 signal recorded at the two measurement sites. The PSDs 
were obtained in order to identify the presence of any oscillations occurring in the 
brain and in the leg and were estimated using Welch‟s method (Welch 1967). 
Computations were performed using a scientific software package (Matlab, 
Mathworks Inc). Four frequency bands were defined (very low (VLF) 0.002-0.25 Hz, 
low (LF) 0.25-0.5 Hz, high (HF) 0.5-1 Hz and very high (VHF) 1-3 Hz) to extract 
vasomotion, respiratory, mechanical (or ECMO pump) and cardiac oscillations. The 
strength of the oscillations between the brain and the leg corresponding to each 
ECMO circuit flow were compared for the LF band containing respiration rate (RR) 
and HF band containing any mechanical oscillation from the ECMO pump.  
 
5.6.1.2 Results 
Figure 5.8 shows the PSDs of the HbO2 signal during weaning for patient D1 
supported on VA ECMO. The raw HbO2 data for this patient are shown in figure 5.5. 
In this case the ECMO flows were reduced sequentially from baseline flow down to 
70% of baseline flow by 10% approximately every 10-20 minutes. In this case, a 
roller pump was used to operate the ECMO circuit. PSD analysis showed the 
presence of a strong oscillation in the brain and leg that remained constant as the 
ECMO circuit flow was decreased. This frequency might correspond to the patient‟s 
respiration rate (RR). A higher frequency appeared in both the brain and leg that 
shifted to the left with decreasing ECMO flow. This frequency was twice the 
frequency of the ECMO roller pump (fpump), which was consistent with the two 
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headed roller pump. In addition, a very slow oscillation (~0.005 Hz) was present 
only in the leg. The strength of this oscillation appeared to increase as the flow was 
reduced and is clear even in the time domain (figure 5.5).  
Figure 5.9 shows: a) HbO2 data and b) the corresponding PSDs for patient D4. 
This patient was supported on a VA ECMO and a centrifugal pump was used to 
operate the ECMO circuit. The PSDs of this patient showed the presence of two 
oscillations, one in the LF band corresponding to the patient‟s RR and the other in 
the HF band corresponding to the patient‟s heart rate (HR). There was no indication 
of the pump frequency. However, oscillations can be observed in the VLF band. In 
comparison to the previous patient these oscillations occurred around 0.015 Hz and 
appeared only in the brain and not in the leg. 
Figure 5.10 shows HbO2 data and corresponding PSDs for patient D3 supported 
on VV ECMO which operated using a roller pump. RR and the HR were present in 
both brain and leg. Oscillations were also shown around 0.005 Hz which only 
appeared in the leg data and around 0.05 Hz only appeared in the brain data. The 
difference between the oscillations in the VLF range can be clearly seen even in the 
time domain plots (figure 5.10a). 
PSD analysis of HbO2 for patient D5 are shown in figure 5.11. This patient was 
supported on VA ECMO and the ECMO circuit operated on a roller pump. 
Oscillations related to the RR and twice the pump frequency (fpump) were observed in 
both brain and leg data. Slow oscillation around 0.01Hz were only present in the 
brain.  Similarly patient D6 (VA ECMO; roller pump) showed oscillations related to 
the RR, HR and 2 x fpump which occurred in both brain and leg (figure 5.12). 
However, this patient showed the presence of a slow oscillation (0.05Hz) in the leg 
and not in the brain. PSD analysis of patient D7 (VA ECMO; roller pump) showed 
the presence of HR oscillations in both the brain and leg, and a slow oscillations 
(0.05Hz) which appeared only in the brain data (figure 5.13). The pump frequency 
and RR were not observed in this case.  
Spectral analysis was performed on patient D2 undergoing VA ECMO with a 
centrifugal pump. The PSDs, shown in Figure 5.13 identify the RR and the HR. 
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Similar to the results of patient 1, the PSD of this patient showed the presence of 
oscillations (~0.005 Hz) in the leg and not in the brain. 
In an effort to compare the strength between cerebral and peripheral oscillations, 
the ratio of the LF and HF powers were obtained as a function of flow change for the 
brain and leg data of the 7 ECMO patients (figure 5.15). The powers of each band 
were measured by obtaining the area under the PSD plots for each band. The results 
are depicted using a colour coded grid shown in figure 5.16 where the LF/HF power 
in the leg was subtracted from the LF/HF power in the brain. A red colour indicates 
that the oscillations are stronger in the brain compared to the leg. A blue colour 
indicates that oscillations in the brain are weaker than in the leg. Comparison 
between these two bands will give an insight into the strength of the mechanical 
oscillations caused by the roller pump frequency and potentially compare between 
the use of a roller and centrifugal pumps. It is worth noting, that in four out of four 
patients who underwent reductions in flows the oscillations appeared to be weaker in 
the brain compared to the leg.  This type of analysis, on data from a larger population 
of patients, may be useful in determining whether the level of pulsatility in flow is 
associated with neurologic dysfunction.  
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Figure 5.8: PSDs in the brain (blue) and leg (pink) of patient D1 at baseline flow 
(100% flow), 90%, 80% and 70% of baseline flow. The show the frequencies 
corresponding to the respiration rate (RR) and twice the pump frequency (2fpump). 
The inserts show the presence of a slow oscillation in the VLF range of the leg data. 
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Figure 5.9: (a) HbO2 data in the brain and leg for Patient D4 monitored during 
reductions in the ECMO flows. (b) Corresponding PSDs in the brain (blue) and leg 
(pink) showing the respiration rate (RR) and heart rate (HR). The inserts show the 
presence of a slow oscillation in the VLF range of the brain data. 
C
h
a
n
g
e
 i
n
 c
o
n
c
e
n
tr
a
ti
o
n
 (
µ
M
)
2 0 0 4 0 0 6 0 0 8 0 0
- 3 0
- 2 0
- 1 0
0
 
 
t i m e  ( s )
2 6 1 0 1 4
- 3 0
- 2 0
- 1 0
0
t i m e  ( m i n )
 
 
brain
leg
C
h
a
n
g
e
 i
n
 c
o
n
c
e
n
tr
a
ti
o
n
 (
µ
M
)
Δ
H
b
O
2
 (
µ
M
) 
C
h
a
n
g
e
 i
n
 c
o
n
c
e
n
tr
a
ti
o
n
(µ
M
)
1 0 0 0 1 2 0 0 1 4 0 0 1 6 0 0
- 4 0
- 2 0
0
t i m e  ( s )
 
 
1 8 2 2 2 6
- 4 0
- 2 0
0
t i m e  ( m i n )
 
 
brain
leg
brain
C
h
a
n
g
e
 i
n
 c
o
n
c
e
n
tr
a
ti
o
n
(µ
M
)
Δ
H
b
O
2
 (
µ
M
) 
(b) PSDs (a) HbO2 signal 
Baseline flow 
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 2
10
0
10
5
Frequency (Hz)
P
o
w
e
r/
F
re
q
u
e
n
c
y
 
 
 
brain
leg
0.02 0.04 0.06 0.08 0.1
0
200
400
600
800
1000
Frequency (Hz)
P
o
w
e
r/
F
re
q
u
e
n
cy
 
 
 
brain
leg
Baseline flow 
Frequency (Hz) 
M
ag
n
it
u
d
e 
(µ
M
2
/ 
H
z)
 
RR 
 HR     RR 
harmonic 
90% flow 
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 2
10
0
10
5
Frequency (Hz)
P
o
w
e
r/
F
re
q
u
e
n
c
y
 
 
 
brain
leg
0.02 0.04 0.06 0.08 0.1
0
200
400
600
800
1000
Frequency (Hz)
P
o
w
e
r/
F
re
q
u
e
n
c
y
 
 
 
brain
leg
90% flow 
Frequency (Hz) 
M
ag
n
it
u
d
e 
(µ
M
2
/ 
H
z)
 
RR 
    RR 
harmonic 
 HR 
80% flow 
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 2
10
-5
10
0
10
5
Frequency (Hz)
P
o
w
e
r/
F
re
q
u
e
n
c
y
 
 
 
brain
leg
0.02 0.04 0.06 0.08 0.1
0
200
400
600
800
1000
Frequency (Hz)
P
ow
er
/F
re
qu
en
cy
 
 
 
brain
leg
80% flow 
Frequency (Hz) 
M
ag
n
it
u
d
e 
(µ
M
2
/ 
H
z)
 
RR 
     RR 
harmonic 
 HR 
1 8 0 0 2 0 0 0 2 2 0 0 2 4 0 0 2 6 0 0
- 4 0
- 2 0
0
t i m e  ( s )
 
 
3 0 3 4 3 8 4 2
- 8 0
- 6 0
- 4 0
t i m e  ( m i n )
 
 
legΔ
H
b
O
2
 (
µ
M
) 
brain 
137 
 
 
 
Figure 5.10: (a) HbO2 data in the brain and leg for Patient D3. (b) Corresponding 
PSDs in the brain (blue) and leg (pink) showing the respiration rate (RR) and heart 
rate (HR). The insert shows the presence of slow oscillations in the VLF range. 
 
 
 
Figure 5.11: (a) HbO2 data in the brain and leg for Patient D5. (b) Corresponding 
PSDs in the brain (blue) and leg (pink) showing the respiration rate (RR) and heart 
rate (HR). The insert shows the presence of slow oscillations in the VLF range 
present in the brain. 
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Figure 5.12: (a) HbO2 data in the brain and leg for Patient D6. (b) Corresponding 
PSDs in the brain (blue) and leg (pink) showing the heart rate (HR) and vasomotion 
oscillations occurring in the brain. 
  
Figure 5.13: PSDs in the brain (blue) and leg (pink) of patient D7 showing the RR 
heart rate (HR) and pump frequency. 
                                       
Figure 5.14: PSDs in the brain (blue) and leg (pink) of patient D2 showing the RR, 
heart rate (HR) and vasomotion oscillations occurring in the brain. The insert shows 
the presence of slow oscillations in the VLF range present in the leg. 
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Figure 5.15: Power ratio as a function of ECMO flow in the brain and leg for the 7 
ECMO patients. 
 
 
Figure 5.16: Comparison between the strength of oscillations in the brain and leg.  
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5.6.2 Coherence 
 
5.6.2.1 Methods 
One of the ECMO patients listed in table 5.1 had systemic and ECMO data 
collected simultaneously with NIRO data. The MAP was obtained by averaging the 
arterial waveform every 0.2s (equivalent to sampling frequency of 5Hz) and the 
NIRO 200 data were downsampled from 6Hz to 5Hz. The concordance between 
MAP and cerebral HbD (difference between HbO2 and HHb) and MAP and 
peripheral HbD for this were quantified in a frequency specific manner using 
coherence function analysis. The signals were divided into sections representing each 
flow period and 9 minute epochs prior to decreasing (or increasing) the flow were 
analysed. The coherence describes the degree of correlation between the waveforms 
at a given frequency or frequency range. A coherence of 1 indicates perfect 
frequency specific correlation, and a coherence of 0 indicates complete lack of 
frequency specific correlation. Coherence scores were computed for each 9-minute 
epoch, representing a specific blood flow, for bandwidths covering the limits of the 
data sampling interval (0-0.01Hz, 0.01-0.25Hz, 0.25-0.5Hz, 0.5-1Hz, 1-2.5Hz for 
ultralow, very low, low, high, and very high frequency ranges, respectively). To 
obtain a measure of the coherence (COH) over a specific frequency band, the 
coherence function was averaged over that frequency band. By convention, COH 
values of ≥0.5, are considered to represent significant concordance between the two 
waveforms (Kuo et al. 1998, Tsuji et al. 2000, Wong et al. 2008). High concordance 
between MAP and HbD, and therefore high COH values, can be anticipated when 
autoregulation is impaired, as in this circumstance CBF and oxygen delivery become 
pressure passive.  
 
5.6.2.2 Results 
Figure 5.17 illustrates the temporal variation in MAP and HbD in the brain and 
leg for a VA patient on a centrifugal pump undergoing manipulations in the ECMO 
circuit flows. The coherence function between cerebral HbD and MAP for the 
ECMO flow period A (baseline [100%] ECMO flow) is shown in figure 5.18. The 
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figure illustrates the variable COH indicating a high degree of concordance between 
the MAP and cerebral HbD in the ULF band (COH >0.5) and low degree of 
concordance in the rest of the frequency bands. COH scores for the rest of the 
ECMO flow periods show a low degree of concordance in all frequency bands (table 
5.2). A high coherence value between cerebral HbD and MAP is an indication that 
CBF is pressure passive and if this is maintained for a long period of time it can 
suggest that cerebrovascular autoregulation is impaired. The COH scores between 
peripheral HbD and MAP, and cerebral HbD and peripheral HbD for all ECMO 
flows are listed in Table 5.2. High COH scores between peripheral HbD and MAP 
are reported in the ULF band when the flows were increased from 80% of baseline 
back to 90% baseline and back to baseline. These high scores are not reflected in 
COH between cerebral HbD and MAP suggesting an intact cerebral autoregulation.  
 
Figure 5.17: Temporal variation in cerebral HbD and peripheral HbD along with 
MAP for patient D8, a VA patient on centrifugal pump. 
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Figure 5.18: Coherence function between cerebral HbD and MAP for patient 8 at 
initial 100% ECMO flow, indicating high COH score (>0.5) in the ULF band (red), 
and low COH score in the VLF (yellow), LF (green), HF (cyan) and VHF (blue).  
 
Table 5.2: COH scores for patient 19. High COH scores (≥0.5) are highlighted. 
cerebral HbD Vs MAP 
 
100% 
flow 
90% 
flow 
80% 
flow 
90% 
flow 
100% 
flow 
ULF 0.57 0.25 0.09 0.19 0.37 
VLF 0.28 0.26 0.31 0.23 0.28 
LF 0.23 0.23 0.28 0.34 0.26 
HF 0.27 0.24 0.29 0.24 0.18 
VHF 0.24 0.24 0.23 0.25 0.21 
      
peripheral HbD Vs MAP 
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flow 
ULF 0.35 0.40 0.18 0.50 0.61 
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LF 0.23 0.23 0.22 0.27 0.21 
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VHF 0.24 0.25 0.25 0.24 0.24 
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Table 5.3:  Oscillations in the ECMO patients 
Patient 
ID 
Type of 
ECMO 
ECMO 
pump HR RR 
Pump 
frequency Vasomotion 
1 VA Roller Yes Yes Yes 0.005Hz (leg) 
4 VA Centrifugal Yes Yes - 0.005Hz (leg) 
7 VV Roller Yes Yes - 
0.005Hz (leg)  
0.05Hz (brain) 
8 VA Centrifugal Yes Yes - 0.015Hz (brain) 
10 VA Roller - Yes Yes 0.01Hz (brain) 
11 VA Roller Yes Yes Yes 0.05Hz (leg) 
13 VA Roller Yes - - 0.05Hz (brain) 
5.7 Discussion  
In assessing the role of NIRS monitoring, it is important to emphasize its unique 
qualities, including non-invasive, continuous real-time measurement of regional 
tissue oxygen saturation. However, caution must be exercised in extrapolating 
regional measurements to global findings. A total of 8 patients were monitored using 
the dual channel system. This was a rather inhomogeneous sample, consisting of 
patients supported on both VA and VV ECMO, operating either on centrifugal or 
roller pumps and with a wide age range (from 1 day to 5 years).Varying baseline 
levels of tissue oxygenation index (TOI) where observed between individual patients. 
The range of TOI value in both the brain and leg of the patients varied between 55-
80% with significant intersubject variability. In addition, variability in the trends of 
other NIRS parameters (HbO2, HHb and HbT) were also observed. The small sample 
size in combination with the diverse population studied made it impracticable to 
formulate group observations by investigating trends or absolute changes in NIRS 
parameters. 
The protocol was designed to include monitoring during routine ECMO 
procedures such as cannulation, weaning from ECMO (including the trial off period) 
and decannulation, and during interventions such as changes in the ECMO circuit 
144 
 
flow, temperature and carbon dioxide changes. Attempts were made to keep the full 
protocol with all patients. However, being the last on the list to have access on the 
unit it was particularly difficult to be present during non scheduled acute procedures 
such as cannulation, weaning and decannulation. NIRS data were obtained from one 
patient during cannulation and from another one during weaning and trial off period. 
Even though these are single data sets some interesting observations can be made. In 
the single dataset obtained with the dual channel NIRS system during the cannulation 
procedure, ligation of the RCCA was associated with a decrease in HbO2 and an 
increase in HHb in the leg data and only a decrease in HbO2 in the brain data. These 
changes were ~0.2 µM. In addition, TOI in the brain and leg decreased by ~3%. In 
the brain TOI returned back to baseline 3min after ligation while in the leg it was 
maintained in the decreased value until clamping the RIJV where it decreased by 
further 3%. TOI in the leg increased back to baseline value after all clamps were 
removed and the patient went on ECMO. An abrupt drop of ~7% in TOI was 
observed in the brain immediately after all clamps were removed and the patient 
went on ECMO and this was associated with abrupt drops in HbO2, HHb and HbT. 
The values of all NIRS parameters in the brain remained lower than baseline values 
15 minutes after ECMO support which was the end of the monitoring period. HbO2 
and HbT in the leg were higher that baseline values 15 minutes after ECMO support 
while TOI returned back to baseline value. Eijike et al. (2000) used the INVOS 
system with channels places on the right and left frontal regions to monitor ECMO 
patients during cannulation. They report that the ligation of the right common carotid 
artery resulted in a 12-25% decrease in rSO2 from baseline in the right frontal region 
for a duration ranging from 17 to 45 mins before returning toward baseline. No 
substantial change in the left frontal region was detected during cannulation. 
Following this depression in rSO2 on the right there was a transient increase above 
baseline in rSO2 in both hemispheres on initialising ECMO support. In a different 
study Van Heijst et al (2007) report a significant decrease in the concentration of 
oxyhaemoglobin and a significant increasse in the concentration deoxyhaemoglobin 
in both cerebral hemispheres after RCCA ligation. RIJV ligation did not cause any 
significant changes in NIRS parameter. 60 min after ECMO initiation, the 
concentration of oxyhaemoglobin increased in both cerebral hemispheres, whereas 
the concentration of deoxyhaemoglobin decreased in both hemispheres.   
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The single patient dataset obtained during the trial off ECMO period showed 
interesting changes in the NIRS parameters during “flushing” of the cannulae. Each 
time the cannlae were “flashed” a sharp increase in HbO2 and decrease in HHb and 
immediate in both brain and leg were observed. This was reflected as a sharp 
increase in TOI in both brain and leg. All NIRS parameters returned to their baseline 
values approximately 2 min after “flushing” the cannulae. This might be due to blood 
from the ECMO circuit rushing in the patient when unclamping the cannulae. Eijike 
et al. (2000) report that periods of trialing off ECMO were not related to any change 
rSO2 in either hemisphere. 
PSDs have been used to identify the presence of any oscillations occurring in the 
brain and leg of 7 ECMO patients undergoing flow manipulations. Table 5.3 
summarizes the results of the PSD analysis. The RR and HR can be picked up in 
most of the patients and is present in both brain and leg. In addition to these 
oscillations, the presence of oscillations in the VLF band were identified. It is 
interesting that a low frequency oscillation (0.005Hz) was present in the leg data of 3 
of the 7 patients studied (2 VA ECMO patients and 1 VV ECMO patient). Kvandal 
et al. report the presence of skin vasomotion oscillations in the interval 0.005-0.0095 
Hz (Kvandal et al. 2006). One patient shows oscillations at 0.05Hz only in the leg. 
Four of the patients showed slow oscillations in the brain (~0.01 in Patient10, 
~0.015Hz in Patient 8, ~0.05Hz in Patients 7 & 13), similar to those described by 
Obrig et al. (Obrig et al. 2000). Oscillations in the HF band appearing at twice the 
frequency of the ECMO pump were detected in brain and leg for 4 out of 5 VA 
patients operating on a roller pump. 
The PSD analysis has shown an interesting distinction between the use of roller 
and centrifugal pumps. The roller pump was found to be associated with an 
oscillatory effect in the systemic and cerebral circulations, even though this does not 
reflect the pulsatile contour of blood pressure. In the absence of a roller pump the 
oscillations do not exists and systemic and cerebral circulations can be flat around 
the frequency of the arterial pressure. The discussion concerning pulsatile and non-
pulsatile flow has been the subject of much research over the last three decades.  It is 
argued that as long as the total blood flow is adequate, the presence of a pulse 
contour is not physiologically important (Van Meurs, Lally, Peek, & Zwischenberger 
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2005a). At low but less than adequate blood flow, the effects of hypoperfusion and 
acidosis are somewhat amelionated by pulsatile flow. During ECMO, all 
management effort is placed on maintaining normal oxygen delivery. It is therefore 
argued that non-pulsatile perfusion does not have any delirious effects. The kidney is 
the organ most sensitive to non-pulsatile flow. Even though the cardiac intensive care 
unit at GOS hospital has stopped using roller pumps in ECMO circuits within the last 
couple of years it would have been interesting to investigate the effect of the 
oscillations resulting from the use of a roller pump further. 
Furthermore, coherence analysis was used to investigate the concordance 
between HbD and MAP. It has been shown previously that similar analysis can be 
used to detect cerebral autoregulation in premature newborns (De Smet et al. 2009, 
Morren et al. 2001, Soul et al. 2007, Tsuji et al. 2000). However, the monitoring 
period in previous studies was much longer than the monitoring period used in this 
study. Cerebral pressure passivity is not an all or none phenomenon but rather 
fluctuates over time (Soul et al. 2007). Since cerebral autoregulation is not a simple 
static system but rather a more complex rate-sensitive system, the total length of the 
signal analysed plays an important role in the concordance between CBF and MAP. 
Static and/or intermittent measurements of cerebral pressure autoregulation used in 
previous studies are likely to miss cerebral pressure passivity (Tyszczuk et al. 1998).  
Furthermore, previous studies have confined the investigation of cerebral 
autoregulation to measurement of coherence only in the range 0-0.1Hz (ULF band). 
These frequencies correspond to changes occurring over several minutes. Changes in 
MAP increase in amplitude as frequency decreases (Parati et al. 1995). Because 
prolonged cerebral ischemia (e.g. several minutes to hours) is likely to be more 
injurious than transient (e.g. several seconds) reductions in CBF, prolonged 
correlations in CBF to these larger changes in MAP are more likely to be 
pathologically significant. These prolonged correlations are captured by ULF. 
However, in the case on ECMO patients our interest lays in higher frequencies since 
the ECMO machine itself induces oscillations driven by the circuit pump. It is in our 
interest to examine the impact of these higher oscillations, in addition to the lower 
oscillations, on cerebral blood flow and cerebral pressure autoregulation.  
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It is worth noting that such spectral analysis was not previously performed on 
ECMO patients. There is interest in investigating novel methods for analysing these 
data with a view to elucidating cerebral autoregulation mechanisms in ECMO 
patients. Further studies are required to more fully explore the relationship between 
oscillations arising in specific frequency bands and the type of ECMO procedures 
used in different patients.  
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Chapter 6 
 
MULTICHANNEL NEAR INFRARED SPECTROSCOPY 
TO MEASURE REGIONAL CEREBRAL OXYGENATION 
IN INFANTS AND CHILDREN SUPPORTED ON ECMO 
 
 
 
 
 
 
6.1 Introduction  
In the current era of extracorporeal membrane oxygenation (ECMO), there are 
serious limitations with inadequate neuromonitoring, misleading neuromonitoring, or 
both, especially in the setting of hemodilution and nonpulsatile flow (Nollert et al. 
1998). The implications of neurological monitoring with relevance to 
neurodevelopmental outcome have not been clearly delineated. As a result, there is 
equipoise about routine neuromonitoring, particularly with near-infrared 
spectroscopy (NIRS) and the relevance of data (Hirsch et al. 2010).  
Near infrared spectroscopy (NIRS) has the advantage of monitoring cerebral 
oxygenation non-invasively and continuously by the bedside. To date, conventional 
NIRS uses single or dual channel systems with the optodes usually placed on the 
forehead of the patients providing information related to perfusion of only a small 
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area of the anterior cerebrum and therefore do not allow evaluation of the status of 
the cerebral circulation and oxygenation in the extended cerebral regions. NIRS was 
used on ECMO patients to study the effect of cannulation on cerebral oxygenation. 
Ligation of RCCA was associated with a decrease in HbO2, an increase in HHb (Van 
Heijst et al. 2004) and a decrease in tissue oxygen saturation (TOS) (Ejike et al. 
2006) while no changes were seen during IJV ligation. Also, an increase in HbO2, a 
decrease in HHb and an increase in TOS was reported after ECMO was established 
compared to pre-cannulation values.  
However, the fact that only regional information in cerebral oxygenation can be 
obtained from the current commercial NIRS systems in clinical use is considered a 
major limitation (Andropoulos et al. 2004b, Hirsch et al. 2010, Su and Undar 2010). 
Alterations in regional oxygen saturation may reflect local changes and not 
necessarily indicate global hypoperfusion.  
This work aims at the development and induction of a multichannel near infrared 
spectroscopy system for use in the intensive care environment. With the specific 
application of the system to monitor ECMO patients and assess regional variations in 
cerebral oxygenation during different ECMO phases. 
 
6.2 Methods 
 
6.2.1 Instrumentation  
The ETG-100 optical topography (OT) system was used to acquire multi-site 
HbO2, HHb and HbT concentrations. The multichannel system does not give 
information on tissue oxygen saturation. The ETG-100 is a CW system with a 
maximum number of 18 optodes; 10 sources emitting at 730 nm and 810 nm and 8 
avalanche photodiodes. The hardware configuration is described elsewhere (chapter 
3). It is mainly designed for functional activation studies, and it has been used to 
study the activity of healthy brain and cerebral pathologies in adults, infants and 
newborns (Homae et al. 2006, Koizumi et al. 2003, Koizumi et al. 2005, Otsuka et al. 
2007).  
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The Hitachi ETG-100 optical topography system has a software which allows the 
digitise NIRS signals to be shown on the monitor of the incorporated PC in real time. 
Also, depending on the operation mode, the software allows for a basic analysis of 
the stored data. However, the ETG-100 software is designed for functional activation 
studies and not for clinical use. Therefore, for the purpose of this study the software 
was only used in the “Measurement Operation” mode for displaying the signals in 
real time, collecting and storing the signals for off line analysis.  
Before starting the data collection, the software performs a test to check whether 
enough light is reaching the detectors. During probe setting, a window appears 
displaying the positions of measurement channels and indicating the gain status of 
each channel. A green colour indicates optimal gain, red indicates over gain and 
yellow indicates under gain. If after placing the fibres on the patient most of the 
channels were over gained or under gained, the percentage gain threshold was 
changed accordingly. The percentage threshold gain is related to the A/D gain, i.e. 
50% of 5V which is equivalent to 2.5V, means detection between -2.5V to 2.5V. 
Outside this region is under gain (yellow) or over gain (red). In other words, if the 
optical intensity was high, the gain threshold was increased. 
Systemic data, arterial blood pressure (ABP), central venous pressure (CVP), 
end-tidal CO2, heart rate (HR), respiration rate (RR), pulse, temperature and arterial 
oxygen saturation (SaO2), were continually measured, recorded and displayed in real 
time at the bedside (Intellvue MP70, Philips Medical). ABP and CVP are obtained 
invasively, usually from radial artery and femoral vein respectively. SaO2 is obtained 
from a pulse oximeter placed on the toe of the patients. ABP, CVP, RR and end-tidal 
CO2 are recorded as continuous waveforms at a frequency of 125Hz (ABP and CVP) 
and 62.5Hz (RR and end-tidal CO2). These four parameters are also collected as 
averaged values at 1Hz.  HR, SpO2, temperature and pulse are also collected at 1Hz. 
Software (Trendface, Ixellence GmbH, Germany) was used to collect and export the 
systemic data onto a PC for subsequent analysis.  
Parameters related with the ECMO circuit were also collected continually at the 
bedside (M3 monitoring system, Spectrum Medical Ltd.). These included arterial 
oxygen saturation (SaO2) and blood flow measured using probes placed on the 
arterial cannula, venous oxygen saturation (SvO2) measured using a probe placed on 
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the venous cannula and haemotocrit. ECMO circuit parameters were collected with a 
random (or irregular) sampling rate and were stored in a S.D memory and exported 
to a PC.  
 
 
Figure 6.1: Illustrating the sequence followed for obtaining simultaneous collection 
of systemic, ECMO parameters and with optical parameters collected with ETG-100. 
 
In order to proceed with data analysis synchronisation of the time base axes 
between the three monitors was addressed. Similar to the dual-channel system 
described in chapter 5, synchronisation between the ETG-100 data and systemic 
parameters was achieved by placing an event marker on the ETG-100 system at the 
time when the Trendface software started collecting the systemic data. For 
synchronising the ECMO circuit parameters with the physiologic parameters the 
clock stamps on the ECMO monitor and Trendface software were used. This 
sequence allowed data collection from the three monitors to be synchronised within 
±1s. A MatLab script was written to synchronise the data from the three different 
files.  
 
6.2.2 Neonatal cap design and construction  
The ETG-100 optical topography system in our lab was previously used for 
functional activation studies in adults. Before we used it in a clinical neonatal 
environment, the optical fibres were changed from the adult probes to the much 
smaller neonatal probes. A neonatal cap was designed and constructed to house the 
neonatal fibres, hold them in place and maintain good contact with the patients‟ 
scalp.  
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Figure 6.2: Source (S) – Detector (D) configuration used allowing measurements of 
haemoglobin concentration to be obtained from a total of 12 channels. 
 
The source-detector configuration used is shown in figure 6.2. A 3x3 
arrangement was used with source-detector separation set at 3cm and each laser 
emitting at 1.2 mW. A source-detector separation of 3cm was previously used in 
NIRS infant studies (Minagawa-Kawai et al. 2007). Taga et al (2007) report a good 
sensitivity and high signal-to-noise ratio when ETG-100 was used on 3 month old 
infants at S-D separation of 3cm and laser power at 1.2mW (Taga et al. 2007). The 
3x3 arrangement placed centrally on the head of a newborn ECMO patient covers the 
largest area available taking into consideration that the occipital and part of the right 
temporal lobes cannot be accessed because the patient is lying down and has 
cannulae stitched above the right ear. This configuration allows data to be collected 
from a total of 12 channels. 
The cap required to be flexible so as to fit different head shapes and sizes, due to 
the variability in head shapes of the newborn and wide age range of patients placed 
on ECMO. In addition, the cap needed to be made from a material that can be 
autoclaved (i.e. sterilised).  
Fibre Holders 
New holders to house the fibres were designed based on the original neonatal 
fibre holder designs obtained from Hitachi Medical Ltd. The holders are shown in 
figure 6.3. They are spring loaded with a very light spring that will allow the fibre tip 
to be kept in contact with the patient‟s scalp. A rubber o-ring is placed at the bottom 
6 cm 
3 cm 
S 
 S 
 S 
 S 
 S 
 D 
 D  D 
 D 
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of the holder to minimise the pressure applied on the scalp. Plastic connectors were 
also designed to connect the holders with each other, maintaining a distance of 3cm 
between them and keeping the desired array configuration.  
 
 
Figure 6.3: The neonatal optical fibres are L-shaped fibres (a) and they are housed 
in spring loaded plastic holders with an o-ring fitted at the bottom (b). The fibres are 
hold together in an array using plastic connectors (c). 
 
 
 
Figure 6.4: 3D reconstructions of MRI scans obtained from the radiology archives of 
GOS hospital courtesy of Claoudio Capelli and Giovani Biglino. Head 
circumferences from right to left: 51 cm, 47.5 cm, 43.5 cm, 41 cm, 37 cm and 33 cm. 
 
 
(a) 
(b) 
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Cap  
A flexible light neonatal cap was constructed using room-temperature 
vulcanising (RTV) T30 high strength silicone mould rubber (Alec Tiranti Ltd.). 
Vulcanisation is a chemical process for converting rubber into more durable 
materials via the addition of sulphur or other equivalent “curative” agents. In its 
uncured state RTV T30 is a thick, white, sticky liquid. The inelastic deformation of 
the silicone rubber is due to its polymeric chemical structure. Polymer chains can 
move independently relative to each other, which enables the material to change 
shape. When RTV T30 is mixed with a curative agent, in a composition of 5% agent 
(by weight), it cures at room temperature to a solid elastomer. In other words, in its 
curable state RTV T30 is a flexible, strong, elastic solid. RTV remains flexible from 
-80 °C to +250 °C and is therefore autoclavable.  Furthermore, RTV T30 can be 
moulded into any shape by pouring it into any container or by simply brush painting 
a surface.  
 
Figure 6.5: ETG-100 neonatal cap on dummy head. 
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Six dummy heads were provided by rapid prototyping 3D image reconstructions 
of MRI scans of baby heads obtained from the archives of the radiology department 
in Great Ormond Street Hospital (with the help of Marina Hughes, Claudio Capelli, 
Giovani Biglino, Martin Watmough). The six dummy heads were chosen to have 
different head circumferences to cover ages from 1 day to 5 years (figure 6.4). The 
cap base was made by brush painting three consecutive layers of RTV T30 mixed 
with black oil paint on a dummy head. This allows the cap to have the right curvature 
and therefore maintain good contact between the fibres and scalp. The silicon rubber 
was then peeled off from the dummy head and holes were cut out to fit the fibre 
holders in a 3x3 array. Straps were also made from silicon rubber reinforced with a 
net. The net allows for Velcro tapes to be sewed on the silicon rubber. A wide strap 
was attached to the base of the cap at the back of the head that goes around the 
periphery of the head and closes at the forehead using the Velcro tapes. Narrower 
straps were attached around the edges of the base so as when pulling them the cap 
fits the head of the patient. Figure 6.4 shows the neonatal cap on the dummy head 
and figure 6.5 shows the cap in use on an ECMO patient.  
 
Figure 6.6: (a) Patient supported on ECMO with arterial and venous cannula 
shown. (b) Putting the neonatal cap on an ECMO patient and (c) the neonatal cap in 
use.  
 
 
(a) (b) 
(c) 
arterial 
cannula 
venous 
cannula 
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Note that prior to the final cap version, two earlier versions of the cap were 
made, prototype1 and prototype2.  Prototype1 was designed before the fibre holders 
were constructed and was therefore susceptible to movement artefacts due to the fact 
that the fibres were not help stable. The design of prototype2 was similar to the final 
cap design, however the base of the cap was obtained based on the curvature of a 
plastic hemispherical bowl as a result the cap did not fit so well on the patients head. 
 
6.2.3 Protocol 
The study protocol followed was similar to the one described in chapter 5. 
However, temperature and CO2 interventions were omitted since preliminary results 
using the dual channel system showed practicality issues in performing those studies. 
Regional cerebral oxygenation was assessed during cannulation, decannulation, 
weaning from ECMO and changes in the ECMO circuit flows. Changes in the 
ECMO flows were carried out by successive reductions in the ECMO circuit flows 
by 10% of the baseline until 70 % of the baseline every 10-15 minutes and 
subsequently sequentially increasing it back to baseline flow. 
  
6.2.4 Patients 
A total of 12 VA ECMO patients were studied with age ranging between 1 to 25 
days. One patient was monitored during weaning, one during cannulation and one 
during decannulation. Ten patients were monitored during ECMO flow changes. A 
full list of the subjects studied is shown in table 6.1. Parental consent was obtained 
prior to the start of each study. 
 
6.2.3 Data rejection 
Optical data collected at a sampling frequency of 5 Hz were resampled at 1 Hz 
and low pass filtered at 0.05 Hz to remove physiological noise. For the conversion of 
the optical attenuation changes to chromophore concentration changes a differential 
pathlength factor (DPF) of 4.99 was applied (Duncan et al. 1995). The recorded 
attenuation measurements for each data set were initially inspected and channels that 
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showed evidence of poor signal-to-noise ratio, mismatch in attenuation at the two 
wavelengths or saturation of the detector were rejected from further analysis.  
 
6.2.4 Data analysis 
During alterations in ECMO flows changes in HbO2, HHb and HbT between 
phase I [from baseline flow (100%) to minimum flow (70%)] and phase II [from 
70% flow back to baseline flow] were calculated from the differences in mean values 
over a 60-s period just before changing the flow. At weaning changes in HbO2, HHb 
and HbT between the difference in mean values over 60-s period just before 
clamping the cannulae and around the minimum or maximum post clamping the 
cannulae were obtained. The results were analysed using a paired t-test (p<0.05). 
 
6.3 Results 
A total of 12 VA ECMO patients were recruited in this study. One patient was 
monitored during cannulation, one during decannulation, one during weaning and 9 
during alterations in the ECMO flows. Attempts were made to follow compete 
protocol and monitor each patient through all procedures as mentioned in the 
methods section above. However, it was particularly difficult to capture procedures 
such as cannulation, decannulation and weaning partly because they were usually 
taking place at inconvenient hours. Out of the 12 patients only 7 were used in the 
data analysis (6 patients monitored during flow changes and 1 during weaning). The 
42% drop out is a result of a number of factors including: bad fitting of the cap 
especially in cases where the prototype versions of the cap were used; low signal-to 
noise ratio due to very high or low light intensity reaching the detectors depending 
on the amount of hair and head transparency of the patients; and incomplete studies 
due to the critical condition of the patients. All the above are summarised in table 6.2 
along with the number of channels used in data analysis after applying the data 
rejection criteria (see methods section above).  
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Table 6.1: Demographics of ECMO patients included in the study. 
Patient 
ID 
Age  
(days) 
Type of ECMO Cannulation sides Type of pump Type of study Indication for ECMO Clinical condition 
1 4  VA RCCA & IJV Roller Flow changes Neonatal Respiratory failure 
Neonatal hypoxaemic respiratory failure due to 
Left CDH 
2 21 VA chest cannulation Centrifugal Cannulation 
Cardiac - post cardiac 
surgery 
Post TAPVC repair 
3 1  VA RCCA&IJV Centrifugal Decannulation Neonatal Respiratory failure 
Neonatal hypoxaemic respiratory failure with 
PPHN and MAS 
4 12  VA RCCA & IJV Centrifugal Flow changes Neonatal Respiratory failure 
Neonatal hypoxaemic respiratory failure due 
RSV infection post cardiac surgery 
5 3  VA RCCA&IJV Centrifugal Flow changes Neonatal Respiratory failure 
Neonatal hypoxaemic respiratory failure with 
PPHN and MAS 
6 5  VA RCCA & IJV Centrifugal Flow changes Neonatal Respiratory failure 
Neonatal hypoxaemic respiratory failure due to 
Left CDH 
7 9  VA RCCA&IJV Centrifugal Flow changes Neonatal Respiratory failure 
Neonatal hypoxaemic respiratory failure with 
PPHN and MAS 
8 16  VA RCCA&IJV & RA Centrifugal Flow changes 
Cardiac - post cardiac 
surgery 
Post Arterial Switch surgery 
9 4  VA RCCA&IJV Centrifugal Weaning Neonatal Respiratory failure 
Neonatal hypoxaemic respiratory failure with 
PPHN, sepsis 
10 3  VA RCCA&IJV Centrifugal Flow changes Neonatal Respiratory failure 
Neonatal hypoxaemic respiratory failure with 
PPHN and MAS 
11 3  VA RCCA&IJV Centrifugal Flow changes Neonatal Respiratory failure 
Neonatal hypoxaemic respiratory failure with 
PPHN and MAS 
12 25  VA RCCA&IJV Centrifugal Flow changes 
Paediatric Respiratory 
failure 
Paediatric hypoxaemic respiratory failure due 
Pertussis 
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Table 6.2: List of patients included in the study showing useful channels after data rejection. Rejected channels are highlighted grey and 
active channels are highlighted green. 
Patient 
ID 
Type of 
study 
Channel Total # 
of 
channels 
Cap 
 
Comments 
 1 2 3 4 5 6 7 8 9 10 11 12 
1 Flow changes             0 Prototype1 No systemic and ECMO data collected. Unstable cap fitting leading to artefacts. 
2 Cannulation             0 Prototype1 Lots of movement artefacts due instability in cap fitting. 
3 Decannulation             0 Prototype1 Lots of movement artefacts due instability in cap fitting. 
4 Flow changes             12 Prototype2  
5 Flow changes             3 Prototype2 Patient has thick black hair. Channels undergain. 
6 Flow changes             5 Prototype2 Incomplete study due to the condition of the patient 
7 Flow changes             8 Prototype2  
8 Flow changes             8 Prototype2  
9 Weaning             10 NeoFlexiCap  
10 Flow changes             12 NeoFlexiCap  
11 Flow changes             8 NeoFlexiCap  
12 Flow changes             0 NeoFlexiCap Too transparent. Channels overgain. 
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6.3.1 Flow changes 
 
Table 6.3: List of patients monitored during alterations in the ECMO flows. Green 
indicates useful data and grey indicated that the period was rejected due to noise. 
Patient 
ID 
ECMO period 
A 
(100%) 
B 
(90%) 
C 
(80%) 
D 
(70%) 
E 
(80%) 
F 
(90%) 
G 
(100%) 
4               
5               
7               
8               
10               
11               
 
Table 3 lists the six patients monitored during flow changes and indicates the 
ECMO flow sequence followed for each patient. The ECMO periods used in the data 
analysis are highlighted green. Five patients were monitored during the complete 
flow changes sequence, i.e. flow periods A to G. However, for one of those patients 
(patient 10) only flow periods A to D were used in the data analysis the rest of the 
flow periods were rejected due to the presence of movement artefacts. In patient 7 
ECMO flow was only decreased to 80% of the baseline and sequentially brought 
back to baseline. It was not possible to reduce the flow further to 70% because the 
patient presented a big drop in MAP, SpO2 and SvO2 when the flows were reduced to 
80%. 
 
Patient 4 
Figure 6.6d shows concentration changes in HbO2 (red), HHb (blue) and HbT 
(black) collected from the 12 channels during changes in ECMO flows in patient 4. 
The systemic variables (MAP, HR, SpO2 and SvO2) are shown in figure 6.6c. The 
channel configuration and ECMO flow sequence are shown by the schematics at the 
top left of figure 6.6. The vertical dotted lines in the concentration and systemic 
variables plots represent the time at which a change in flow was induced so that each 
section in the plots corresponds to a specific flow period. Sequential reduction in 
ECMO flows resulted in considerable increase in HHb and HbT in all 12 channels, 
161 
 
with moderate changes seen in HbO2. Figure 6.7 shows the responses in the 
concentration changes (HHb and HbO2) and systemic variables (MAP, HR, SpO2 and 
SvO2) during phases I (mean changes from baseline to minimum flow) and II (mean 
changes from minimum flow back to baseline). The range in the change of HHb 
concentration during phase I was from 9.7μM (channel 8) to 25.1μM (channel 10). In 
this patient a decrease in ECMO flow is associated with a decrease in SvO2 (of 20%) 
and SpO2 (of 8%) and an increase in HR (of 21 bpm) and MAP (of 5 mmHg). The 
effect is reversed when the flow is gradually increased back to baseline. Similar to 
the haemoglobin concentration data, these systemic and ECMO circuit parameters do 
not return to their baseline values by the end of the monitoring period. 
 
Patient 5 
The chromophore concentrations (HbO2, HHb and HbT) data, along with the 
systemic variables (MAP, HR and SvO2) during sequential changes in ECMO flow 
for patient 5 are shown in figure 6.8. The SpO2 data were too noisy and are not 
shown here. This patient was monitored during the whole ECMO flow sequence 
from flow periods A to G as shown schematically in figure 6.8b. Unfortunately, the 
black hair of this patient did not allow collecting data from all channels and only 
channels 1, 2 and 3 were kept after the rejection criteria. The responses in the 
concentration data and systemic variables during phases I and II are shown in figure 
6.9. In this patient sequential reduction in flows caused a decrease in HbO2 between 
8.7 µM (channel 3) and 2.2 µM (channel 2) and an increase in HHb between 2.3 µM 
(channel 2) and 1.7 µM (channel 3). In comparison to patient 4 the responses in 
patient 5 are not as big while the decrease in HbO2 in greater than the increase in 
HHb. Reduction in flow from baseline to minimum was associated with a decrease in 
MAP (4.2 mmHg), decrease in HR (5.5 bpm) and a decrease in SvO2 (6.4 %). Even 
though changes in HHb appear to be reversed during phase II changes in HbO2 
remain lower than baseline with the exception of channel 3. Also changes in SvO2 
are reversed while changes in MAP and HR remain lower than baseline values.  
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Patient 7 
The results for patient 7 are presented in figures 6.10 and 6.11. Figure 6.10 shows 
the time course data of the chromophore concentrations and systemic variables 
during flow changes. The figure also shows the flow sequence followed by this 
patient (figure 6.10b). In this patient the flows were only reduced by a total of 20 %, 
i.e. they were only brought down to 80 % of baseline, and then sequentially increased 
back to baseline. Figure 6.11 shows the responses of the cerebral and systemic 
parameters during phases I (mean changes between baseline [A=100 % flow] and 
minimum flow [C=80 % flow]) and II (mean changes between minimum flow [C] 
and back to baseline [G]). Similar to patient 4, reduction in flows in patient 6 resulted 
in an increase in HHb and a smaller decrease in HbO2 across all the channels. 
However, the changes seen in HHb ranged from 7.6 µM (channel 9) to 3.1 µM 
(channel 1) and are lower compared to those seen in patient 4. Responses during 
phase II indicate the changes are not reverse when the flow returns back to baseline. 
Reduction to minimum flow in this patient caused a decrease in SvO2 of 14.6 % and 
a decrease in SpO2 of 6.9 % while an increase in MAP (3.6 mmHg) and HR (0.6 
bpm) were observed.  
 
Patient 8 
Time course data of chromophore concentrations and systemic variables during 
the complete ECMO flow changes sequence (from flow periods A to G) for patient 7 
are shown in figure 6.12. The responses during phases I and II are shown in figure 
6.13. In this patient the responses during phase I show that a decrease in flows is 
associated with a decrease in HbO2 in all channels (ranging between 5.2 µM in 
channel 1 and 2.2 µM in channel 11).  During phase II changes in HbO2 are reversed 
in most channels and in some channels HbO2 increases above baseline values. An 
increase in HHb is observed during phase I and most channels show an increase of 
HHb above baseline values during phase II. The increase in HbO2 and HHb above 
baseline values during phase II could be due to the fact the MAP and HR increase 
above their baseline values during phase II. Reduction in flows during phase I cause 
a decrease in SpO2 and SvO2 by 0.2 % and 6 %, respectively. 
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Patient 10 
The results of patient 8 are presented in figures 6.14 and 6.15. Figure 6.14 shows 
the time course data for cerebral parameters and systemic parameters during 
sequential reduction in ECMO flows (ECMO period A to D). Note that that in this 
patient data for ECMO periods E to F (increasing the flows back to baseline) are not 
shown due to the presence of movement artefacts. Consequently, figure 6.15 shows 
the responses in cerebral and systemic parameters during phase I. In this case, there 
is no evident trend in cerebral parameters and the changes are minor in relation to the 
previous patients. A decrease in SvO2 of 6.7 % and SpO2 of 3.4 % is observed. MAP 
and HR also decrease by 0.2 mmHg and 7.4 bpm, respectively.  
Patient 11 
Figures 6.16 and 6.17 show the results obtained for patient 10. Similar to patient 
8, patient 9 shows minor changes in cerebral parameters during phase I. However, a 
decrease below baseline values is seen in both HHb and HbO2 during phase II. In this 
patient reduction in flow is associated with drop in SvO2 of 4.8 % and a drop in SpO2 
of 0.2 %.  
6.3.2 Weaning 
Figure 6.18 shows chromophore concentration data collected with the 
multichannel ETG-100 system for patient 9. This patient was monitored during 
weaning off ECMO and the data in figure 6.18 show the effect of clamping the 
cannulae on cerebral oxygenation. When the cannulae are clamped the patient goes 
off ECMO, i.e. the heart and lungs stop being dependent on the ECMO circuit. 
Clamping the cannulae causes a decrease in HbO2 and an increase in HHb. The 
changes are reflected in all channels and are in the order of 5µM as shown in figure 
6.19. A decrease in MAP and HR are also observed (figure 6.19b).   
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Figure 6.7: Multisite brain oxygenation and haemodynamics of Patient 4 during flow 
changes. (a) Schematic of the 12-channel arrangement, (b) Sequence of flow changes 
indicating the different flow periods (A=100%, B=90%, C=80%, D=70%, E=80%, 
F=90%, G=100%), (c) Systemic parameters (MAP, HR, SpO2 and SvO2), (d) 
Multichannel NIRS parameters, HbO2 (red), HHb (blue) and HbT (black).The 
vertical dotted lines split the plots into the different flow periods. 
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Figure 6.8: Mean absolute changes in haemoglobin concentrations across the 12-
channels and systemic parameters during phases I (from baseline to minimum flow) 
and II (from minimum flow back to baseline) for Patient 4. 
* Statistically significant differences in HHb (p<0.05) 
° Statistically significant differences in HbO2 (p<0.05) 
♦ Statistically significant differences is systemic parameters (p<0.05) 
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Figure 6.9: Multisite brain oxygenation and haemodynamics of Patient 5 during flow 
changes. (a) Schematic of the 12-channel arrangement, (b) Sequence of flow changes 
indicating the different flow periods (A=100%, B=90%, C=80%, D=70%, E=80%, 
F=90%, G=100%), (c) Systemic parameters (MAP, HR, SpO2 and SvO2), (d) 
Multichannel NIRS parameters, HbO2 (red), HHb (blue) and HbT (black).The 
vertical dotted lines split the plots into the different flow periods. 
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Figure 6.10: Mean absolute changes in haemoglobin concentrations across the 12-
channels and systemic parameters during phases I (from baseline to minimum flow) 
and II (from minimum flow back to baseline) for Patient 5. 
* Statistically significant differences in HHb (p<0.05) 
° Statistically significant differences in HbO2 (p<0.05) 
♦ Statistically significant differences is systemic parameters (p<0.05) 
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Figure 6.11: Multisite brain oxygenation and haemodynamics of Patient 7 during 
flow changes. (a) Schematic of the 12-channel arrangement, (b) Sequence of flow 
changes indicating the different flow periods (A=100%, B=90%, C=80%, D=70%, 
E=80%, F=90%, G=100%), (c) Systemic parameters (MAP, HR, SpO2 and SvO2), 
(d) Multichannel NIRS parameters, HbO2 (red), HHb (blue) and HbT (black).The 
vertical dotted lines split the plots into the different flow periods. 
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Figure 6.12: Mean absolute changes in haemoglobin concentrations across the 12-
channels and systemic parameters during phases I (from baseline to minimum flow) 
and II (from minimum flow back to baseline) for Patient 7. 
* Statistically significant differences in HHb (p<0.05) 
° Statistically significant differences in HbO2 (p<0.05) 
♦ Statistically significant differences is systemic parameters (p<0.05) 
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Figure 6.13: Multisite brain oxygenation and haemodynamics of Patient 8 during 
flow changes. (a) Schematic of the 12-channel arrangement, (b) Sequence of flow 
changes indicating the different flow periods (A=100%, B=90%, C=80%, D=70%, 
E=80%, F=90%, G=100%), (c) Systemic parameters (MAP, HR, SpO2 and SvO2), 
(d) Multichannel NIRS parameters, HbO2 (red), HHb (blue) and HbT (black).The 
vertical dotted lines split the plots into the different flow periods. 
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Figure 6.14: Mean absolute changes in haemoglobin concentrations across the 12-
channels and systemic parameters during phases I (from baseline to minimum flow) 
and II (from minimum flow back to baseline) for Patient 8. 
* Statistically significant differences in HHb (p<0.05) 
° Statistically significant differences in HbO2 (p<0.05) 
♦ Statistically significant differences is systemic parameters (p<0.05) 
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Figure 6.15: Multisite brain oxygenation and haemodynamics of Patient 10 during 
flow changes. (a) Schematic of the 12-channel arrangement, (b) Sequence of flow 
changes indicating the different flow periods (A=100%, B=90%, C=80%, D=70%, 
E=80%, F=90%, G=100%), (c) Systemic parameters (MAP, HR, SpO2 and SvO2), 
(d) Multichannel NIRS parameters, HbO2 (red), HHb (blue) and HbT (black).The 
vertical dotted lines split the plots into the different flow periods. 
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Figure 6.16: Mean absolute changes in haemoglobin concentrations across the 12-
channels and systemic parameters during phases I (from baseline to minimum flow) 
and II (from minimum flow back to baseline) for Patient 10 
* Statistically significant differences in HHb (p<0.05) 
° Statistically significant differences in HbO2 (p<0.05) 
♦ Statistically significant differences is systemic parameters (p<0.05) 
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Figure 6.17: Multisite brain oxygenation and haemodynamics of Patient 11 during 
flow changes. (a) Schematic of the 12-channel arrangement, (b) Sequence of flow 
changes indicating the different flow periods (A=100%, B=90%, C=80%, D=70%, 
E=80%, F=90%, G=100%), (c) Systemic parameters (MAP, HR, SpO2 and SvO2), 
(d) Multichannel NIRS parameters, HbO2 (red), HHb (blue) and HbT (black).The 
vertical dotted lines split the plots into the different flow periods. 
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Figure 6.18: Mean absolute changes in haemoglobin concentrations across the 12-
channels and systemic parameters during phases I (from baseline to minimum flow) 
and II (from minimum flow back to baseline) for Patient 11. 
* Statistically significant differences in HHb (p<0.05) 
° Statistically significant differences in HbO2 (p<0.05) 
♦ Statistically significant differences is systemic parameters (p<0.05) 
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Figure 6.19: Multisite brain oxygenation and haemodynamics of Patient 9 during 
weaning. (a) Schematic of the 12-channel arrangement, (b) Systemic parameters 
(MAP and HR), (d) Multichannel NIRS parameters, HbO2 (red), HHb (blue) and 
HbT (black).The vertical dotted lines mark flow reduction, unclamping the bridge 
and  clamping of the cannulae so that the patient is off ECMO, as indicated in 
channel 1. 
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Figure 6.20: Mean absolute changes in haemoglobin concentrations across the 12-
channels and systemic parameters between prior to clamping the cannulae and at 
maximum/minimum after clamping the cannulae for Patient 9 during weaning. 
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6.4 Discussion and Conclusions 
The results indicate the effective use of the multichannel near infrared 
spectroscopy system to measure cerebral oxygenation on infants and children 
supported on ECMO.  
Some general observations can be made for the 6 patients monitored during 
alterations in the ECMO flows. Significant changes in systemic oxygenation 
parameters and cerebral haemoglobin concentrations in response to changes in 
ECMO flows were observed.  
In patients 4 and 5 a drop in SvO2 in the order of 20% at minimum flows is 
observed. In these patients a reduction flow is associated with a higher increase in 
HHb than a decrease in HbO2. A decrease in ECMO flow is associated with a 
decrease in oxygen delivery especially in the early course of ECMO treatment when 
the heart and lungs have not fully recovered. If ECMO flow is inadequate, there is a 
reduction in SvO2 and a subsequent decrease in SpO2. Consequently, in an effort to 
increase cardiac output, there is a compensatory increase in HR. The decrease in 
SpO2 and SvO2 seen in these patients suggest that lowering of ECMO flows has a 
similar effect to a hypoxemic challenge and the absence of decrease in HbO2 in 
relation to increase in HHb could be explained by arterial dilation as a compensatory 
response to decreased blood flow due to decreased ECMO flows .  
In particular, the changes seen in the total haemoglobin in patient 4 are relatively 
large compared to the suggested total cerebral blood volume in an infant of 
2.2mL/100g (50μM) (Wyatt et al. 1990). Van Heijst et al. (2004) report changes in 
HbO2 and HHb in the order of 1μmol/100g (10μM) 60 min after ECMO induction 
and suggest no interhemispheric differences. EIjike et al. (2006) report no 
relationship between ECMO flow and tissue oxygen saturation but changes in the 
individual HbO2 and HHb parameters were not reported. 
Minor changes in the haemoglobin parameters were observed in patients 8 and 10 
possible due to the fact that in these patients a 30 % reduction in flows caused only 
minor reductions in venous (6.7% and 4.8%) and arterial (3.4% and 0.2%) 
saturations. 
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Multichannel optical topography can provide information on regional cerebral 
haemodynamics and oxygenation in ECMO patients. Simultaneous measurement of 
systemic and cerebral parameters can be used to characterise the response to changes 
in ECMO flows. Even though some interesting observations can be made by 
studying the trends in cerebral oxygenation parameters, it difficult to address 
regional variations just by examining the absolute changes in these parameters. More 
sophisticated analytical tools are needed in to identify patterns and investigate 
regional variation in cerebral circulation.       
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Chapter 7 
 
WAVELET CROSS-CORRELATION TO INVESTIGATE 
REGIONAL VARIATION IN CEREBRAL OXYGENATION 
IN INFANTS SUPPORTED ON ECMO 
  
 
 
 
 
 
7.1 Introduction 
Extracorporeal membrane oxygenation (ECMO) has dramatically improved the 
survival rate of newborns with cardio-respiratory failure.  The severity of illness that 
precipitates the initiation of ECMO, as well as the risks associated with the 
procedure itself, have raised concerns about morbidity among the survivors. 
Intracerebral complications are the largest cause of morbidity and mortality in these 
patients, with the reported frequency of abnormal neuroimaging ranging from 28-
52% depending on techniques and methods of classification (Bulas and Glass 2005).  
Initiation of ECMO involves cannulation of the major great vessels - right 
common carotid artery and internal jugular vein – which may cause lateralising 
cerebrovascular injury. Several studies noted an increase in injuries to the right 
hemisphere in infants who underwent ligation of the right carotid artery (Hahn et al. 
1992, Hofkosh et al. 1991, Mendoza et al. 1991). Other studies however showed no 
selective or greater injury to the right hemisphere as compared with the left (Adolph 
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et al. 1990, Bulas et al. 1995, Graziani et al. 1997b). Furthermore, most ECMO 
infants suffer from hypoxia, asphyxia and hypercarbia, prior to the induction of 
ECMO. All these physiological changes can disrupt cerebral autoregulation leaving 
the cerebral microcirculation vulnerable to alterations in systemic blood pressure. 
Liam et al (1995) used near infrared spectroscopy and demonstrated increased 
cerebral blood volume and loss of autoregulation in patients supported on ECMO. 
Short et al (1993) evaluated the effect on cerebral autoregulation of exposure to VA 
ECMO in a lamb model. Exposure to VA ECMO for 1 hour in the healthy newborn 
lamb resulted in an alteration of cerebral autoregulation. Right to left blood flow 
differences were seen in this study when CBF decreased. In another study, Short et al 
(1994) exposed newborn lambs to 2 hours of severe hypoxia (SaO2 = 40%) with 
carotid artery and jugular vein ligation, simulating the hypoxia seen in patients pre-
ECMO. Cerebral autoregulation was evaluated 1 hour after hypoxic insult and was 
found to be abnormal. 
Cerebral autoregulation refers to the regulatory properties of the brain vascular 
bed to maintain constant cerebral blood flow (CBF) despite changes in blood 
pressure. Conversely, when changes in mean arterial pressure (MAP) result in 
concordant changes in CBF, the cerebral circulation is deemed „pressure passive‟ and 
cerebral autoregulation is considered to be no longer intact. A MAP below the lower 
limit of pressure autoregulation increases the brain‟s vulnerability to ischemia while 
a MAP above the upper limit may result in cerebral oedema and haemorrhage. This 
has led to a body of literature attempting to assess the status of autoregulation by 
considering the relationship between spontaneous fluctuations in MAP and CBF 
surrogates either in the time or frequency domain. CBF surrogates include cerebral 
blood flow velocity (CBFV) measured using TCD and haemoglobin concentration 
parameters measured using NIRS (Czosnyka et al. 2009, van Beek et al. 2008). 
Methods in the time domain include the calculation of linear Pearson‟s 
correlation between consecutive samples of averaged MAP and CBF determining a 
correlation index. For example, Czosnyka et al (1997) used the moving correlation 
coefficient between the MAP and ICP to obtain an index (pressure-reactivity index, 
PRx), which quantifies cerebrovascular reactivity with the strength of linear 
correlation between fluctuations in the two parameters (Czosnyka et al. 1997).  A 
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positive PRx value signifies a positive correlation between MAP and ICP, implying a 
passive behaviour of a non-reactive vascular bed. A negative PRx signifies an absent 
or negative correlation, reflecting a normally reactive vascular bed. This index was 
reported to correlate with indices of autoregulation based on CBFV measurements 
using trascranial Doppler ultrasonography (Czosnyka et al. 1996, Lang et al. 2002). 
Similarly, a positive correlation between MAP and CBFV indicates disrupted 
autoregulation, while a negative correlation implies that autoregulation is intact. 
Brady et al used this method of moving linear correlation between MAP and tissue 
oxygen saturation (TOS) measured by NIRS to assess cerebral autoregulation in 
children undergoing cardiac surgery with cardiopulmonary bypass for correction of 
congenital heart defects (Brady et al. 2010b). The averaged correlation index values 
were sorted by MAP and an autocorrelation curve was constructed for each patient. 
Similar method was performed in adults undergoing CPB using both TCD and NIRS 
parameters (Brady et al. 2010a). The measures based on Pearson‟s correlation 
coefficient between the averaged values of the ABP and CBFV time series despite 
their appealing simplicity and proven clinical significance, are inherently incapable 
of taking into account non linear effects. In fact Giller and Mueller (2003) using four 
methods of comparison, conclude that there is strong evidence that cerebral 
autoregulation is nonlinear (Giller and Mueller 2003). Furthermore, Mitsis et al. not 
only concur in the findings regarding nonlinearity but also conclude that cerebral 
autoregulation is non stationary as well (Mitsis et al. 2004). 
Typical frequency methods for investigating the regulation of cerebral 
haemodynamics include power spectral analysis under various physiological or 
pathological conditions (Papademetriou et al. 2010, Tachtsidis et al. 2004). However, 
large inter-subject variability are often found in these absolute measurements of 
power spectra, which makes statistical differences hard to achieve. Transfer function 
and coherence analysis have been developed as methods to quantify the frequency 
dependent covariation of MAP and CBF. These methods rely on the presence of 
oscillations in MAP and CBF surrogates. The regulation of CBF is effective in the 
low-frequency range of MAP fluctuations, i.e. respiratory waves (from 0.1 Hz to 0.4 
Hz) and slow waves (<0.1 Hz), but not in the high frequency range, i.e. heart rate, 
because cerebral autoregulation acts primarily via active alteration of the diameter of 
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cerebral arterioles in time scales of a few seconds in healthy individuals (Czosnyka et 
al. 2009). Therefore, cerebral autoregulation functions like a high pass filter, 
allowing rapid MAP changes to be transmitted to CBF, whereas slow MAP changes 
are filtered (Van Beek et al. 2008). 
The transfer function utilises cross spectral analysis and assumes that 
autoregulation mechanisms can be described by a linear dynamic system with arterial 
blood pressure as input and blood flow velocity as output. The transfer magnitude, or 
gain, quantifies the damping effect between the input and the output of the transfer 
function. A low gain indicates an efficient autoregulation, whereas an increase in 
gain represents a diminished efficiency of the dynamic process of cerebral 
autoregulation. The phase shift between the two signals is another parameter 
obtained from the transfer function analysis with a positive phase shift indicating an 
intact autoregulation. Transfer function analysis was used in premature infants to 
study the concordance between MAP and NIRS parameters (Soul et al. 2007, Tsuji et 
al. 2000). Wong et al used transfer function and coherence analysis to quantify the 
relation between MAP and NIRS parameters in the slow oscillations region (<0.1Hz) 
in preterm infants (Wong et al. 2008). The coherence function is describing the 
linearity of the relation between the input (MAP) and output (CBF) signals and 
ranges between 0 and 1 depending on the degree of correlation between the 2 
waveforms. High coherence values can be anticipated when autoregulation is 
impaired.  
Recent studies have emphasized that cerebral autoregulation is in fact a dynamic 
process (Giller & Mueller 2003, Mitsis et al. 2006, Panerai 1998, Panerai et al. 1999, 
Panerai et al. 2005). The transfer function analysis suffers from the big drawback of 
averaging out all the potential useful time information, hence treating cerebral 
autoragulation as a stationary, linear process. To overcome this drawback, it is 
natural to consider time-frequency analysis which combines the advantages of both 
time and frequency domain analysis. Unlike the Fourier Transform, the continuous 
wavelet transform (CWT) possesses to the ability to construct a time-frequency 
representation of a signal that offers very good time and frequency localisation. 
Latka et al (2005) used the complex Mortlet wavelet with the CWT to compute the 
instantaneous phase of the CBFV and ABP signals and a synchronisation index 
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between the two signals, defined as the standard deviation of the phase difference 
(Latka et al. 2005). Besides investigating the instantaneous phase difference, wavelet 
cross-correlation was introduced in Rowley et al (2007) as the cross correlation 
between CWT coefficients of two time series (Rowley et al. 2007). Compared to 
ordinary cross-correlation, wavelet cross-correlation is also a measure of similarity 
between two time series, but localised to different frequencies. This CWT-based 
technique was used by Rowley (2007) to analyse the coupling between oscillations in 
ABP and NIRS measured HbO2 in both autonomic failure patients and age matched 
controls. They demonstrated that the frequency (wavelet scale) at where high 
correlation between MAP and HbO2 occurs is posture dependent in patients but not 
in controls. Spectral analysis using wavelets provides a mathematical framework for 
analysis of both nonlinear and non-stationary effects in cerebral haemodynamics, 
thus overcoming the restrictions intrinsic to earlier methods. 
To date, the focus of near infrared spectroscopy studies on ECMO patients have 
been concentrated on relative and absolute changes in the amplitudes of NIRS 
parameters during vessel ligation and alterations in the ECMO flows. Furthermore, 
single or dual channel systems have been used in these studies with optodes usually 
place on the forehead which monitor only a small area of the anterior cerebrum. In a 
previous study we have used a dual NIRS system and showed the presence of 
oscillations related to vasomotion, respiration rate and heart rate (Papademetriou et al 
2010). Preliminary results using a multichannel NIRS system indicate regional 
variation in cerebral oxygenation responses during ECMO flow changes 
(Papademetriou et al. 2011). Here, we are investigating the use of wavelet cross-
correlation as a method to study the concordance between multisite cerebral 
oxyhaemoglobin concentration measures and mean arterial pressure in order to 
assess regional variations in cerebral oxygenation in neonates supported on ECMO. 
 
 
 
 
 
 
185 
 
7.2 Methods 
 
7.2.1 Subjects 
The study was approved by the Institute of Child Health/Great Ormond Street 
Hospital Research Ethics Committee. A total of 12 veno-arterial (VA) ECMO 
patients, age range 1-25 days, were monitored during cannulation, decannulation, 
weaning from ECMO and alterations in the ECMO flows. The results from seven out 
of the twelve patients were used in the wavelet analysis described in this chapter. 
Data from the rest of the patients was rejected due to poor signal-to-noise ratio or 
movement artefacts. Six of these patients were monitored during alteration in ECMO 
flows and 1 during weaning. The demographics of the seven patients are shown in 
table 7.1. The chromophore concentration data along with the systemic variables for 
these patients are presented and discussed in chapter 6. Written informed parental 
consent was obtained from all participants prior to inclusion in the study. 
 
 
Figure 7.1: Schematic diagram showing the sequence followed during alterations in 
the ECMO flows. Flows were reduced sequentially by 10% from baseline 
approximately every 10 minutes and subsequently increase back to baseline. The 
letters at the bottom of the plot indicate the different flow periods (A=100%, B=90%, 
C=80%, D=70%, E=80%, G=90%, F=100%). 
 
 
Alterations in the ECMO flows refer to successive decrease in the ECMO flow 
by 10% from the initial flow, approximately every 10 minutes, down to 70% of the 
initial flow followed by successive increase back to baseline (figure 7.1). Out of the 
six patients monitored during alterations in the ECMO flows four were monitored 
during the complete sequence (from flow periods A to G). One patient was 
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monitored from 100% down to only 80% of baseline and then sequentially back to 
baseline. For another patient only half sequence was used, i.e. reductions in flows 
only (periods A to D), the other half of the sequence was affected by movement 
artefacts. 
 
7.2.2 Instrumentation 
A multichannel continuous wave near infrared spectroscopy system (ETG-100, 
Hitachi Medical Ltd., Japan) was used to measure changes in oxyhaemoglobin 
(HbO2), deoxyhaemoglobin (HHb) and total haemoglobin (HbT) concentrations 
using the modified Beer-Lambert Law. A differential pathlength factor (DPF) of 4.67 
was used for the conversion of optical data to haemoglobin concentrations (Duncan 
et al. 1995). A novel neonatal cap was constructed to accommodate the optical 
sources and detectors in a 3 x 3 array (interoptode distance = 3 cm), allowing data to 
be collected from 12 channels. Alterations in ECMO flows and weaning were 
monitored at 5 Hz. Multimodal data were collected synchronously with the optical 
data that included systemic parameters (arterial blood pressure, heart rate [HR], and 
arterial oxygen saturation [SpO2]) and ECMO circuit parameters (venous oxygen 
saturation [SvO2], arterial saturation at the cannula [SaO2], ECMO flows and 
hematocrit). Synchronisation between optical, systemic and ECMO circuit 
parameters is described in detail elsewhere (chapter 6). 
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Table 7.1: Demographics of the patients used in the analysis of this chapter 
Patient 
ID 
Age  
(days) 
Type of ECMO Cannulation sides Type of pump Type of study Indication for ECMO Clinical condition 
4 12  VA RCCA & IJV Centrifugal Flow changes Neonatal Respiratory failure 
Neonatal hypoxaemic respiratory failure due 
RSV infection post cardiac surgery 
5 3  VA RCCA&IJV Centrifugal Flow changes Neonatal Respiratory failure 
Neonatal hypoxemic respiratory failure with 
PPHN and MAS  
7 9  VA RCCA&IJV Centrifugal Flow changes Neonatal Respiratory failure 
Neonatal hypoxemic respiratory failure with 
PPHN and MAS 
8 16  VA RCCA&IJV & RA Centrifugal Flow changes Cardiac-Post cardiac surgery Post Arterial Switch surgery 
9 4  VA RCCA&IJV Centrifugal Weaning Neonatal Respiratory failure 
Neonatal hypoxemic respiratory failure with 
PPHN, sepsis 
10 3  VA RCCA&IJV Centrifugal Flow changes Neonatal Respiratory failure 
Neonatal hypoxemic respiratory failure with 
PPHN and MAS 
11 3  VA RCCA&IJV Centrifugal Flow changes Neonatal Respiratory failure 
Neonatal hypoxemic respiratory failure with 
PPHN and MAS 
 
 
Table 7.2: Active channels and flow periods used in the group analysis of the six ECMO patients monitored during alterations in the 
ECMO flows. Active channels and flow periods within each channels are highlighted green. Rejected channels/flow periods are 
highlighted grey. 
A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G A B C D E F G
4
5
7
8
10
11
5
ECMO period
6
ECMO period
12
ECMO period ECMO period ECMO period ECMO period ECMO period ECMO period
Patient 
ID
7 8
ECMO period ECMO period ECMO period ECMO period
1 2 3 4
c h a n n e l s 
9 10 11
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7.2.3 Data Analysis 
Spectral analysis using wavelets was performed on the multichannel HbO2 data. 
Specifically, the wavelet cross-correlation (WCC) and synchronisation index, γ, were 
used as methods to investigate the relation between MAP and HbO2.  
The complex Morlet wavelet was used to calculate the continuous wavelet 
transform coefficients for each time series, MAP and HbO2, using the MatLab 
(Mathworks, ) wavelet toolbox function cwt.  
The continuous wavelet transform (CWT) of a signal )(tx  is defined as 
(Semmlow 2004): 
dt
bt
txbW )(
1
),(       (7.1) 
where ψ(t) is a continuous function in both the time domain and the frequency 
domain called the mother wavelet and * represents operation of complex conjugate. 
Here, the complex Morlet wavelet was chosen as the mother wavelet which consists 
of a plane wave modulated by a Gaussian function (Torrence and Compo 1998): 
bc fttfi
b
ee
f
t
/2 21
)(       (7.2) 
where fb is the bandwidth and fc the wavelet centre frequency. The main purpose of 
the mother wavelet is to provide a source function to generate the daughter wavelets 
which are simply the translated and scaled versions of the mother wavelet. Hence, 
the variable b in equation 7.1 acts to translate the function across )(tx  and the 
variable α acts to vary the time scale of the probing function, ψ. If α is greater than 
one, the wavelet function, ψ, is stretched along the time axis, and if it is less than one 
(but still positive) it contracts the function. The normalising factor 1/√α ensures that 
the energy is the same for all values of α. To be “admissible” as a wavelet, ψ must 
have zero mean and be localised in both time and frequency space (Torrence & 
Compo 1998). Hence, the centre frequency, fc, was taken to be 1. The real and 
imaginary parts of the Morlet wavelet are shown in figure 7.2 along with some of its 
family members produced by dilation and contraction. 
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Figure 7.2: (a) Real and Imaginary part of the Morlet wavelet (b) the Morlet Wavelet 
with dilations, contraction and translations.(modified from Semmlow 2004) 
 
 
While there is a general relationship between the scale α in the wavelet domain 
and frequency in the Fourier transform, no precise relationship exists. The translation 
from scale to frequency depends upon the particular choice of wavelet. However, an 
approximate relationship between wavelet scale and translated frequency, pseudo-
frequency, fa, can be computed as:  
(a) 
(b) 
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t
f
f c        (7.3) 
where fc is the centre frequency and δt is the sampling period. This approximate 
relationship was previously used by (Latka et al. 2005, Rowley et al. 2007) to study 
similar physiological oscillations as reported herein.  
Mean arterial pressure (MAP) was obtained by trapezoid integration of the 
arterial blood pressure waveform every 0.2 s, equivalent to sampling frequency of 5 
Hz. The time series of MAP and HbO2 were divided into sections representing each 
ECMO flow period. Each section of data was then high pass filtered using a fifth-
order Butterworth filter with cut off frequency of 0.008 Hz to remove very slow 
variations and baseline shift and subsequently low pass filtered using a fifth-order 
Butterworth filter with a cut-off frequency of 1 Hz to remove variability in the signal 
due to the cardiac cycle. A scale range with unit spacing from 5 to 100, representing 
frequencies 0.008-1 Hz was use to obtain two complex time series, WMAP(a,t) and 
WHbO2(a,t) for each flow period A to G (see figure 7.1) and across each of the 12 
channels.  
The wavelet cross-correlation (WCC) between MAP and HbO2 in each channel 
and for each flow was obtained using the equation below (Rowley 2007): 
    (7.4) 
in which RX,Y(s1, s2, a, τ) denotes the cross-correlation of the wavelet coefficients of 
the series s1 and s2 at a scale a and for a relative time shift τ and RX,X(s1, a, 0) 
denotes the autocorrelation of the time series s1 for zero time shift. WCC(a, τ) 
represents the cross-spectral power in the two time series (shifted relative to each 
other by τ) as a fraction of the total power in the two time series. WCC ranges from 0 
to 1. At a given wavelet scale, WCC=1 would indicate that the coefficients of the two 
wavelet transforms are related to each other by a simple scaling factor, suggesting 
strong synchronization at this frequency (Rowley et al. 2007). Figure 7.3 shows 
simulated data to demonstrate strong and weak synchronization between two signals.  
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Figure 7.3: Wavelet cross-correlation and synchronisation index between signals 
with the same frequency content (signals 1 &2), same frequency content but out of 
phase (signals 1 & 3), and signals with different frequency content (signals 1 & 4).  
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The synchronization index, γ(α), which is the inverse circular statistical mean 
analogue of variance was also calculated using (Rosenblum et al. 2001) 
   (7.5) 
 
in which N is the number of points in the series and ΔΦ(α, τ) is the instantaneous 
phase difference between the two signals. The instantaneous phase difference was 
calculated using 
 
WMAP.WHbO2
*
 = r.e
i ΔΦ
    (7.6)    
   
The synchronization index varies from 0 to 1. Zero γ indicates uniform distribution 
of phase differences, so the time series are statistically independent of one another. 
The phase difference between the two time series, Map and HbO2 was also 
calculated using the circular mean,  , of the phase difference over the duration 
of a test segment was the calculated using (Fisher 1995)  
 
     (7.7)  
 
For each time series pair at each flow period and for each channel, the maximum 
value of WCC(a, τ) was found within three scale bands: ai = 5<a<20 (fai = 0.25 Hz 
<fa< 1 Hz), aii = 20<a<40 (faii = 0.13 Hz <fa< 0.25 Hz), aiii = 40<a<80 (faiii = 0.06 
Hz <fa< 0.13 Hz). These bands were chosen to overlap with respiration rate (RR), 
ventilation rate (VR), and slow M-waves respectively. The maximum 
synchronization index, γmax, and circular mean , ΔΦmax, were also calculated within 
each scale band, for each flow period and each channel. Students; t-test was then 
used to analyse the statistical significance of the differences in the group mean of 
each of these variables between channels and within each flow period.  
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7.3 Results 
Wavelet cross-correlation and synchronisation index were calculated for the 
patients listed in table 7.1. Group data were obtained for the six patients monitored 
during alterations in ECMO flows while individual data are presented for the one 
patient monitored during weaning. WCC was calculated for every flow period and 
every channel. The active channels and rejected channels and flow periods for the six 
patients are listed in table 7.2.  
7.3.1 Wavelet cross-correlation (WCC)  
 
7.3.1.1 Alterations in the ECMO flows 
 
 
 
Figure 7.4: Wavelet cross-correlation between MAP and HbO2 for two ECMO 
patients. Low correlation is shown at baseline ECMO flows (a and c) and high 
correlation around scales 16 and 30 for patient 1 at minimum flow (b) and around 
scales 16 and 40-80 for patient 2 (d) at minimum flow. 
 
Figure 7.3 shows a set of typical wavelet cross-correlation contours obtained 
from two patients at baseline flow and minimum flow. For patient 8 WCC shows no 
distinct peaks at baseline flows indicating no correlation between MAP and HbO2. At 
minimum flow, peaks in the WCC contours are shown at scales 15 (fa= 0.33 Hz), 29 
(fa = 0.17 Hz) and a relatively weaker peak at scale 55 (fa = 0.09 Hz) . The wavelet 
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cross correaltion contour for patient 7 at baseline flow shows a relatively weak peak 
at a scale 34 (fa = 0.15 Hz). As with patient 8 correlation between MAP and HbO2 
becomes stronger at minimum flow with the peak at scale 34 spreading to higher 
Mayer-waves related scales and another  peak occuring at scale 10 (fa = 0.5 Hz). 
These peaks appear shifted form zero time lag. Rowley et al (2007) in their study of 
wavelet-cross correlation between MAP and HbO2 also report a shift from zero time 
lag in WCC peaks in autonomic failure patients but not in healthy control subjects.  
In general, wavelet cross-correlation between MAP and HbO2 revealed three 
distinct peaks within three scale regions. The first peak typically occurs at a scale of 
around 14 (0.36 Hz), the second at a scale around 30 (0.16 Hz) and the third at a 
scale around 50 (0.1 Hz). These peaks could correspond to the respiration rate (RR), 
ventlation rate (VR) and Mayer-waves, respectively.  
Figure 7.5c shows the group data for the mean of the maximum wavelet cross-
correlation, WCCmax
i
, within scale band ai = 5<a<20 (fa
i
 = 0.25 Hz <fa< 1 Hz) at 
each flow period and across the 12 channels. The channel arrangement is shown in 
figure 7.5a. The sequence of ECMO flow changes, with letters A to G representing 
the different flow periods, is shown in figure 7.5b. By convention a value of WCC 
below 0.5 indicates no correlation between MAP and HbO2 (Latka et al. 2005, Latka 
et al. 2007, Rowley et al. 2007).  A + sign is used to indicate that HbO2 lags MAP, 
i.e. ΔΦ > 0, only for WCC greater than 0.5, i.e. strong correlation between the two 
signals. A – sign is used to indicate that HbO2 is leading MAP, i.e. ΔΦ < 0, where 
WCC > 0.5. The following observations can be made: 
 There are statistically significant differences (p<0.05) in the mean WCCmax
i
 
across all flows between symmetrical channels most likely positioned on the right 
(channels 7, 10 and 12) and left (channels 6, 8 11) parietal lobes (figure 7.4d). 
WCCmax
i
 for all flows in the three channels positioned on the left parietal lobe is 
below 0.5 suggesting no correlation between MAP and HbO2 in these channels. 
 Similarities are shown between symmetrical channels on the right (2 and 5) and 
left (1 and 3) frontal lobes. While for symmetrical channels 1 and 2 WCCmax
i 
> 
0.5 after minimum flow (period D) is reached, for symmetrical channels 3 and 5 
WCCmax
i
 > 0.5 for at flow periods.  
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 A general increase in WCCmax
i
 was observed with decrease in flow across all 
channels. WCCmax
i
 is highest either at flow period E or F.  
 The group data showed that amax
i
 across flow changes for all channels ranges 
from 9 to 17 (0.29-0.56 Hz) (figure 7.4e). Most of the channels show a shift in 
amax
i
 to a lower scale when the highest WCCmax
i
 is reached (flow period E) and a 
shift back to higher scales when the flow continues to increase back to baseline. 
Figure 7.6 shows the group data for the mean maximum wavelet cross-
correlation, WCCmax
ii
, within scale band aii = 20<a<40 (faii = 0.13 Hz <fa< 0.25 Hz) 
for each flow period and across all 12 channels. The results obtained in the group 
analysis of the scale band aii are similar to those described above for scale band aii:  
 Statistically significant differences in mean WCCmax
ii
 across flow periods are 
observed between symmetrical channels potentially placed on the right and left 
parietal lobes with channels on the right generally showing higher values of 
WCCmax
ii
 than those on the left (figure 7.6d). Channels 6, 8 and 11 positioned on 
the left parietal lobe show no correlation (WCC<0.5) between MAP and HbO2 
across all flow periods. 
 The highest WCCmax
ii
 occurs at flow period E for all channels.   
 The group data of amax
ii
, ranges from 15 to 32 (0.16-0.33 Hz) (figure 7.6e). A 
shift to higher scales is observed during decrease in flow, from flow periods A to 
D, and shift back to lower scales from flow periods D to F.  
 In general values WCCmax
ii
 are lower in this scale band that in ai.  
The group data for maximum wavelet cross-correlation, WCCmax
iii
, within scale 
band aiii= 40<a<80 (faiii = 0.06 Hz <fa< 0.13 Hz) across flows periods and channels 
is shown in figure 7.7. Mean WCCmax
iii
 across flow periods is higher on the right 
hemisphere than on the left, even though, with the exception of channels 5 and 3, 
these differences were not found to be statistically significant (figure 7.7d). 
Analogous to the other two scale bands, the strongest correlation between MAP and 
HbO2 is observed at flow period E across all the channels. The scale at which 
WCCmax
iii 
occurs, amax
iii
, is shifted to lower scales as ECMO flow changes from flow 
period A to F (figure 7.7e). 
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Figure 7.5: Group wavelet cross-correlation between MAP and HbO2 within scale 
band ai = 5<a<20 (fai = 0.25 Hz <fa< 1 Hz): (a) Channel arrangement; (b) 
Sequence of flow changes (A=100%, B=90%, C=80%, D=70%, E=80%, F=90%, 
G=100%); (c) WCCmax
i
 at all flow periods across all channels; (d) mean WCCmax
i
 
across all flow periods of channels on the right side and symmetrical channels on the 
left side; (e) mean of scale at WCCmax
i
, amax
i
, for each flow period across all 
channels. 
+/-  denotes HbO2 lagging/leading MAP for WCCmax
i
 > 0.5 
 Statistically significant difference between flow period with highest WCCmax
i
 at each 
channel and the all the rest flow periods at the same channel (p < 0.05) 
 Statistical significant difference between symmetrical channels on right and left 
hemispheres(p < 0.05). 
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Figure 7.6: Group wavelet cross-correlation between MAP and HbO2 within scale 
band aii = 20<a<40 (faii = 0.13 Hz <fa< 0.25 Hz):(a)Channel arrangement, (b) Flow 
changes sequence (A=100%, B=90%, C=80%, D=70%, E=80%, F=90%, 
G=100%), (c) WCCmax
ii
 at all flow periods across all channels, (d) mean WCCmax
ii
 
across all flow periods of channels on the right side and symmetrical channels on the 
left side, and (e) mean of scale at WCCmax
ii
, amax
ii
, for each flow period across all 
channels. 
+ denotes HbO2 lagging MAP for WCCmax
ii
 > 0.5 
-  denotes HbO2 leading MAP for WCCmax
ii
 > 0.5 
 Statistically significant difference between flow period with highest WCCmax
ii
 at each 
channel and the all the rest flow periods at the same channel (p < 0.05) 
 Statistical significant difference between symmetrical channels on the right and 
the left hemispheres (p < 0.05).  
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Figure 7.7: Group wavelet cross-correlation between MAP and HbO2 within scale 
band aiii = 20<a<40 (faii = 0.06 Hz <fa< 0.13 Hz):(a)Channel arrangement, (b) 
Flow changes sequence (A=100%, B=90%, C=80%, D=70%, E=80%, F=90%, 
G=100%), (c) WCCmax
iii
 at all flow periods across all channels (d) mean WCCmax
iii
 
across all flow periods of channels on the right side and symmetrical channels on the 
left side, and (d) mean of scale at WCCmax
ii
, amax
ii
, for each flow period across all 
channels. 
+ denotes HbO2 lagging MAP for WCCmax
iii
 > 0.5 
-  denotes HbO2 leading MAP for WCCmax
iii
 > 0.5 
 Statistically significant difference between flow period with highest WCCmax
iii
 at 
each channel and the all the rest flow periods at the same channel (p < 0.05) 
 Statistical significant difference between symmetrical channels on the right and 
on the left hemispheres (p < 0.05).  
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7.3.1.2 Weaning  
The results of the wavelet cross-correlation, WCC, within the three scale bands 
for the one patient monitored during weaning are shown in figures 7.8 to 7.10.  As 
mentioned in the methods section above, here we compare maximum wavelet cross 
correlation values between MAP and HbO2 within the three scale bands pre- and 
post- clamping the arterial and venous cannulae. Pre- clamping the cannulae the 
patient is still on ECMO but at minimum flows and when both arterial and venous 
cannulae are clamped the patient is off ECMO and the patient‟s own heart and lungs 
are entirely responsible for blood circulation and oxygenation. 
Figure 7.8 shows multichannel results for WCCmax for scale band ai. The channel 
configuration is shown in 7.8a and X and Y in 7.8b indicate results pre- and post 
clamping the cannulae, respectively. The scales at which WCCmax occurs pre- and 
post- clamping and across the 12 channels are shown in 7.8c. High correlation 
between MAP and HbO2 is observed prior to clamping the cannulae across all 
channels with HbO2 leading MAP, as indicated by the – sign on the plots. 
Interestingly, the low values of WCC obtained after clamping the cannulae suggest 
no correlation between MAP and HbO2 when the patient goes off ECMO.  
Similar results are obtained for the scale band aii. Strong correlation between 
MAP and HbO2 is shown prior to clamping across all channels with correlation 
decreasing post-clamping. However, in contrast to the results of scale band ai, in this 
band HbO2 is lagging MAP prior to clamping and for most channels post-clamping 
correlation values are greater than 0.5 indicating that MAP and HbO2 are still 
correlated. A shift in amax to higher scales upon clamping the cannula is shown across 
all channels (figure 7.8c). 
In contrast to the results obtained for scale bands ai and aii, WCC results for scale 
band aiii show no correlation between MAP and HbO2 prior to clamping while the 
correlation increases above 0.5 for most channels after clamping the cannulae.  
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Figure 7.8: Wavelet cross-correlation between MAP and HbO2 within scale band ai 
= 5<a<20 (fai = 0.25 Hz<fa<1 Hz) for patient 9 during weaning (a) Channel 
arrangement, (b)WCCmax
i
 at pre–clamping the cannulae, X, and post-clamping the 
cannulae, Y, across all channels, (c)scale at WCCmax
i
, amax
i
, pre- (X) and post- 
(Y)clamping across all channels. 
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Figure 7.9: Wavelet cross-correlation between MAP and HbO2 within scale band aii 
= 20<a<40 (faii = 0.13 Hz<fa<0.25 Hz) for patient 9 during weaning (a) Channel 
arrangement, (b)WCCmax
ii
 at pre–clamping the cannulae, X, and post-clamping the 
cannulae, Y, across all channels, (c) scale at WCCmax
ii
, amax
ii
, pre- (X) and post- (Y) 
clamping across all channels. 
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Figure 7.10: Wavelet cross-correlation between MAP and HbO2 within scale band 
aiii = 40<a<80 (faiii = 0.06 Hz<fa<0.13 Hz) for patient 9 during weaning (a) 
Channel arrangement, (b)WCCmax
iii
 at pre–clamping the cannulae, X, and post-
clamping the cannulae, Y, across all channels, (c)scale at WCCmax
iii
, amax
iii
, pre- (X) 
and post- (Y)clamping across all channels. 
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7.3.2 Synchronisation index (γ) 
 
7.3.2.1 Alteration in ECMO flows  
Analogous to the wavelet cross-correlation analysis, the synchronisation index 
analysis showed three distinct peaks in scales around 14 (0.36 Hz) (RR), 30 (0.17 
Hz) (VR) and 50 (0.1 Hz) (M-waves). The synchronisation index, γ, as function of 
scale at baseline and minimum flows for patients 8 and 7 are shown in figure 7.11. 
The three peaks corresponding to RR, VR and M-waves are clearly shown in the 
synchronisation index plot of patient 8, both at baseline and minimum flows (figure 
7.11a).  However, at baseline flow γ values are below 0.5 at the RR and M-wave 
peaks indicating weak synchronisation between MAP and HbO2. At minimum flow 
the peaks become higher with an increase in γ value above 0.5 indicating strong 
synchronisation between MAP and HbO2. The synchronisation index curve for 
patient 7 shows a broad but weak peak at a scale of 28 (0.18 Hz) on baseline flow 
(figure 7.11b). In this case, at minimum flow the peak becomes higher and is shifted 
to higher scales, spreading over to the Mayer-waves region.  
 
Figure 7.11: Synchronisation index, γ, as a function of scale at baseline and 
minimum flows for patient 8 (a) and patient 7 (b). 
 
Group data for the maximum synchronisation index, γmax
i
, within scale band ai at 
each flow and across the 12 channels are shown in figure 7.12c. Statistical significant 
difference between the mean γmax
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channels on the right hemisphere show higher γ values than the symmetrical 
channels in the left hemisphere. However, the synchronisation index, γ, appears to be 
greater than 0.5 only in channels 1, 2 and 3 (frontal lobe), and only when the flows 
are reduced to minimum (flow period D). In channels 1 and 2, which are symmetric, 
synchronisation continues to be strong when the flows are gradually increased back 
to baseline (flow periods E-G). The circular mean of the phase difference, ΔΦ, 
between the two signals is negative during these periods of high synchronisation 
suggesting that HbO2 is leading MAP. The rest of the channels show weak 
synchronisation (γ < 0.5) across all flows. The group data of the scale at γmax
i
, a
γ
max
i
, 
across flow changes for all channels ranges from 10 to 16 (0.31 Hz to 0.5 Hz) (figure 
7.12e). Similar to the wavelet cross-correlation analysis a shift in a
γ
max
i
 to lower 
scales at the highest γmax
i
 is observed.  
For scale band aii the group data of the maximum synchronisation index, γmax
ii
, 
across all events and for all channels are shown in figure 7.13c. Strong 
synchronisation between MAP and HbO2 is shown only in channels 1, 2 and 5 at 
flow period E and channel 6 at flow period D. The circular mean of the phase 
difference was found to be positive in these flow periods indicating that HbO2 is 
lagging MAP. Similar results were obtained for the group data of maximum 
synchronisation, γmax
iii
, within the scale band aiii with the difference that in this scale 
band channel 7 also appears to have high γmax
iii 
(> 0.5) at flow period E (figure 7.14). 
 
205 
 
 
Figure 7.12: Group synchronisation index, γ, between MAP and HbO2 within scale 
band ai = 5<a<20 (fai = 0.25 Hz <fa< 1.0 Hz):(a) Channel arrangement, (b) Flow 
changes sequence (A=100%, B=90%, C=80%, D=70%, E=80%, F=90%, 
G=100%), (c) γmax
i
 at all flow periods across all channels and (d) mean of scale at 
γmax
i
, amax
i
, for each flow period across all channels. 
+ denotes HbO2 lagging MAP for γmax
i
 > 0.5 
-  denotes HbO2 leading MAP for γmax
i
 > 0.5 
 Statistically significant difference between flow period with highest γmax
i
 at each 
channel and the all the rest flow periods at the same channel (p < 0.05) 
 Statistical significant difference between mean γmax
i
 across all flow periods of 
channels on the right side and symmetrical channels on the left side (p < 0.05).  
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Figure 7.13: Group synchronisation index, γ, between MAP and HbO2 within scale 
band aii = 20<a<40 (fai = 0.13 Hz <fa< 0.25 Hz):(a) Channel arrangement, (b) Flow 
changes sequence (A=100%, B=90%, C=80%, D=70%, E=80%, F=90%, 
G=100%), (c) γmax
ii
 at all flow periods across all channels and (d) mean of scale at 
γmax
ii
, amax
ii
, for each flow period across all channels. 
+ denotes HbO2 lagging MAP for γmax
ii
 > 0.5 
-  denotes HbO2 leading MAP for γmax
ii
 > 0.5 
 Statistically significant difference between flow period with highest γmax
ii
 at each 
channel and the all the rest flow periods at the same channel (p < 0.05) 
 Statistical significant difference between mean γmax
ii
 across all flow periods of 
channels on the right side and symmetrical channels on the left side (p < 0.05). 
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Figure 7.14: Group synchronisation index, γ, between MAP and HbO2 within scale 
band aiii = 40<a<80 (fai = 0.06 Hz <fa< 0.13 Hz):(a) Channel arrangement, (b) 
Flow changes sequence (A=100%, B=90%, C=80%, D=70%, E=80%, F=90%, 
G=100%), (c) γmax
iii
 at all flow periods across all channels and (d) mean of scale at 
γmax
iii
, amax
iii
, for each flow period across all channels. 
+ denotes HbO2 lagging MAP for γmax
iii
 > 0.5 
-  denotes HbO2 leading MAP for γmax
iii
 > 0.5 
 Statistically significant difference between flow period with highest γmax
iii
 at each 
channel and the all the rest flow periods at the same channel (p < 0.05) 
 Statistical significant difference between mean γmax
iii
 across all flow periods of 
channels on the right side and symmetrical channels on the left side (p < 0.05). 
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7.3.2.2 Weaning  
The results of the synchronization index, γ, within the three scale bands for the 
patient monitored during weaning are shown in figures 7.15 to 7.17. The results for 
the synchronization index are similar to the ones obtained for the wavelet cross 
correlation. 
Figure 7.15 shows multichannel results for γmax within scale band ai. The channel 
configuration is shown in 7.15a and X and Y in 7.15b in indicate results pre- and 
post clamping the cannulae, respectively. The scales at which WCCmax occurs pre- 
and post- clamping and across the 12 channels are shown in 7.15c. High correlation 
between MAP and HbO2 is observed prior to clamping the cannulae across all 
channels with HbO2 leading MAP, as indicated by the – sign on the plots. 
Interestingly, the low values of WCC obtained after clamping the cannulae suggest 
no correlation between MAP and HbO2 when the patient goes off ECMO.  
Figure 7.16 shows the results for the synchronization index for the scale band aii. 
Strong correlation between MAP and HbO2 is shown prior to clamping across all 
channels with correlation decreasing post-clamping. However, in contrast to the 
results of scale band ai, in this band HbO2 is lagging MAP prior to clamping and for 
most channels at post-clamping γ values are greater than 0.5 indicating that MAP and 
HbO2 are still synchronized. A shift in amax to higher scales upon clamping the 
cannula is shown across all channels (figure 7.16c).  
In contrast to the results obtained for scale bands ai and aii, γ results for scale 
band aiii show no synchronization between MAP and HbO2 prior to clamping while 
the correlation increases above 0.5 for most channels after clamping the cannulae. 
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Figure 7.15: Synchronisation index between MAP and HbO2 within scale band ai = 
5<a<20 (fai = 0.25 Hz<fa<1 Hz) for patient 9 during weaning (a) Channel 
arrangement, (b)γmax
i
 at pre–clamping the cannulae, X, and post-clamping the 
cannulae, Y, across all channels, (c)scale at γmax
i
, amax
i
, pre- (X) and post- 
(Y)clamping across all channels. 
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Figure 7.16: Synchronisation index between MAP and HbO2 within scale band aii = 
20<a<40 (faii = 0.13 Hz<fa<0.25 Hz) for patient 9 during weaning (a) Channel 
arrangement, (b)γmax
ii
 at pre–clamping the cannulae, X, and post-clamping the 
cannulae, Y, across all channels, (c)scale at γmax
ii
, amax
ii
, pre- (X) and post- 
(Y)clamping across all channels. 
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Figure 7.17: Synchronisation index between MAP and HbO2 within scale band aiii = 
40<a<80 (faiii = 0.06 Hz<fa<0.13 Hz) for patient 9 during weaning (a) Channel 
arrangement, (b)γmax
iii
 at pre–clamping the cannulae, X, and post-clamping the 
cannulae, Y, across all channels, (c)scale at γmax
iii
, amax
iii
, pre- (X) and post- 
(Y)clamping across all channels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
0.2
0.4
0.6
0.8
1
channel 1 channel 2 
channel 3 channel 4 channel 5 
channel 6 channel 7 
channel 8 channel 9 channel 10 
channel 11 channel 12 
X Y X Y 
X Y 
X Y 
X Y X Y 
X Y 
X Y 
X Y 
X Y 
X Y 
X Y 
 
   - 
  
   - 
  
+  - 
 -  + 
 + 
  
S
y
n
ch
ro
n
is
at
io
n
 I
n
d
ex
, 
γ 
 
1 2 
3 4 5 
6 7 
8 9 10 
11 12 
S 
S 
S 
S 
S 
D 
D 
D 
 D 
 Frontal Lobe 
Occipital Lobe 
Parietal Lobe 
 
 Source 
  Channel 
Detector 
(a) 
(b) 
channel 1 channel 2 
channel 3 channel 4 channel 5 
channel 6 channel 7 
channel 8 channel 9 channel 10 
channel 11 channel 12 
    
  
  
    
  
  
    
 
    
  
    
  
   
    
  
  
S
ca
le
, 
a
 
 
(c) 
X Y
40
60
80
X Y
40
60
80
X Y
40
60
80
X Y
40
60
80
X Y
40
60
80
X Y
40
60
80
1 2
40
60
80
X Y
40
60
80
X Y
40
60
80
X Y
40
60
80
X Y
40
60
80
212 
 
 
7.4 Discussion  
Wavelet cross-correlation (WCC) between MAP and multisite cerebral HbO2, 
across 12 channels, has been computed for 6 neonates supported on veno-arterial 
(VA) ECMO during sequential changes in the ECMO flow and one patient during 
weaning from ECMO. The wavelet cross-correlation (WCC) applied herein typically 
exhibits three peaks, the first at a scale corresponding to a frequency around 0.33Hz, 
the second at a frequency around 0.16 Hz and the third at a frequency around 0.1 Hz 
and could correspond respiration rate (RR), ventilation rate (VR) and Mayer-waves, 
respectively. Rowley et al. (2007) also applied WCC between MAP and HbO2 in 
adult patients suffering from autonomic failure and age-matched controls and report 
peaks in WCC around 0.33 Hz and 0.1 Hz which they relate to respiration and M-
waves, respectively. These findings are also in agreement with Latka et al (2005) 
where synchronisation index was obtained for healthy adult volunteers. Even though, 
these studies do not report a frequency around 0.16 Hz, in another study Latka et al 
(2007) used synchronisation index on ?adult patients with brain injuries and reported 
high variability of arterial blood pressure around 0.2 Hz as a direct consequence of 
mechanical ventilation.  
The maximum wavelet cross-correlation, WCCmax, within three scale bands 
around the three frequency peaks were obtained for each ECMO flow period and 
each channel.  Group data showed that WCCmax appears to be increasing with 
decreasing ECMO flow and peaks during flow period E, i.e. when the flow is 
brought back to 80% of the baseline from minimum flow. Even though a decrease in 
WCC is observed after flow period E, WCC is still typically higher than the baseline 
flows. High WCC (>0.5 by convention) indicates that any changes in MAP are 
mirrored in blood flow, i.e. cerebral blood flow is pressure passive, suggesting that 
cerebral autoregulation maybe impaired. In two out of the six patients monitored 
during alteration in the ECMO flows a drop in SpO2 in the order of 20% was 
observed at minimum flows. Interestingly, these two patients showed the highest 
values in WCC compared to the rest of the patients. Regional variations in WCC 
were observed between channels potentially placed in the right parietal lobe and left 
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parietal lobes with channels on the right exhibiting higher values of WCC. Outcome 
and follow up of neonates treated with ECMO have shown that ECMO survivors are 
likely to have medical and developmental issues after discharge and tend to be at 
high risk for learning and/or behavioural problems in childhood (Glass and Brown 
2005). Attention, memory and learning are described as “higher executive brain 
functions” and are localised in specialised regions of the brain known as the 
“association cortex” where much more complex information processing is 
conducted. The association cortex is part of the parietal lobes (Martini 2009). Further 
work could elucidate whether there is a robust link between the regions of the brain 
where altered WCC were observed and those regions associated with long term 
neurodevelopmental deficit. 
A shift in the scale of maximum correlation across flow periods was also 
observed indicating that cerebral circulation is indeed challenged by changes in 
ECMO flows.  
The synchronisation index, γ, was also calculated and also showed the presence 
of three peaks in agreement with WCC. The maximum synchronisation index within 
the three scale bands as a function of flow period and channel has revealed similar 
results to WCC analysis. However, in general γmax values appear to be lower than 
WCCmax values. Rowley et al (2007) also used both methods, WCC and γ, to 
investigate the correlation between MAP and HbO2 in autonomic failure patients and 
age matched controls during posture changes. They also report lower values in γ 
compared to WCC for both for both groups and at all postures.  
Another observation that can be made is that generally correlation was highest in 
scale band ai (RR) and lowest in aiii (M-waves).  WCC allows us to determine the 
dependency of the time series, in this case MAP and HbO2, on multiple time scales 
and consequently determine the multiscale nature of the underlying dynamics. Our 
results suggest that the dependence of the fluctuations in MAP and HbO2 time series 
is manifested differently in different scales. It is apparent that the interplay of the 
fluctuations of MAP and HbO2 for high frequencies is different from that in the low 
frequency part of the spectrum. The strong reactivity of cerebral vessels to carbon 
dioxide arterial content might underlie the respiratory origin of the peak in scale band 
ai. The origin of the low frequency, non respiratory oscillation in blood pressure still 
214 
 
remains controversial. Current evidence suggests that the baroreflex mechanisms 
substantially contribute ton oscillations in this frequency range.  
Other studies use coherence and transfer function between MAP and HbD (where 
HbD = HbO2 – HHb) as a NIRS parameter to assess cerebral autoregulation (Tsuji et 
al. 2000, Wong et al. 2008). However, HbO2 was previously used by Rowley et al 
(2007) when applying wavelet cross-correlation in patients suffering from autonomic 
failure and age matched controls. In addition, the previous work on spectral analysis 
using Fourier transforms on patients supported on ECMO, described extensively in 
chapter 5, showed that oscillations in HbO2 are stronger than in other NIRS 
parameters (Papademetriou et al 2010).  The presence of slow spontaneous 
oscillations may be more significant in the oxyhaemoglobin signal measured by 
NIRS than in the deoxyhaemoglobin or total haemoglobin signal (Elwell et al 1999; 
Orbig et al). It will be interesting however, to apply the method to other NIRS 
parameters and compare the results between them. 
Wavelet cross-correlation (WCC) decomposes the MAP and HbO2 signals into 
wavelet modes which are highly localised in frequency and allows investigation of 
which modes are most likely linearly related (Rowley 2007). Unlike other methods 
based on Fourier transforms, i. e. transfer function and coherence, WCC makes no 
assumption about the stationarity of the relationship between time series, and if other 
modes of oscillation in cerebral haemodynamics exists which are not driven by  
systemic variables these will show a low value of wavelet cross correlation. The 
Fourier transform of the signal yields a function that depends only on frequency, 
whereas the wavelet transform of that signal depends on both frequency and time. 
This distinction becomes important since the relation between MAP amd HbO2 
signals is a non-stationary stochastic process, in which case the frequency spectrum 
of the signals changes over time. This time change is ill defined for a Fourier 
spectrum, but is well defined for a wavelet spectrum. Another important difference 
between the wavelet transforms and Fourier transforms is frequency resolution. The 
freqency resolution of a power density spectrum depends on the length of the sliding 
window in which the fast Fourier tranforms (FFT) are applied (see chapter 6). The 
greater the length of the sliding window (higher number of samples) the higher the 
resolution but at the expence of lower signal to noise ratio (S/N). Consequently, the 
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length of the sliding window depnds on the length and sampling frequency of the 
signal, i.e. number of sampling points.  As a result a high sampling frequncy and a 
long signal are required to resolve frequencies in the lower range which are of 
interest when studying cerebral autoregulation. Even if the frequency resolution is 
high enough it can still be difficult to capture frequencies in the lower range due to 
low S/N. In contrast to the Fourier transform, the Wavelet transform depends on 
scale which is inversly related to frequency. Consequently, there is a higher 
resolution at lower frequencies. Furthermore, wavelet cross-correlation is a meaasure 
of the level of similarity between two signals in a given frequency band and does not 
depend upon the power of those signals provided that the time series are compared 
for a sufficiently long time interval. 
 
7.5 Conclusions  
WCC between HbO2 and MAP provides a useful method to investigate the 
dynamics of global and/or regional cerebral autoregulation. Cerebral autoregulation 
on ECMO is poorly studied, the most common reason being that that there have been 
no easy non-invasive methods to study and interpret complex cerebral physiological 
process such as cerebral autoregulation. There are potential challenges to global and 
regional cerebral autoregulation whilst supported on ECMO starting from the time of 
cannulation when the great vessels (artery and vein) on the right side of neck are 
ligated for cannulation. Multichannel Near infrared spectroscopy (NIRS) offers the 
advantage of a continuous, non-invasive monitoring of regional cerebral 
oxyhaemoglobin concentration (HbO2). The analysis presented in this chapter 
showed a relationship between WCC and ECMO flow in the grouped data of 6 
patients. These differences were statistically significant between right and left 
hemispheres, especially when the flows were weaned sequentially by 10 and 20% of 
the baseline. Further more studies are necessary to elucidate this relationship and to 
understand regional differences in cerebral autoregulation during different clinical 
states on ECMO. 
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Chapter 8 
 
CONCLUSIONS AND FURTHER WORK 
 
 
 
 
 
 
8.1 Introduction 
Infants and children placed on extracorporeal membrane oxygenation (ECMO) 
for cardiorespiratory failure are at risk of developing neurological injuries. The 
causes are multifactorial and are not yet fully understood. They can be associated 
both to pre-ECMO events and to the ECMO procedure itself.  Most ECMO 
candidates suffer from hypoxemia, acidosis, hypercarbia and hypotension (Bulas & 
Glass 2005). Hypotension before or during ECMO may result in cerebral ischemia. 
Diminished pulsatility and blood pressure fluctuations affect cerebral blood flow. All 
these physiological changes can disrupt cerebral autoregulation leaving the cerebral 
microcirculation vulnerable to alterations in systemic blood pressure (Barlett 2006). 
Ligation of the major vessels in the neck-right common carotid artery and internal 
jugular vein-may cause lateralising cerebrovascular injuries.   
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The understanding of the origin and early detection of neurological dysfunction 
in this group of patients is highly significant. Near infrared spectroscopy offers a 
non-invasive, continuous real-time measurement of cerebral oxygenation. To date, 
there are only a few studies reporting of the use of this technology in this patient 
population. Moreover, all studies use commercially available single or dual channel 
NIRS systems and report only on absolute changes in haemoglobin concentrations or 
tissue oxygen saturation mainly during vessel ligation and induction of ECMO. 
The work presented in this thesis describes the successful development and 
effective use of a multichannel NIRS system to monitor multisite cerebral 
oxygenation in patients supported on ECMO. Wavelet cross-correlation was 
generated as a novel method of analysis to investigate regional variations in cerebral 
oxygenation and assess cerebral autoregulation. The results of the work reported 
herein indicate that wavelet cross-correlation applied on multichannel NIRS can be 
used to investigate the dynamics of cerebral autoregulation during ECMO which may 
potentially have an important bearing on clinical outcome.  
 
8.2 Summary and Concluding work on this thesis 
The protocol was designed by the clinical team of the neonatal intensive care unit 
(NICU) in Great Ormond Street Hospital (GOSH) and included the use of NIRS to 
monitor all VA and VV ECMO candidates during routine ECMO procedures such as 
cannulation, weaning and decannulation and during interventions such as alterations 
in ECMO flows, CO2 challenge and temperature challenge. ECMO candidates are 
critically ill and in fact the ECMO support is used as their last resort. While on 
ECMO these patients require intense bedside management with two specifically 
trained nurses per bed. Obtaining ethics approval was not trivial and also, obtaining 
parental consent was particularly challenging.  
In the first instance, the intention was to investigate the feasibility of establishing 
this type of protocol. Hence, initially, a well clinically established NIRS instrument, 
the dual-channel NIRO-200, was used to obtain a series of pilot data. Even though 
the aim was to follow the complete protocol with every patient this was not 
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achievable in practice. The temperature and CO2 challenges were attempted only 
once, on different patients. Due to the complex physiology of the ECMO circuit it 
was particularly difficult to induce changes in both these parameters and these two 
interventions were excluded from the protocol. In addition, being the last on the list 
to be informed and the last on the list to have access on the unit, it was difficult to be 
available for non scheduled acute procedures such as cannulation, weaning and 
decannulation. Furthermore, it was particularly difficult to single handle monitoring 
in such a busy intense environment.  
The protocol also included multimodal data collection simultaneously with NIRS 
parameters which included systemic parameters (arterial pressure [ABP], central 
venous pressure [CVP], arterial saturation [SpO2], end-tidal CO2, heart rate [HR] and 
respiration rate [RR]) and ECMO parameters (venous saturation [SvO2], arterial 
saturation measured at the arterial cannula [SaO2], hematocrit and ECMO flow). The 
integration of the optical systems with established monitoring was not straight 
forward. The instrumentation used, especially the multichannel system, was not 
optimised for this setting and significant part of the work was spent in creating an 
environment where these measurements could be feasible.  
The initial stage of the project involved the use of a dual-channel NIRS system 
(NIRO-200, Hamamatsu, Japan) to monitor cerebral and peripheral (calf muscle) 
tissue oxygenation. A total of 8 patients were monitored using the dual channel 
system. This was a rather inhomogeneous sample, consisting of patients supported on 
both VA and VV ECMO, operating either on centrifugal or roller pumps and with a 
wide age range (from 1 day to 5 years). Varying baseline levels of oxygenation 
(tissue oxygenation index) were observed between individual patients. In addition, 
variability in the trends of other NIRS parameters (HbO2, HHb and HbT) were also 
observed. The small sample size in combination with the diverse population studied 
made it impractical to formulate group observations by investigating trends or 
absolute changes in NIRS parameters.  
However, this pilot data from the dual channel system were used to investigate 
spectral analysis tools, using Fourier transforms, reported widely in the literature (De 
Smet et al 2009, Tachtsidis et al 2004, Tsuji et al 2000, Wong et al 2008). Power 
spectral density was used to investigate the presence of oscillations in cerebral and 
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peripheral circulations. PSD plots were obtained for the brain and leg data during 
changes in the ECMO flows and revealed the presence of oscillations in four 
frequency bands - (very low (VLF) 0.002-0.25 Hz, low (LF) 0.25-0.5 Hz, high (HF) 
0.5-1 Hz and very high (VHF) 1-3 Hz). Oscillations within each of these frequency 
bands could correspond to skin vasomotion, respiratory rate, mechanical oscillation 
related to the roller ECMO pump and heart rate, respectively (Papademetriou et al. 
2010). Coherence analysis was used to investigate the concordance between NIRS 
parameters and MAP as a means of assessing cerebral autoregulation. The 
intersubject variability found in the measurements of power spectra made it hard to 
obtain a direct comparison between the two measurement sites. In addition, analysis 
methods using Fourier transforms require high sampling frequncy and a long signal 
in order to resolve frequencies in the lower range. Increasing the frequency 
resolution in both power spectra and coherence resulted in low signal-to-noise ratio 
making it diffucult to obtain peaks in the frequncy range of interest. Futhermore, the 
Fourier transform of the signal yields a function that depends only on frequency. 
This distinction becomes important since the relation between MAP and NIRS 
parameters (or CBF surrogates) is a non-stationary stochastic process, in which case 
the frequency spectrum of the signals changes over time. The coherence analysis 
suffers from the big drawback of averaging out all the potential useful time 
information, hence treating cerebral autoragulation as a stationary, linear process. 
In assessing the role of NIRS monitoring, it is important to emphasize its unique 
qualities, including non-invasive, continuous real-time measurement of regional 
tissue oxygen saturation. However, caution must be exercised in extrapolating 
regional measurements to global findings. For example, alterations in regional 
oxygen saturation may reflect local changes and not necessarily indicate global 
hypoperfusion. The fact that only regional information in cerebral oxygenation can 
be obtained from the current commercial NIRS in clinical use is considered a major 
limitation by a number of review papers (Andropoulos et al. 2004b, Hirsch et al. 
2010, Su & Undar 2010). 
A multichannel NIRS system (Optical Topography, ETG-100, Hitachi Medical 
Ltd., Japan) was developed for clinical use. The specific instrument was designed for 
functional activation studies in adults. Adapting the instrument and software of the 
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system for use in a paediatric intensive care environment was not an easy task. 
Designing and constructing the multichannel neonatal cap was one of the biggest 
challenges of the project. Testing the cap in patients where access is restricted by the 
surgically positioned cannulae was particularly complex. Individual specific 
approach was required in these vulnerable patients in whom even a small head 
movement can be catastrophic. A novel flexible neonatal cap was designed and 
constructed to house a 3 x 3 array of sources and detectors (interoptode distance = 30 
mm).  This configuration allowed HbO2, HHb and HbT concentrations to be 
collected from a total of 12 channels. The desirable fitting of the cap was achieved 
by the use of dummy heads obtained from informed MRI scans of real patients. A 
major limitation of this system was the fact that the intensity of the laser sources 
could not be controlled automatically as a result data were lost from patients with 
thick hair or too transparent.  
Some general observations could be made for the 6 patients monitored during 
alterations in the ECMO flows. Significant changes in systemic oxygenation 
parameters and cerebral haemoglobin concentrations in response to changes in 
ECMO flows were observed. A major drop in SvO2 (~20%) could be associated with 
a considerable increase in HHb and a moderate change in HbO2 across all channels.  
Even though the trends in the NIRS haemoglobin concentration parameters might 
indicate variations in regional cerebral oxygenation, it was practically impossible to 
address them by simply relying on the absolute changes in the signals.  
A novel method of analysis was generated to investigate regional variations in 
cerebral oxygenation and potentially assess cerebral autoregulation. Wavelet cross-
correlation (WCC) between MAP and multisite cerebral HbO2, across 12 channels, 
was computed for 6 neonates supported on veno-arterial (VA) ECMO during 
sequential changes in the ECMO flow. The wavelet cross-correlation (WCC) 
analysis showed the existence of three peaks, the first at a scale corresponding to a 
frequency around 0.33Hz, the second at a frequency around 0.16 Hz and the third at 
a frequency around 0.1 Hz which could correspond to respiration rate (RR), 
ventilation rate (VR) and Mayer-waves, respectively. The maximum wavelet cross-
correlation, WCCmax, within three scale bands around the three frequency peaks were 
obtained for each ECMO flow period and each channel.  Group data showed that 
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WCCmax appears to be increasing with decreasing ECMO flow. High WCC (>0.5 by 
convention) indicates that any changes in MAP are mirrored in blood flow, i.e. 
cerebral blood flow is pressure passive, suggesting that cerebral autoregulation 
maybe impaired. Regional variations in WCC were observed between channels 
potentially placed in the right parietal lobe and left parietal lobes with channels on 
the right exhibiting higher values of WCC. Outcome and follow up of neonates 
treated with ECMO have shown that ECMO survivors are likely to have medical and 
developmental issues after discharge and tend to be at high risk for learning and/or 
behavioural problems in childhood (Glass & Brown 2005). Attention, memory and 
learning are described as “higher executive brain functions” and are localised in 
specialised regions of the brain known as the “association cortex” where much more 
complex information processing is conducted. The association cortex is part of the 
parietal lobes (Martini 2009). Further work could elucidate whether there is a robust 
link between the regions of the brain where altered WCC were observed and those 
regions associated with long term neurodevelopmental deficit. 
 
8.3 Further work 
The work presented in this thesis describes the successful development of a novel 
multichannel NIRS and multimodal protocol for providing regional measures of 
cerebral oxygenation and haemodynamics in intensive care units with the specific 
application in neonatal and paediatric patients supported on ECMO. Following the 
full clinical protocol, as designed originally, for each patient could potentially help to 
identify the causes of cerebrovascular injuries in this group of patients. It is worth 
considering monitoring these patients when admitted to the intensive care unit prior 
to ECMO induction as well as monitoring when the patient in removed from ECMO 
while still in recovery. Research nurses or clinical research fellows need to be 
recruited for this purpose. The restricted monitoring period and the fact that the 
intensity of the laser sources of the current system cannot be varied via the system‟s 
software are limitations that need to be considered when extending the project 
further. 
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ECMO in the cardiac intensive care unit could be a surrogate model similar to a 
patient undergoing cardiac surgery during cardiopulmonary bypass. Therefore, the 
developed multichannel NIRS protocol can be extended for use in cardiac theatres. 
High rates of ischemic brain injury are the modern challenge to the perioperative 
congenital heart team (Andropoulos et al. 2004b). In the current era of advanced 
paediatric cardiac surgery for the treatment of congenital heart defects there are 
serious limitations with inadequate neuromonitoring, misleading neuromonitoring, or 
both (Nollert et al. 1998).  
The wavelet cross-correlation generated as part of this work is based on the use 
of the continuous wavelet transform. As a result, the developed MatLab codes take a 
long time to generate the results. In addition, WCC is a bivariate method of analysis 
and in this case cerebral circulation was only compared with fluctuations in the 
MAP. However, cerebral circulation is much complex (Panerai et al. 1999). It has 
been suggested that the relation between synchronously measured spontaneous slow 
waves of perfusion pressure and CBF is vulnerable to confounding influences such 
as CO2 changes (Czosnyka et al. 2009). The recently developed Maximal Overlap 
Discrete Wavelet Packet transform has the ability to calculate multivariate systems 
instantaneously and can be used as a method to assess dynamical changes in cerebral 
autoregulation continuously by the bedside (Peng 2008).  
Continuous monitoring seems to be important as autoregulation status may 
change dynamically. The work presented in this thesis describes the development 
and establishment of a non invasive neuromonitoring system which has the prospects 
to assess regional variations in cerebral oxygenation in neonates supported on ECMO 
continuously by the bedside. For such a system to be useful in a clinical environment 
a threshold in the WCC index needs to be established to differentiate between 
patients with impaired and intact autoregulation. Establishing a threshold for such an 
index of autoregulation would appear to hold predictive value with special regard to 
favourable outcome. Consequently, the main objectives of brain monitoring are 
guiding therapeutic interventions, the prediction of outcome and the detection of 
ongoing secondary brain injury following the primary insult.  Ideally, brain 
monitoring should prompt a timely and appropriate intervention and should be 
included in scheduled management protocols.  
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Continuous monitoring seems to be important as autoregulation status may 
change dynamically. The work presented in this thesis describes the development 
and establishment of a non invasive neuromonitoring system which has the prospects 
to assess regional variations in cerebral autoregulation in neonates supported on 
ECMO continuously by the bedside. For such a system to be useful in a clinical 
environment a threshold in the WCC index needs to be established to differentiate 
between patients with impaired and intact autoregulation. Establishing a threshold for 
such an index of autoregulation would appear to hold predictive value with special 
regard to favourable outcome. Consequently, the main objectives of brain monitoring 
are guiding therapeutic interventions, the prediction of outcome and the detection of 
ongoing secondary brain injury following the primary insult.  Further development to 
assign such a threshold in the WCC index might aid clinical management of patients 
supported on ECMO. 
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